US20220381788A1 - Methods of enhancing ms detection of tagged glycans - Google Patents
Methods of enhancing ms detection of tagged glycans Download PDFInfo
- Publication number
- US20220381788A1 US20220381788A1 US17/734,690 US202217734690A US2022381788A1 US 20220381788 A1 US20220381788 A1 US 20220381788A1 US 202217734690 A US202217734690 A US 202217734690A US 2022381788 A1 US2022381788 A1 US 2022381788A1
- Authority
- US
- United States
- Prior art keywords
- glycan
- glycans
- compounds
- acid
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 134
- 238000001514 detection method Methods 0.000 title description 30
- 230000002708 enhancing effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 211
- 150000004676 glycans Chemical class 0.000 claims abstract description 80
- 238000006268 reductive amination reaction Methods 0.000 claims abstract description 44
- -1 hydroxy, amino Chemical group 0.000 claims description 104
- 239000001257 hydrogen Substances 0.000 claims description 75
- 229910052739 hydrogen Inorganic materials 0.000 claims description 75
- 125000000217 alkyl group Chemical group 0.000 claims description 59
- 150000003839 salts Chemical class 0.000 claims description 58
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 49
- 239000012453 solvate Substances 0.000 claims description 48
- 125000003282 alkyl amino group Chemical group 0.000 claims description 47
- 125000001188 haloalkyl group Chemical group 0.000 claims description 45
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 44
- 229910052736 halogen Inorganic materials 0.000 claims description 44
- 150000002367 halogens Chemical class 0.000 claims description 44
- 150000002431 hydrogen Chemical class 0.000 claims description 44
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 42
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 42
- 125000004423 acyloxy group Chemical group 0.000 claims description 42
- 125000003342 alkenyl group Chemical group 0.000 claims description 42
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 42
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 42
- 125000004414 alkyl thio group Chemical group 0.000 claims description 42
- 125000000304 alkynyl group Chemical group 0.000 claims description 42
- 125000003368 amide group Chemical group 0.000 claims description 42
- 125000000262 haloalkenyl group Chemical group 0.000 claims description 42
- 125000000232 haloalkynyl group Chemical group 0.000 claims description 42
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 42
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 42
- 238000004949 mass spectrometry Methods 0.000 claims description 36
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 14
- 238000001077 electron transfer detection Methods 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- 230000002378 acidificating effect Effects 0.000 claims description 10
- 150000001408 amides Chemical class 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 239000004202 carbamide Substances 0.000 claims description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 239000011593 sulfur Substances 0.000 claims description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 8
- 102000003886 Glycoproteins Human genes 0.000 claims description 7
- 108090000288 Glycoproteins Proteins 0.000 claims description 7
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- UQBIAGWOJDEOMN-UHFFFAOYSA-N 2-O-(2-O-(alpha-D-mannopyranosyl)-alpha-D-mannopyranosyl)-D-mannopyranose Natural products OC1C(O)C(CO)OC(O)C1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 UQBIAGWOJDEOMN-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 claims description 3
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims description 3
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 claims description 3
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- YETHWGOYCQLNKG-FHERGOJNSA-N alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@H]1O[C@@H]1[C@@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YETHWGOYCQLNKG-FHERGOJNSA-N 0.000 claims description 3
- LHAOFBCHXGZGOR-NAVBLJQLSA-N alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1 LHAOFBCHXGZGOR-NAVBLJQLSA-N 0.000 claims description 3
- LUEWUZLMQUOBSB-MHJOMNRISA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](OC(O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O LUEWUZLMQUOBSB-MHJOMNRISA-N 0.000 claims description 3
- OCIBBXPLUVYKCH-KKQGKRJZSA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](O[C@@H](O[C@@H]4[C@H](O[C@@H](O[C@@H]5[C@H](OC(O)[C@@H](O)[C@H]5O)CO)[C@@H](O)[C@H]4O)CO)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O OCIBBXPLUVYKCH-KKQGKRJZSA-N 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 3
- 125000001589 carboacyl group Chemical group 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 238000001212 derivatisation Methods 0.000 abstract description 16
- 229920001222 biopolymer Polymers 0.000 abstract description 14
- 102000002068 Glycopeptides Human genes 0.000 description 54
- 108010015899 Glycopeptides Proteins 0.000 description 54
- 150000002500 ions Chemical class 0.000 description 54
- 238000004458 analytical method Methods 0.000 description 51
- 0 C.CN.[3*]C Chemical compound C.CN.[3*]C 0.000 description 43
- 239000003153 chemical reaction reagent Substances 0.000 description 43
- 125000002252 acyl group Chemical group 0.000 description 42
- 108090000765 processed proteins & peptides Proteins 0.000 description 41
- 238000002372 labelling Methods 0.000 description 35
- 238000006243 chemical reaction Methods 0.000 description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 238000004811 liquid chromatography Methods 0.000 description 23
- 239000000203 mixture Substances 0.000 description 23
- 239000000523 sample Substances 0.000 description 23
- 102000004196 processed proteins & peptides Human genes 0.000 description 22
- 238000000926 separation method Methods 0.000 description 19
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 239000002585 base Substances 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 15
- 230000004044 response Effects 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 150000001299 aldehydes Chemical class 0.000 description 12
- 239000003643 water by type Substances 0.000 description 12
- 125000003172 aldehyde group Chemical group 0.000 description 11
- 239000003638 chemical reducing agent Substances 0.000 description 11
- 229920001542 oligosaccharide Polymers 0.000 description 11
- 150000002482 oligosaccharides Chemical class 0.000 description 11
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 241000283690 Bos taurus Species 0.000 description 9
- 229930182474 N-glycoside Natural products 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 9
- 239000007850 fluorescent dye Substances 0.000 description 9
- 150000002341 glycosylamines Chemical class 0.000 description 9
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 8
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 235000011054 acetic acid Nutrition 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 108010066476 ribonuclease B Proteins 0.000 description 8
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 8
- BWBDAEIIXBEFSS-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) n-[2-[2-(diethylamino)ethylcarbamoyl]quinolin-6-yl]carbamate Chemical compound C1=CC2=NC(C(=O)NCCN(CC)CC)=CC=C2C=C1NC(=O)ON1C(=O)CCC1=O BWBDAEIIXBEFSS-UHFFFAOYSA-N 0.000 description 7
- WRZKOALEDCMZNG-UHFFFAOYSA-N CC(C)N(C)C.COC(C)C Chemical compound CC(C)N(C)C.COC(C)C WRZKOALEDCMZNG-UHFFFAOYSA-N 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 238000001215 fluorescent labelling Methods 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 230000013595 glycosylation Effects 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 125000000468 ketone group Chemical group 0.000 description 7
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 7
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 7
- 125000000547 substituted alkyl group Chemical group 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000004429 atom Chemical group 0.000 description 6
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 6
- 238000013467 fragmentation Methods 0.000 description 6
- 238000006062 fragmentation reaction Methods 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 229960000244 procainamide Drugs 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- 230000001268 conjugating effect Effects 0.000 description 5
- 238000000132 electrospray ionisation Methods 0.000 description 5
- 125000004404 heteroalkyl group Chemical group 0.000 description 5
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 5
- 238000001819 mass spectrum Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 150000003141 primary amines Chemical class 0.000 description 5
- 150000003335 secondary amines Chemical class 0.000 description 5
- 241000894007 species Species 0.000 description 5
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 4
- 238000004807 desolvation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 4
- 102000013361 fetuin Human genes 0.000 description 4
- 108060002885 fetuin Proteins 0.000 description 4
- 238000001506 fluorescence spectroscopy Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 150000002772 monosaccharides Chemical group 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XMNGSPOWUCNRMO-UHFFFAOYSA-N CNC(=O)ON1C(=O)CCC1=O Chemical compound CNC(=O)ON1C(=O)CCC1=O XMNGSPOWUCNRMO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- 239000002879 Lewis base Substances 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 229960000956 coumarin Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 150000007527 lewis bases Chemical class 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 3
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 3
- KNYFQPCOTBQKTN-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl)carbamic acid Chemical class OC(=O)NN1C(=O)CCC1=O KNYFQPCOTBQKTN-UHFFFAOYSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- QCXJEYYXVJIFCE-UHFFFAOYSA-N 4-acetamidobenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C=C1 QCXJEYYXVJIFCE-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- SZAXMXCWIORXOL-UHFFFAOYSA-N CCC(=O)CCCN(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=O)CCCN(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN SZAXMXCWIORXOL-UHFFFAOYSA-N 0.000 description 2
- YKSNHWBWIZWIMF-UHFFFAOYSA-N CCCCCN(CC)CC.CN.c1ccccc1 Chemical compound CCCCCN(CC)CC.CN.c1ccccc1 YKSNHWBWIZWIMF-UHFFFAOYSA-N 0.000 description 2
- YGCUAEKLRSJIIA-UHFFFAOYSA-N CCCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 YGCUAEKLRSJIIA-UHFFFAOYSA-N 0.000 description 2
- MERWBSBCSAQQSU-UHFFFAOYSA-N CCCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 MERWBSBCSAQQSU-UHFFFAOYSA-N 0.000 description 2
- FZYQBBWMDMPTJI-UHFFFAOYSA-N CCCCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CCCCCP(=O)(O)O.CN.c1ccccc1 FZYQBBWMDMPTJI-UHFFFAOYSA-N 0.000 description 2
- BIDWDJQZXFPKIP-UHFFFAOYSA-N CCCCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CCCCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 BIDWDJQZXFPKIP-UHFFFAOYSA-N 0.000 description 2
- CDIHAYDXRLUZTE-UHFFFAOYSA-N CCCCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CCCCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 CDIHAYDXRLUZTE-UHFFFAOYSA-N 0.000 description 2
- SUEIMDVPPBGRHQ-UHFFFAOYSA-N CCCCCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CCCCCS(=O)(=O)O.CN.c1ccccc1 SUEIMDVPPBGRHQ-UHFFFAOYSA-N 0.000 description 2
- MWXINAOBTOZGNQ-UHFFFAOYSA-N CCCCNC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CCCCNC(=N)N.CN.c1ccc2ccccc2c1 MWXINAOBTOZGNQ-UHFFFAOYSA-N 0.000 description 2
- VHBCXSHIDYHIKO-UHFFFAOYSA-N CCCCNC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CCCCNC(=N)N.CN.c1ccc2ncccc2c1 VHBCXSHIDYHIKO-UHFFFAOYSA-N 0.000 description 2
- CJNOJWAOYKHAHL-UHFFFAOYSA-N CCCCNC(=N)N.CN.c1ccccc1 Chemical compound CCCCNC(=N)N.CN.c1ccccc1 CJNOJWAOYKHAHL-UHFFFAOYSA-N 0.000 description 2
- JXGDJACLSCOAOA-UHFFFAOYSA-N CCCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 JXGDJACLSCOAOA-UHFFFAOYSA-N 0.000 description 2
- MZQMBINMEWZCID-UHFFFAOYSA-N CCCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 MZQMBINMEWZCID-UHFFFAOYSA-N 0.000 description 2
- QRTNILXLDHUTSW-UHFFFAOYSA-N CCCCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CCCCOP(=O)(O)O.CN.c1ccccc1 QRTNILXLDHUTSW-UHFFFAOYSA-N 0.000 description 2
- FDMPGSHAJZESGB-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCS(=O)(=O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCS(=O)(=O)O FDMPGSHAJZESGB-UHFFFAOYSA-N 0.000 description 2
- XJAKMCDBHQPUDX-UHFFFAOYSA-N CN.COC(=O)CCCCP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)CCCCP(=O)(O)O.c1ccc2ccccc2c1 XJAKMCDBHQPUDX-UHFFFAOYSA-N 0.000 description 2
- QYEGVSQQLVTELC-UHFFFAOYSA-N CN.COCCCP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COCCCP(=O)(O)O.c1ccc2ncccc2c1 QYEGVSQQLVTELC-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000005515 capillary zone electrophoresis Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000001360 collision-induced dissociation Methods 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 125000004982 dihaloalkyl group Chemical group 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 125000004438 haloalkoxy group Chemical group 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 125000006684 polyhaloalkyl group Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BMQVVXZGDNDLEQ-MXGYIUITSA-N *.B.C.CC(C)(C)OC(=O)Nc1ccc2nc(C(=O)O)ccc2c1.CCN(CC)CCN.CCN(CC)CCNC(=O)c1ccc2cc(N)ccc2n1.CCN(CC)CCNC(=O)c1ccc2cc(NC(=O)OC(C)(C)C)ccc2n1.Nc1ccc2nc(C(=O)O)ccc2c1.[2HH] Chemical compound *.B.C.CC(C)(C)OC(=O)Nc1ccc2nc(C(=O)O)ccc2c1.CCN(CC)CCN.CCN(CC)CCNC(=O)c1ccc2cc(N)ccc2n1.CCN(CC)CCNC(=O)c1ccc2cc(NC(=O)OC(C)(C)C)ccc2n1.Nc1ccc2nc(C(=O)O)ccc2c1.[2HH] BMQVVXZGDNDLEQ-MXGYIUITSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 description 1
- IGERFAHWSHDDHX-UHFFFAOYSA-N 1,3-dioxanyl Chemical group [CH]1OCCCO1 IGERFAHWSHDDHX-UHFFFAOYSA-N 0.000 description 1
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 101000856746 Bos taurus Cytochrome c oxidase subunit 7A1, mitochondrial Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- IHZWIZLRGYYWKA-UHFFFAOYSA-N CC(=O)CCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)CCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN IHZWIZLRGYYWKA-UHFFFAOYSA-N 0.000 description 1
- FFTQTGOFGFNLCQ-UHFFFAOYSA-N CC(=O)CCCCC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)CCCCC(=N)N.CN.c1ccc2ccccc2c1 FFTQTGOFGFNLCQ-UHFFFAOYSA-N 0.000 description 1
- IWWSKIIBOXFRAJ-UHFFFAOYSA-N CC(=O)CCCCC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)CCCCC(=N)N.CN.c1ccc2ncccc2c1 IWWSKIIBOXFRAJ-UHFFFAOYSA-N 0.000 description 1
- WWDQSSBYQCBQBQ-UHFFFAOYSA-N CC(=O)CCCCC(=N)N.CN.c1ccccc1 Chemical compound CC(=O)CCCCC(=N)N.CN.c1ccccc1 WWDQSSBYQCBQBQ-UHFFFAOYSA-N 0.000 description 1
- JIXXCYHUOHNZNW-UHFFFAOYSA-N CC(=O)CCCCCC(=N)N.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCCCCC(=N)N.CN.O=c1ccc2ccccc2o1 JIXXCYHUOHNZNW-UHFFFAOYSA-N 0.000 description 1
- FCVMXIQBPKFMBU-UHFFFAOYSA-N CC(=O)CCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 FCVMXIQBPKFMBU-UHFFFAOYSA-N 0.000 description 1
- PIHWDPOJSBWDBX-UHFFFAOYSA-N CC(=O)CCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)CCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 PIHWDPOJSBWDBX-UHFFFAOYSA-N 0.000 description 1
- ORWTUKRJEPUTCR-UHFFFAOYSA-N CC(=O)CCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)CCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN ORWTUKRJEPUTCR-UHFFFAOYSA-N 0.000 description 1
- RDPHVEMQOUVLMH-UHFFFAOYSA-N CC(=O)CCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 RDPHVEMQOUVLMH-UHFFFAOYSA-N 0.000 description 1
- GAGRDILOBQJXCW-UHFFFAOYSA-N CC(=O)CCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)CCCP(=O)(O)O.CN.c1ccccc1 GAGRDILOBQJXCW-UHFFFAOYSA-N 0.000 description 1
- CIVUCCSEJWNGQF-UHFFFAOYSA-N CC(=O)CCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 CIVUCCSEJWNGQF-UHFFFAOYSA-N 0.000 description 1
- FHRVLHWLVJIMMD-UHFFFAOYSA-N CC(=O)CCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)CCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 FHRVLHWLVJIMMD-UHFFFAOYSA-N 0.000 description 1
- GUXICLUXJJQACO-UHFFFAOYSA-N CC(=O)CCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)CCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 GUXICLUXJJQACO-UHFFFAOYSA-N 0.000 description 1
- YXTJNDCFVDRSQV-UHFFFAOYSA-N CC(=O)CCNC(=N)N.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCNC(=N)N.CN.O=c1ccc2ccccc2o1 YXTJNDCFVDRSQV-UHFFFAOYSA-N 0.000 description 1
- RRQCWEXFUWWQIN-UHFFFAOYSA-N CC(=O)CCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)CCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN RRQCWEXFUWWQIN-UHFFFAOYSA-N 0.000 description 1
- SLGFJNTYYPKIQV-UHFFFAOYSA-N CC(=O)CCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 SLGFJNTYYPKIQV-UHFFFAOYSA-N 0.000 description 1
- PUPCHKSZPPOOHH-UHFFFAOYSA-N CC(=O)CCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)CCOP(=O)(O)O.CN.c1ccccc1 PUPCHKSZPPOOHH-UHFFFAOYSA-N 0.000 description 1
- HHUOJHQXSFIWQW-UHFFFAOYSA-N CC(=O)CCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)CCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN HHUOJHQXSFIWQW-UHFFFAOYSA-N 0.000 description 1
- ZVSVIEZZWMHXDI-UHFFFAOYSA-N CC(=O)CCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)CCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 ZVSVIEZZWMHXDI-UHFFFAOYSA-N 0.000 description 1
- AZDGYWXFIGCEJB-UHFFFAOYSA-N CC(=O)CCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CC(=O)CCS(=O)(=O)O.CN.c1ccccc1 AZDGYWXFIGCEJB-UHFFFAOYSA-N 0.000 description 1
- OJLDCUIRBOQUFG-UHFFFAOYSA-N CC(=O)NCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)NCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN OJLDCUIRBOQUFG-UHFFFAOYSA-N 0.000 description 1
- CRWHYFVCUXADHE-UHFFFAOYSA-N CC(=O)NCCCC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)NCCCC(=N)N.CN.c1ccc2ccccc2c1 CRWHYFVCUXADHE-UHFFFAOYSA-N 0.000 description 1
- YYYNEIBVIDQTNP-UHFFFAOYSA-N CC(=O)NCCCC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)NCCCC(=N)N.CN.c1ccc2ncccc2c1 YYYNEIBVIDQTNP-UHFFFAOYSA-N 0.000 description 1
- HHHQIJMIJRFVQG-UHFFFAOYSA-N CC(=O)NCCCC(=N)N.CN.c1ccccc1 Chemical compound CC(=O)NCCCC(=N)N.CN.c1ccccc1 HHHQIJMIJRFVQG-UHFFFAOYSA-N 0.000 description 1
- IGPXNEQAANOJQN-UHFFFAOYSA-N CC(=O)NCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)NCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN IGPXNEQAANOJQN-UHFFFAOYSA-N 0.000 description 1
- GJSCJELKOGKIRS-UHFFFAOYSA-N CC(=O)NCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)NCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 GJSCJELKOGKIRS-UHFFFAOYSA-N 0.000 description 1
- JQIOFVBRDZIMAH-UHFFFAOYSA-N CC(=O)NCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)NCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 JQIOFVBRDZIMAH-UHFFFAOYSA-N 0.000 description 1
- RFKRDEAFJLXAHO-UHFFFAOYSA-N CC(=O)NCCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)NCCCP(=O)(O)O.CN.c1ccccc1 RFKRDEAFJLXAHO-UHFFFAOYSA-N 0.000 description 1
- VDEBICQCYDRTRX-UHFFFAOYSA-N CC(=O)NCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)NCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN VDEBICQCYDRTRX-UHFFFAOYSA-N 0.000 description 1
- YKEDITVIJADLAV-UHFFFAOYSA-N CC(=O)NCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)NCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 YKEDITVIJADLAV-UHFFFAOYSA-N 0.000 description 1
- KQUALGGUCAEXAN-UHFFFAOYSA-N CC(=O)NCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)NCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 KQUALGGUCAEXAN-UHFFFAOYSA-N 0.000 description 1
- MFNYMNBIVPGDJT-UHFFFAOYSA-N CC(=O)NCCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)NCCOP(=O)(O)O.CN.c1ccccc1 MFNYMNBIVPGDJT-UHFFFAOYSA-N 0.000 description 1
- QLZLXWBUPMPXIY-UHFFFAOYSA-N CC(=O)NCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)NCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN QLZLXWBUPMPXIY-UHFFFAOYSA-N 0.000 description 1
- WZIJUZJYYDWROI-UHFFFAOYSA-N CC(=O)NCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)NCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 WZIJUZJYYDWROI-UHFFFAOYSA-N 0.000 description 1
- GCUSHVGJDRUWDI-UHFFFAOYSA-N CC(=O)NCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)NCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 GCUSHVGJDRUWDI-UHFFFAOYSA-N 0.000 description 1
- CFWIMAUNZIANAQ-UHFFFAOYSA-N CC(=O)NCCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CC(=O)NCCS(=O)(=O)O.CN.c1ccccc1 CFWIMAUNZIANAQ-UHFFFAOYSA-N 0.000 description 1
- XHWIBTSJIFCCDN-UHFFFAOYSA-N CC(=O)OCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)OCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN XHWIBTSJIFCCDN-UHFFFAOYSA-N 0.000 description 1
- NVWNVTKHEPACMZ-UHFFFAOYSA-N CC(=O)OCCCC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)OCCCC(=N)N.CN.c1ccc2ccccc2c1 NVWNVTKHEPACMZ-UHFFFAOYSA-N 0.000 description 1
- AIENPMDPRNPTMX-UHFFFAOYSA-N CC(=O)OCCCC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)OCCCC(=N)N.CN.c1ccc2ncccc2c1 AIENPMDPRNPTMX-UHFFFAOYSA-N 0.000 description 1
- KDRQABQFTAAPRQ-UHFFFAOYSA-N CC(=O)OCCCC(=N)N.CN.c1ccccc1 Chemical compound CC(=O)OCCCC(=N)N.CN.c1ccccc1 KDRQABQFTAAPRQ-UHFFFAOYSA-N 0.000 description 1
- SJLIYUJIVAEDLN-UHFFFAOYSA-N CC(=O)OCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)OCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN SJLIYUJIVAEDLN-UHFFFAOYSA-N 0.000 description 1
- YCHPYJXEFQWLEQ-UHFFFAOYSA-N CC(=O)OCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)OCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 YCHPYJXEFQWLEQ-UHFFFAOYSA-N 0.000 description 1
- DWDKOMBSSXMLPS-UHFFFAOYSA-N CC(=O)OCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)OCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 DWDKOMBSSXMLPS-UHFFFAOYSA-N 0.000 description 1
- YKGQWEKGYWCMQN-UHFFFAOYSA-N CC(=O)OCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)OCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 YKGQWEKGYWCMQN-UHFFFAOYSA-N 0.000 description 1
- BDRACCQXIIYVQC-UHFFFAOYSA-N CC(=O)OCCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)OCCCP(=O)(O)O.CN.c1ccccc1 BDRACCQXIIYVQC-UHFFFAOYSA-N 0.000 description 1
- XOCHNWLDJKQUSV-UHFFFAOYSA-N CC(=O)OCCNC(=N)N.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)OCCNC(=N)N.CN.O=c1ccc2ccccc2o1 XOCHNWLDJKQUSV-UHFFFAOYSA-N 0.000 description 1
- WLDOOTMEDVOOQM-UHFFFAOYSA-N CC(=O)OCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)OCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN WLDOOTMEDVOOQM-UHFFFAOYSA-N 0.000 description 1
- HBQLIKLZQCNVBA-UHFFFAOYSA-N CC(=O)OCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)OCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 HBQLIKLZQCNVBA-UHFFFAOYSA-N 0.000 description 1
- WNEDICCILQZVBI-UHFFFAOYSA-N CC(=O)OCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)OCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 WNEDICCILQZVBI-UHFFFAOYSA-N 0.000 description 1
- IMUNKAQMIFMARF-UHFFFAOYSA-N CC(=O)OCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)OCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 IMUNKAQMIFMARF-UHFFFAOYSA-N 0.000 description 1
- ABJJLDVILVDCPR-UHFFFAOYSA-N CC(=O)OCCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CC(=O)OCCOP(=O)(O)O.CN.c1ccccc1 ABJJLDVILVDCPR-UHFFFAOYSA-N 0.000 description 1
- YXAHDDMYPMZVSS-UHFFFAOYSA-N CC(=O)OCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CC(=O)OCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN YXAHDDMYPMZVSS-UHFFFAOYSA-N 0.000 description 1
- JBTHKNXRRLGOOT-UHFFFAOYSA-N CC(=O)OCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CC(=O)OCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 JBTHKNXRRLGOOT-UHFFFAOYSA-N 0.000 description 1
- STDVBLZMMVYSIC-UHFFFAOYSA-N CC(=O)OCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CC(=O)OCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 STDVBLZMMVYSIC-UHFFFAOYSA-N 0.000 description 1
- PAERGRRIRNAIPV-UHFFFAOYSA-N CC(=O)OCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CC(=O)OCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 PAERGRRIRNAIPV-UHFFFAOYSA-N 0.000 description 1
- PEKFSLQWOISZHN-UHFFFAOYSA-N CC(=O)OCCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CC(=O)OCCS(=O)(=O)O.CN.c1ccccc1 PEKFSLQWOISZHN-UHFFFAOYSA-N 0.000 description 1
- YFHARBHAQXVGJZ-UHFFFAOYSA-N CC(C)=[N+](C)C Chemical compound CC(C)=[N+](C)C YFHARBHAQXVGJZ-UHFFFAOYSA-N 0.000 description 1
- FMNDZDUIJSHXRA-UHFFFAOYSA-N CC(C)OP(C)(=O)O.CC(C)P(C)(=O)O.CC(C)S(C)(=O)=O Chemical compound CC(C)OP(C)(=O)O.CC(C)P(C)(=O)O.CC(C)S(C)(=O)=O FMNDZDUIJSHXRA-UHFFFAOYSA-N 0.000 description 1
- KSMNZQVPQSEHFX-UHFFFAOYSA-N CCC(=O)CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=O)CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN KSMNZQVPQSEHFX-UHFFFAOYSA-N 0.000 description 1
- XPXMDKRORDLOGW-UHFFFAOYSA-N CCC(=O)CCCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=O)CCCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN XPXMDKRORDLOGW-UHFFFAOYSA-N 0.000 description 1
- RMMOLFGFXKPBQY-UHFFFAOYSA-N CCC(=O)CCCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=O)CCCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN RMMOLFGFXKPBQY-UHFFFAOYSA-N 0.000 description 1
- KIWZDXPAAAWLNW-UHFFFAOYSA-N CCC(=O)CCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=O)CCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 KIWZDXPAAAWLNW-UHFFFAOYSA-N 0.000 description 1
- YHLGIQLHOCGUPA-UHFFFAOYSA-N CCC(=O)CCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=O)CCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 YHLGIQLHOCGUPA-UHFFFAOYSA-N 0.000 description 1
- QYODWBJSRLIKKA-UHFFFAOYSA-N CCC(=O)CCCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CCC(=O)CCCCP(=O)(O)O.CN.c1ccccc1 QYODWBJSRLIKKA-UHFFFAOYSA-N 0.000 description 1
- CTOAIZQMYFIAKF-UHFFFAOYSA-N CCC(=O)CCCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=O)CCCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 CTOAIZQMYFIAKF-UHFFFAOYSA-N 0.000 description 1
- WXYIFZDTNZYSMY-UHFFFAOYSA-N CCC(=O)CCCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=O)CCCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 WXYIFZDTNZYSMY-UHFFFAOYSA-N 0.000 description 1
- UXFTZXFCRXISNH-UHFFFAOYSA-N CCC(=O)CCCCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CCC(=O)CCCCS(=O)(=O)O.CN.c1ccccc1 UXFTZXFCRXISNH-UHFFFAOYSA-N 0.000 description 1
- GXKGODDTAIKOGA-UHFFFAOYSA-N CCC(=O)CCCN(CC)CC.CN.c1ccc2ccccc2c1 Chemical compound CCC(=O)CCCN(CC)CC.CN.c1ccc2ccccc2c1 GXKGODDTAIKOGA-UHFFFAOYSA-N 0.000 description 1
- KPILNNYKXXFZJR-UHFFFAOYSA-N CCC(=O)CCCN(CC)CC.CN.c1ccc2ncccc2c1 Chemical compound CCC(=O)CCCN(CC)CC.CN.c1ccc2ncccc2c1 KPILNNYKXXFZJR-UHFFFAOYSA-N 0.000 description 1
- RTHJBNHGFLNXMZ-UHFFFAOYSA-N CCC(=O)CCCN(CC)CC.CN.c1ccccc1 Chemical compound CCC(=O)CCCN(CC)CC.CN.c1ccccc1 RTHJBNHGFLNXMZ-UHFFFAOYSA-N 0.000 description 1
- WVACBJAIJOXTLX-UHFFFAOYSA-N CCC(=O)CCCNC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CCC(=O)CCCNC(=N)N.CN.c1ccc2ccccc2c1 WVACBJAIJOXTLX-UHFFFAOYSA-N 0.000 description 1
- RCIKITAVIYFWGF-UHFFFAOYSA-N CCC(=O)CCCNC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CCC(=O)CCCNC(=N)N.CN.c1ccc2ncccc2c1 RCIKITAVIYFWGF-UHFFFAOYSA-N 0.000 description 1
- RETGXVFVOQRFIR-UHFFFAOYSA-N CCC(=O)CCCNC(=N)N.CN.c1ccccc1 Chemical compound CCC(=O)CCCNC(=N)N.CN.c1ccccc1 RETGXVFVOQRFIR-UHFFFAOYSA-N 0.000 description 1
- YDEIQRWRVZFFEM-UHFFFAOYSA-N CCC(=O)CCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=O)CCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 YDEIQRWRVZFFEM-UHFFFAOYSA-N 0.000 description 1
- YTXPRSRRDKNIQD-UHFFFAOYSA-N CCC(=O)CCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=O)CCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 YTXPRSRRDKNIQD-UHFFFAOYSA-N 0.000 description 1
- HJZZJFOAJATZSY-UHFFFAOYSA-N CCC(=O)CCCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CCC(=O)CCCOP(=O)(O)O.CN.c1ccccc1 HJZZJFOAJATZSY-UHFFFAOYSA-N 0.000 description 1
- APZMBJVFJSAXSC-UHFFFAOYSA-N CCC(=O)CCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=O)CCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN APZMBJVFJSAXSC-UHFFFAOYSA-N 0.000 description 1
- IDSCAHQDRAZJQC-UHFFFAOYSA-N CCC(=S)CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=S)CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN IDSCAHQDRAZJQC-UHFFFAOYSA-N 0.000 description 1
- WPBRZTJIONJNIW-UHFFFAOYSA-N CCC(=S)CCCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=S)CCCCCP(=O)(O)O.CN.c1ccc2ccccc2c1 WPBRZTJIONJNIW-UHFFFAOYSA-N 0.000 description 1
- LEXUESHCSMECMN-UHFFFAOYSA-N CCC(=S)CCCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=S)CCCCCP(=O)(O)O.CN.c1ccc2ncccc2c1 LEXUESHCSMECMN-UHFFFAOYSA-N 0.000 description 1
- CVJZSODOHLVKBK-UHFFFAOYSA-N CCC(=S)CCCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=S)CCCCOP(=O)(O)O.CN.c1ccc2ccccc2c1 CVJZSODOHLVKBK-UHFFFAOYSA-N 0.000 description 1
- AINWDKVVLVQFAB-UHFFFAOYSA-N CCC(=S)CCCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=S)CCCCOP(=O)(O)O.CN.c1ccc2ncccc2c1 AINWDKVVLVQFAB-UHFFFAOYSA-N 0.000 description 1
- LUEVTVMHAMPDCL-UHFFFAOYSA-N CCC(=S)CCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=S)CCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN LUEVTVMHAMPDCL-UHFFFAOYSA-N 0.000 description 1
- LTYJCMXVLNMOGF-UHFFFAOYSA-N CCC(=S)CCCCP(=O)(O)O.CN.c1ccccc1 Chemical compound CCC(=S)CCCCP(=O)(O)O.CN.c1ccccc1 LTYJCMXVLNMOGF-UHFFFAOYSA-N 0.000 description 1
- FTPCHSURQXQUTQ-UHFFFAOYSA-N CCC(=S)CCCN(CC)CC.CN.c1ccc2ccccc2c1 Chemical compound CCC(=S)CCCN(CC)CC.CN.c1ccc2ccccc2c1 FTPCHSURQXQUTQ-UHFFFAOYSA-N 0.000 description 1
- IAFWEFDEZGMEGL-UHFFFAOYSA-N CCC(=S)CCCN(CC)CC.CN.c1ccc2ncccc2c1 Chemical compound CCC(=S)CCCN(CC)CC.CN.c1ccc2ncccc2c1 IAFWEFDEZGMEGL-UHFFFAOYSA-N 0.000 description 1
- FEONGORVKRVFJB-UHFFFAOYSA-N CCC(=S)CCCN(CC)CC.CN.c1ccccc1 Chemical compound CCC(=S)CCCN(CC)CC.CN.c1ccccc1 FEONGORVKRVFJB-UHFFFAOYSA-N 0.000 description 1
- NETPJRDLUPPKQZ-UHFFFAOYSA-N CCC(=S)CCCNC(=N)N.CN.c1ccc2ccccc2c1 Chemical compound CCC(=S)CCCNC(=N)N.CN.c1ccc2ccccc2c1 NETPJRDLUPPKQZ-UHFFFAOYSA-N 0.000 description 1
- SZPWMIORERVWLW-UHFFFAOYSA-N CCC(=S)CCCNC(=N)N.CN.c1ccc2ncccc2c1 Chemical compound CCC(=S)CCCNC(=N)N.CN.c1ccc2ncccc2c1 SZPWMIORERVWLW-UHFFFAOYSA-N 0.000 description 1
- YKTHNKDYCPBAHW-UHFFFAOYSA-N CCC(=S)CCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=S)CCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN YKTHNKDYCPBAHW-UHFFFAOYSA-N 0.000 description 1
- AMKIOIIQQOGYRC-UHFFFAOYSA-N CCC(=S)CCCOP(=O)(O)O.CN.c1ccccc1 Chemical compound CCC(=S)CCCOP(=O)(O)O.CN.c1ccccc1 AMKIOIIQQOGYRC-UHFFFAOYSA-N 0.000 description 1
- ZDOXCZHOPBUMLT-UHFFFAOYSA-N CCC(=S)CCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCC(=S)CCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN ZDOXCZHOPBUMLT-UHFFFAOYSA-N 0.000 description 1
- VEOLWYRCZFLMQP-UHFFFAOYSA-N CCC(=S)CCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 Chemical compound CCC(=S)CCCS(=O)(=O)O.CN.c1ccc2ccccc2c1 VEOLWYRCZFLMQP-UHFFFAOYSA-N 0.000 description 1
- GMFQQBONKXLGMK-UHFFFAOYSA-N CCC(=S)CCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 Chemical compound CCC(=S)CCCS(=O)(=O)O.CN.c1ccc2ncccc2c1 GMFQQBONKXLGMK-UHFFFAOYSA-N 0.000 description 1
- OVJFUIDMIVRKEY-UHFFFAOYSA-N CCC(=S)CCCS(=O)(=O)O.CN.c1ccccc1 Chemical compound CCC(=S)CCCS(=O)(=O)O.CN.c1ccccc1 OVJFUIDMIVRKEY-UHFFFAOYSA-N 0.000 description 1
- KLZXVCMVILOBQT-UHFFFAOYSA-N CCC(CC)CCCCC(=S)OC.CN.c1ccc2ncccc2c1 Chemical compound CCC(CC)CCCCC(=S)OC.CN.c1ccc2ncccc2c1 KLZXVCMVILOBQT-UHFFFAOYSA-N 0.000 description 1
- HTTPJNZPCAIUHV-UHFFFAOYSA-N CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN HTTPJNZPCAIUHV-UHFFFAOYSA-N 0.000 description 1
- CHAAISFKAUKHIT-UHFFFAOYSA-N CCCCCC(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCCC(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN CHAAISFKAUKHIT-UHFFFAOYSA-N 0.000 description 1
- CJQPUNUGGFPXIX-UHFFFAOYSA-N CCCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCCCC(=N)N.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN CJQPUNUGGFPXIX-UHFFFAOYSA-N 0.000 description 1
- WNVXIYFQFAOSFQ-UHFFFAOYSA-N CCCCCN(CC)CC.CN.c1ccc2ccccc2c1 Chemical compound CCCCCN(CC)CC.CN.c1ccc2ccccc2c1 WNVXIYFQFAOSFQ-UHFFFAOYSA-N 0.000 description 1
- SSZQAXNYEBNBAY-UHFFFAOYSA-N CCCCCN(CC)CC.CN.c1ccc2ncccc2c1 Chemical compound CCCCCN(CC)CC.CN.c1ccc2ncccc2c1 SSZQAXNYEBNBAY-UHFFFAOYSA-N 0.000 description 1
- PQLJFAPJXVOKPM-UHFFFAOYSA-N CCCCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CCCCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 PQLJFAPJXVOKPM-UHFFFAOYSA-N 0.000 description 1
- KENHJDJVBRHNEM-UHFFFAOYSA-N CCCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN KENHJDJVBRHNEM-UHFFFAOYSA-N 0.000 description 1
- CMNDKRKAPHKHSO-UHFFFAOYSA-N CCCCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN CMNDKRKAPHKHSO-UHFFFAOYSA-N 0.000 description 1
- MNXJQPJFPWGAQH-UHFFFAOYSA-N CCCCN(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCN(CC)CC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN MNXJQPJFPWGAQH-UHFFFAOYSA-N 0.000 description 1
- PDDBYWCBFLMCGE-UHFFFAOYSA-N CCCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN PDDBYWCBFLMCGE-UHFFFAOYSA-N 0.000 description 1
- HIRHDMOOSABLET-UHFFFAOYSA-N CCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN HIRHDMOOSABLET-UHFFFAOYSA-N 0.000 description 1
- OGFFUWNYBZVENH-UHFFFAOYSA-N CCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CCCCP(=O)(O)O.CN.O=c1ccc2ccccc2o1 OGFFUWNYBZVENH-UHFFFAOYSA-N 0.000 description 1
- GDQJINLWMNRBIB-UHFFFAOYSA-N CCCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCCS(=O)(=O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN GDQJINLWMNRBIB-UHFFFAOYSA-N 0.000 description 1
- QPUNMKXZRIAIRT-UHFFFAOYSA-N CCCN(CC)CC.CN.O=c1ccc2ccccc2o1 Chemical compound CCCN(CC)CC.CN.O=c1ccc2ccccc2o1 QPUNMKXZRIAIRT-UHFFFAOYSA-N 0.000 description 1
- QEVRLKRIDJMLTI-UHFFFAOYSA-N CCCNC(=N)N.CN.O=c1ccc2ccccc2o1 Chemical compound CCCNC(=N)N.CN.O=c1ccc2ccccc2o1 QEVRLKRIDJMLTI-UHFFFAOYSA-N 0.000 description 1
- FMCZVXXYXFPJCG-UHFFFAOYSA-N CCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCCOP(=O)(O)O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN FMCZVXXYXFPJCG-UHFFFAOYSA-N 0.000 description 1
- NOLSSGDCEDUIKO-UHFFFAOYSA-N CCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CCCOP(=O)(O)O.CN.O=c1ccc2ccccc2o1 NOLSSGDCEDUIKO-UHFFFAOYSA-N 0.000 description 1
- NJEAMNRVBBYAJG-UHFFFAOYSA-N CCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 Chemical compound CCCS(=O)(=O)O.CN.O=c1ccc2ccccc2o1 NJEAMNRVBBYAJG-UHFFFAOYSA-N 0.000 description 1
- QLCNFHSIUGFPAN-UHFFFAOYSA-N CCN(CC)CCC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN QLCNFHSIUGFPAN-UHFFFAOYSA-N 0.000 description 1
- AOFILRQORHDSKJ-UHFFFAOYSA-N CCN(CC)CCC(C)=O.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCC(C)=O.CN.O=c1ccc2ccccc2o1 AOFILRQORHDSKJ-UHFFFAOYSA-N 0.000 description 1
- DKDDZIJKGBIUPY-UHFFFAOYSA-N CCN(CC)CCC(C)=O.CN.c1ccccc1 Chemical compound CCN(CC)CCC(C)=O.CN.c1ccccc1 DKDDZIJKGBIUPY-UHFFFAOYSA-N 0.000 description 1
- LMYKNBLSAGADFH-UHFFFAOYSA-N CCN(CC)CCCC(=O)NC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCCC(=O)NC.CN.O=c1ccc2ccccc2o1 LMYKNBLSAGADFH-UHFFFAOYSA-N 0.000 description 1
- MNFRCMPSXVSXIE-UHFFFAOYSA-N CCN(CC)CCCC(=O)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCCC(=O)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN MNFRCMPSXVSXIE-UHFFFAOYSA-N 0.000 description 1
- YWPTWANJFIGIAT-UHFFFAOYSA-N CCN(CC)CCCC(=O)OC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCCC(=O)OC.CN.O=c1ccc2ccccc2o1 YWPTWANJFIGIAT-UHFFFAOYSA-N 0.000 description 1
- JROARBDWAFKDOJ-UHFFFAOYSA-N CCN(CC)CCCC(=S)NC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCCC(=S)NC.CN.O=c1ccc2ccccc2o1 JROARBDWAFKDOJ-UHFFFAOYSA-N 0.000 description 1
- FQKMFYDCGBUCCM-UHFFFAOYSA-N CCN(CC)CCCC(=S)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCCC(=S)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN FQKMFYDCGBUCCM-UHFFFAOYSA-N 0.000 description 1
- VJXOKGJQEQWIQQ-UHFFFAOYSA-N CCN(CC)CCCC(=S)OC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCCC(=S)OC.CN.O=c1ccc2ccccc2o1 VJXOKGJQEQWIQQ-UHFFFAOYSA-N 0.000 description 1
- NBPJNBDVMUFOKB-UHFFFAOYSA-N CCN(CC)CCCC(C)=O.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCCC(C)=O.CN.O=c1ccc2ccccc2o1 NBPJNBDVMUFOKB-UHFFFAOYSA-N 0.000 description 1
- PUCBLRBGBHSMPN-UHFFFAOYSA-N CCN(CC)CCCC(C)=O.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCCC(C)=O.CN.c1ccc2ccccc2c1 PUCBLRBGBHSMPN-UHFFFAOYSA-N 0.000 description 1
- HKQQANDRWVXKQD-UHFFFAOYSA-N CCN(CC)CCCC(C)=O.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCCC(C)=O.CN.c1ccc2ncccc2c1 HKQQANDRWVXKQD-UHFFFAOYSA-N 0.000 description 1
- JZWOGNSXOAQSBJ-UHFFFAOYSA-N CCN(CC)CCCCC(=O)OC.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCCCC(=O)OC.CN.c1ccc2ccccc2c1 JZWOGNSXOAQSBJ-UHFFFAOYSA-N 0.000 description 1
- WSPSZZIYWYQJJD-UHFFFAOYSA-N CCN(CC)CCCCC(=O)OC.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCCCC(=O)OC.CN.c1ccc2ncccc2c1 WSPSZZIYWYQJJD-UHFFFAOYSA-N 0.000 description 1
- BCMVHFPEIODAOE-UHFFFAOYSA-N CCN(CC)CCCCC(=O)OC.CN.c1ccccc1 Chemical compound CCN(CC)CCCCC(=O)OC.CN.c1ccccc1 BCMVHFPEIODAOE-UHFFFAOYSA-N 0.000 description 1
- FJYXWYWIIWVKMV-UHFFFAOYSA-N CCN(CC)CCCCC(=S)OC.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCCCC(=S)OC.CN.c1ccc2ccccc2c1 FJYXWYWIIWVKMV-UHFFFAOYSA-N 0.000 description 1
- ICTKYGTUJNGLMH-UHFFFAOYSA-N CCN(CC)CCCCC(=S)OC.CN.c1ccccc1 Chemical compound CCN(CC)CCCCC(=S)OC.CN.c1ccccc1 ICTKYGTUJNGLMH-UHFFFAOYSA-N 0.000 description 1
- HBHLWIFNYHRCKD-UHFFFAOYSA-N CCN(CC)CCCOC(=O)OC.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCCOC(=O)OC.CN.c1ccc2ccccc2c1 HBHLWIFNYHRCKD-UHFFFAOYSA-N 0.000 description 1
- DEHLPSQPFDJNLA-UHFFFAOYSA-N CCN(CC)CCCOC(=O)OC.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCCOC(=O)OC.CN.c1ccc2ncccc2c1 DEHLPSQPFDJNLA-UHFFFAOYSA-N 0.000 description 1
- IBOZKQVSZGVKPT-UHFFFAOYSA-N CCN(CC)CCCOC(=O)OC.CN.c1ccccc1 Chemical compound CCN(CC)CCCOC(=O)OC.CN.c1ccccc1 IBOZKQVSZGVKPT-UHFFFAOYSA-N 0.000 description 1
- VZYAFQOREWSJRZ-UHFFFAOYSA-N CCN(CC)CCCOC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCCOC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN VZYAFQOREWSJRZ-UHFFFAOYSA-N 0.000 description 1
- YBFMNNIEJPYAAC-UHFFFAOYSA-N CCN(CC)CCCOC.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCCOC.CN.c1ccc2ccccc2c1 YBFMNNIEJPYAAC-UHFFFAOYSA-N 0.000 description 1
- DSMXYCNSRVIGGG-UHFFFAOYSA-N CCN(CC)CCCOC.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCCOC.CN.c1ccc2ncccc2c1 DSMXYCNSRVIGGG-UHFFFAOYSA-N 0.000 description 1
- NEKIPUKRQJANQX-UHFFFAOYSA-N CCN(CC)CCCOC.CN.c1ccccc1 Chemical compound CCN(CC)CCCOC.CN.c1ccccc1 NEKIPUKRQJANQX-UHFFFAOYSA-N 0.000 description 1
- BTSCPIUQTYVXOE-UHFFFAOYSA-N CCN(CC)CCCSC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCCSC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN BTSCPIUQTYVXOE-UHFFFAOYSA-N 0.000 description 1
- HREYBMGUISUQKE-UHFFFAOYSA-N CCN(CC)CCNC(=O)c1ccc2cc(N)ccc2n1 Chemical compound CCN(CC)CCNC(=O)c1ccc2cc(N)ccc2n1 HREYBMGUISUQKE-UHFFFAOYSA-N 0.000 description 1
- SXZSAEDKPOXTKP-UHFFFAOYSA-N CCN(CC)CCNC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCNC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN SXZSAEDKPOXTKP-UHFFFAOYSA-N 0.000 description 1
- FTGIFCLHCFBESK-UHFFFAOYSA-N CCN(CC)CCNC(C)=O.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCNC(C)=O.CN.c1ccc2ccccc2c1 FTGIFCLHCFBESK-UHFFFAOYSA-N 0.000 description 1
- CPNFZMWTJYKQGH-UHFFFAOYSA-N CCN(CC)CCNC(C)=O.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCNC(C)=O.CN.c1ccc2ncccc2c1 CPNFZMWTJYKQGH-UHFFFAOYSA-N 0.000 description 1
- MXQFOQDFLXFRFJ-UHFFFAOYSA-N CCN(CC)CCNC(C)=O.CN.c1ccccc1 Chemical compound CCN(CC)CCNC(C)=O.CN.c1ccccc1 MXQFOQDFLXFRFJ-UHFFFAOYSA-N 0.000 description 1
- KQALOARTPARUEO-UHFFFAOYSA-N CCN(CC)CCNC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCNC.CN.O=c1ccc2ccccc2o1 KQALOARTPARUEO-UHFFFAOYSA-N 0.000 description 1
- ZLVIYEHMGGRZFF-UHFFFAOYSA-N CCN(CC)CCOC(=O)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCOC(=O)OC.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN ZLVIYEHMGGRZFF-UHFFFAOYSA-N 0.000 description 1
- CZSFCOILZREXHR-UHFFFAOYSA-N CCN(CC)CCOC(=O)OC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCOC(=O)OC.CN.O=c1ccc2ccccc2o1 CZSFCOILZREXHR-UHFFFAOYSA-N 0.000 description 1
- JDBGPHYSTGORET-UHFFFAOYSA-N CCN(CC)CCOC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN Chemical compound CCN(CC)CCOC(C)=O.CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN JDBGPHYSTGORET-UHFFFAOYSA-N 0.000 description 1
- IDDZEQBZGHCTDG-UHFFFAOYSA-N CCN(CC)CCOC(C)=O.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCOC(C)=O.CN.O=c1ccc2ccccc2o1 IDDZEQBZGHCTDG-UHFFFAOYSA-N 0.000 description 1
- CVAYNTNRZUPUAP-UHFFFAOYSA-N CCN(CC)CCOC(C)=O.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCOC(C)=O.CN.c1ccc2ccccc2c1 CVAYNTNRZUPUAP-UHFFFAOYSA-N 0.000 description 1
- NVILDZQBNCDZIB-UHFFFAOYSA-N CCN(CC)CCOC(C)=O.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCOC(C)=O.CN.c1ccc2ncccc2c1 NVILDZQBNCDZIB-UHFFFAOYSA-N 0.000 description 1
- QGZSBRBBTKHKBK-UHFFFAOYSA-N CCN(CC)CCOC(C)=O.CN.c1ccccc1 Chemical compound CCN(CC)CCOC(C)=O.CN.c1ccccc1 QGZSBRBBTKHKBK-UHFFFAOYSA-N 0.000 description 1
- BGKLPKUCCLBEHU-UHFFFAOYSA-N CCN(CC)CCOC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCOC.CN.O=c1ccc2ccccc2o1 BGKLPKUCCLBEHU-UHFFFAOYSA-N 0.000 description 1
- IRIYTLCUTLITCQ-UHFFFAOYSA-N CCN(CC)CCSC.CN.O=c1ccc2ccccc2o1 Chemical compound CCN(CC)CCSC.CN.O=c1ccc2ccccc2o1 IRIYTLCUTLITCQ-UHFFFAOYSA-N 0.000 description 1
- FNFOISHVWOFFLL-UHFFFAOYSA-N CCN(CC)CCSC.CN.c1ccc2ccccc2c1 Chemical compound CCN(CC)CCSC.CN.c1ccc2ccccc2c1 FNFOISHVWOFFLL-UHFFFAOYSA-N 0.000 description 1
- BPMCKGUUJGYDAU-UHFFFAOYSA-N CCN(CC)CCSC.CN.c1ccc2ncccc2c1 Chemical compound CCN(CC)CCSC.CN.c1ccc2ncccc2c1 BPMCKGUUJGYDAU-UHFFFAOYSA-N 0.000 description 1
- VSPJGHMGPDMNJN-UHFFFAOYSA-N CCN(CC)CCSC.CN.c1ccccc1 Chemical compound CCN(CC)CCSC.CN.c1ccccc1 VSPJGHMGPDMNJN-UHFFFAOYSA-N 0.000 description 1
- WBQRIHZCGHLGEQ-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCCC(=N)N Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCCC(=N)N WBQRIHZCGHLGEQ-UHFFFAOYSA-N 0.000 description 1
- HEUFQOIZXMFWHJ-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCCP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCCP(=O)(O)O HEUFQOIZXMFWHJ-UHFFFAOYSA-N 0.000 description 1
- YUKRWEOZDQMZOD-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCOP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)CCCCOP(=O)(O)O YUKRWEOZDQMZOD-UHFFFAOYSA-N 0.000 description 1
- LROHXBDOVKRSHM-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCCC(=N)N Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCCC(=N)N LROHXBDOVKRSHM-UHFFFAOYSA-N 0.000 description 1
- HHEPKZXOKIQXJS-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCCP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCCP(=O)(O)O HHEPKZXOKIQXJS-UHFFFAOYSA-N 0.000 description 1
- GEJYOEOWTSQHQF-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCOP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCCOP(=O)(O)O GEJYOEOWTSQHQF-UHFFFAOYSA-N 0.000 description 1
- ZLXNEJQDYPWBFF-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCS(=O)(=O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=O)OCCS(=O)(=O)O ZLXNEJQDYPWBFF-UHFFFAOYSA-N 0.000 description 1
- CPEAWHDMVHOQCC-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCCCC(=N)N Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCCCC(=N)N CPEAWHDMVHOQCC-UHFFFAOYSA-N 0.000 description 1
- VNMKYQYLEMPDDB-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCCP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCCP(=O)(O)O VNMKYQYLEMPDDB-UHFFFAOYSA-N 0.000 description 1
- NYMRRFRBIJDWHZ-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCOP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COC(=S)CCCOP(=O)(O)O NYMRRFRBIJDWHZ-UHFFFAOYSA-N 0.000 description 1
- OVTLARUQRRKUMR-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCCC(=N)N Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCCC(=N)N OVTLARUQRRKUMR-UHFFFAOYSA-N 0.000 description 1
- WCMDPZDIVCSUAJ-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCP(=O)(O)O WCMDPZDIVCSUAJ-UHFFFAOYSA-N 0.000 description 1
- PSINULKPIBNRGE-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCS(=O)(=O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCCS(=O)(=O)O PSINULKPIBNRGE-UHFFFAOYSA-N 0.000 description 1
- QMNDIMNTDUYUDM-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCOP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.COCCOP(=O)(O)O QMNDIMNTDUYUDM-UHFFFAOYSA-N 0.000 description 1
- PSGKANRGCYCGCF-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCCC(=N)N Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCCC(=N)N PSGKANRGCYCGCF-UHFFFAOYSA-N 0.000 description 1
- SVFBVOGKLVQRFK-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCP(=O)(O)O SVFBVOGKLVQRFK-UHFFFAOYSA-N 0.000 description 1
- UOIJYIONUJGHOT-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCS(=O)(=O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCCS(=O)(=O)O UOIJYIONUJGHOT-UHFFFAOYSA-N 0.000 description 1
- ORRRFDOFNGAFIF-UHFFFAOYSA-N CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCOP(=O)(O)O Chemical compound CCN(CC)c1ccc2c(-c3ccccc3)c3ccc(=[N+](CC)CC)cc-3oc2c1.CN.CSCCOP(=O)(O)O ORRRFDOFNGAFIF-UHFFFAOYSA-N 0.000 description 1
- BVTSJSZPMDBVCZ-UHFFFAOYSA-N CCOCCN(CC)CC.CN.c1ccc2ccccc2c1 Chemical compound CCOCCN(CC)CC.CN.c1ccc2ccccc2c1 BVTSJSZPMDBVCZ-UHFFFAOYSA-N 0.000 description 1
- BGYVQZHGQAIWHN-UHFFFAOYSA-N CCOCCN(CC)CC.CN.c1ccc2ncccc2c1 Chemical compound CCOCCN(CC)CC.CN.c1ccc2ncccc2c1 BGYVQZHGQAIWHN-UHFFFAOYSA-N 0.000 description 1
- SFUMAMCNSRFYMU-UHFFFAOYSA-N CN.CNC(=O)CCCCCC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=O)CCCCCC(=N)N.O=c1ccc2ccccc2o1 SFUMAMCNSRFYMU-UHFFFAOYSA-N 0.000 description 1
- RHMFSQPIBUTSTF-UHFFFAOYSA-N CN.CNC(=O)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=O)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 RHMFSQPIBUTSTF-UHFFFAOYSA-N 0.000 description 1
- SIEFWPDYFLLYAT-UHFFFAOYSA-N CN.CNC(=O)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=O)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 SIEFWPDYFLLYAT-UHFFFAOYSA-N 0.000 description 1
- XEFZSKGOYUFNRM-UHFFFAOYSA-N CN.CNC(=O)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=O)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 XEFZSKGOYUFNRM-UHFFFAOYSA-N 0.000 description 1
- JZVPBHKHAUIXTE-UHFFFAOYSA-N CN.CNC(=S)CCCCCC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=S)CCCCCC(=N)N.O=c1ccc2ccccc2o1 JZVPBHKHAUIXTE-UHFFFAOYSA-N 0.000 description 1
- MXXUNYLLIFNKIQ-UHFFFAOYSA-N CN.CNC(=S)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=S)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 MXXUNYLLIFNKIQ-UHFFFAOYSA-N 0.000 description 1
- BEBLCHDPUOHLHZ-UHFFFAOYSA-N CN.CNC(=S)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=S)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 BEBLCHDPUOHLHZ-UHFFFAOYSA-N 0.000 description 1
- NACSCJXUSZHPPW-UHFFFAOYSA-N CN.CNC(=S)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNC(=S)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 NACSCJXUSZHPPW-UHFFFAOYSA-N 0.000 description 1
- ABDZDZBMZIOVDW-UHFFFAOYSA-N CN.CNCCCNC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.CNCCCNC(=N)N.O=c1ccc2ccccc2o1 ABDZDZBMZIOVDW-UHFFFAOYSA-N 0.000 description 1
- PMXODXYVQUEKLV-UHFFFAOYSA-N CN.CNCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNCCCP(=O)(O)O.O=c1ccc2ccccc2o1 PMXODXYVQUEKLV-UHFFFAOYSA-N 0.000 description 1
- UNWCGMJRKOBEKQ-UHFFFAOYSA-N CN.CNCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNCCOP(=O)(O)O.O=c1ccc2ccccc2o1 UNWCGMJRKOBEKQ-UHFFFAOYSA-N 0.000 description 1
- WJINTKYYWAOCMZ-UHFFFAOYSA-N CN.CNCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CNCCS(=O)(=O)O.O=c1ccc2ccccc2o1 WJINTKYYWAOCMZ-UHFFFAOYSA-N 0.000 description 1
- NJXIDXKQMDVUAL-UHFFFAOYSA-N CN.COC(=O)CCCCCC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)CCCCCC(=N)N.O=c1ccc2ccccc2o1 NJXIDXKQMDVUAL-UHFFFAOYSA-N 0.000 description 1
- FCMSEGDIDDZPNB-UHFFFAOYSA-N CN.COC(=O)CCCCCNC(=N)N.c1ccccc1 Chemical compound CN.COC(=O)CCCCCNC(=N)N.c1ccccc1 FCMSEGDIDDZPNB-UHFFFAOYSA-N 0.000 description 1
- ZKIAUDCWHLENDA-UHFFFAOYSA-N CN.COC(=O)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 ZKIAUDCWHLENDA-UHFFFAOYSA-N 0.000 description 1
- RIDHOEDWPQBCGZ-UHFFFAOYSA-N CN.COC(=O)CCCCP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)CCCCP(=O)(O)O.c1ccc2ncccc2c1 RIDHOEDWPQBCGZ-UHFFFAOYSA-N 0.000 description 1
- BCEAKHOVDBDUEC-UHFFFAOYSA-N CN.COC(=O)CCCCP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=O)CCCCP(=O)(O)O.c1ccccc1 BCEAKHOVDBDUEC-UHFFFAOYSA-N 0.000 description 1
- NHRFXZWVJRNNDM-UHFFFAOYSA-N CN.COC(=O)CCCNC(=N)N.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)CCCNC(=N)N.c1ccc2ccccc2c1 NHRFXZWVJRNNDM-UHFFFAOYSA-N 0.000 description 1
- CPNVXQFCBPLLSH-UHFFFAOYSA-N CN.COC(=O)CCCNC(=N)N.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)CCCNC(=N)N.c1ccc2ncccc2c1 CPNVXQFCBPLLSH-UHFFFAOYSA-N 0.000 description 1
- ZSQKOMRUQYTJAK-UHFFFAOYSA-N CN.COC(=O)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 ZSQKOMRUQYTJAK-UHFFFAOYSA-N 0.000 description 1
- MRUDRXIWHIBATB-UHFFFAOYSA-N CN.COC(=O)CCCOP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)CCCOP(=O)(O)O.c1ccc2ncccc2c1 MRUDRXIWHIBATB-UHFFFAOYSA-N 0.000 description 1
- IADZXLXLAZDKCZ-UHFFFAOYSA-N CN.COC(=O)CCCOP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=O)CCCOP(=O)(O)O.c1ccccc1 IADZXLXLAZDKCZ-UHFFFAOYSA-N 0.000 description 1
- YPIILMLRCXBLPC-UHFFFAOYSA-N CN.COC(=O)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 YPIILMLRCXBLPC-UHFFFAOYSA-N 0.000 description 1
- VUQAGPQVNKPKAT-UHFFFAOYSA-N CN.COC(=O)CCCS(=O)(=O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)CCCS(=O)(=O)O.c1ccc2ccccc2c1 VUQAGPQVNKPKAT-UHFFFAOYSA-N 0.000 description 1
- HQIRXBDJQCMLTI-UHFFFAOYSA-N CN.COC(=O)CCCS(=O)(=O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)CCCS(=O)(=O)O.c1ccc2ncccc2c1 HQIRXBDJQCMLTI-UHFFFAOYSA-N 0.000 description 1
- BYHYVXZJESYMLH-UHFFFAOYSA-N CN.COC(=O)CCCS(=O)(=O)O.c1ccccc1 Chemical compound CN.COC(=O)CCCS(=O)(=O)O.c1ccccc1 BYHYVXZJESYMLH-UHFFFAOYSA-N 0.000 description 1
- KSSPQTZFQVBCFN-UHFFFAOYSA-N CN.COC(=O)OCCCCC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)OCCCCC(=N)N.O=c1ccc2ccccc2o1 KSSPQTZFQVBCFN-UHFFFAOYSA-N 0.000 description 1
- HXGMUJSWIGSGLG-UHFFFAOYSA-N CN.COC(=O)OCCCCC(=N)N.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)OCCCCC(=N)N.c1ccc2ccccc2c1 HXGMUJSWIGSGLG-UHFFFAOYSA-N 0.000 description 1
- MXMXIZUOVZYJDB-UHFFFAOYSA-N CN.COC(=O)OCCCCC(=N)N.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)OCCCCC(=N)N.c1ccc2ncccc2c1 MXMXIZUOVZYJDB-UHFFFAOYSA-N 0.000 description 1
- URTNCQWDACXFCT-UHFFFAOYSA-N CN.COC(=O)OCCCCC(=N)N.c1ccccc1 Chemical compound CN.COC(=O)OCCCCC(=N)N.c1ccccc1 URTNCQWDACXFCT-UHFFFAOYSA-N 0.000 description 1
- QSUKEXCYUPGYDN-UHFFFAOYSA-N CN.COC(=O)OCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)OCCCP(=O)(O)O.O=c1ccc2ccccc2o1 QSUKEXCYUPGYDN-UHFFFAOYSA-N 0.000 description 1
- SZOWQEAXBCACOB-UHFFFAOYSA-N CN.COC(=O)OCCCP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)OCCCP(=O)(O)O.c1ccc2ccccc2c1 SZOWQEAXBCACOB-UHFFFAOYSA-N 0.000 description 1
- PEVQEMSVZWXLBF-UHFFFAOYSA-N CN.COC(=O)OCCCP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)OCCCP(=O)(O)O.c1ccc2ncccc2c1 PEVQEMSVZWXLBF-UHFFFAOYSA-N 0.000 description 1
- UCPAIIRORGOYAO-UHFFFAOYSA-N CN.COC(=O)OCCCP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=O)OCCCP(=O)(O)O.c1ccccc1 UCPAIIRORGOYAO-UHFFFAOYSA-N 0.000 description 1
- WLHKYABMZRPOLY-UHFFFAOYSA-N CN.COC(=O)OCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)OCCOP(=O)(O)O.O=c1ccc2ccccc2o1 WLHKYABMZRPOLY-UHFFFAOYSA-N 0.000 description 1
- XYPQDQSDHSVJNF-UHFFFAOYSA-N CN.COC(=O)OCCOP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)OCCOP(=O)(O)O.c1ccc2ccccc2c1 XYPQDQSDHSVJNF-UHFFFAOYSA-N 0.000 description 1
- KQLCFGDKSNUALO-UHFFFAOYSA-N CN.COC(=O)OCCOP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)OCCOP(=O)(O)O.c1ccc2ncccc2c1 KQLCFGDKSNUALO-UHFFFAOYSA-N 0.000 description 1
- LHAVUEIGCIQLAO-UHFFFAOYSA-N CN.COC(=O)OCCOP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=O)OCCOP(=O)(O)O.c1ccccc1 LHAVUEIGCIQLAO-UHFFFAOYSA-N 0.000 description 1
- BUVUNMZUNCAZLR-UHFFFAOYSA-N CN.COC(=O)OCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=O)OCCS(=O)(=O)O.O=c1ccc2ccccc2o1 BUVUNMZUNCAZLR-UHFFFAOYSA-N 0.000 description 1
- AEFQIZYOUDUVCJ-UHFFFAOYSA-N CN.COC(=O)OCCS(=O)(=O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=O)OCCS(=O)(=O)O.c1ccc2ccccc2c1 AEFQIZYOUDUVCJ-UHFFFAOYSA-N 0.000 description 1
- VRQUQDZJWCANLV-UHFFFAOYSA-N CN.COC(=O)OCCS(=O)(=O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=O)OCCS(=O)(=O)O.c1ccc2ncccc2c1 VRQUQDZJWCANLV-UHFFFAOYSA-N 0.000 description 1
- JMSYBDXMBOHDAH-UHFFFAOYSA-N CN.COC(=O)OCCS(=O)(=O)O.c1ccccc1 Chemical compound CN.COC(=O)OCCS(=O)(=O)O.c1ccccc1 JMSYBDXMBOHDAH-UHFFFAOYSA-N 0.000 description 1
- NZLXLCUEVMSGSJ-UHFFFAOYSA-N CN.COC(=S)CCCCCC(=N)N.c1ccccc1 Chemical compound CN.COC(=S)CCCCCC(=N)N.c1ccccc1 NZLXLCUEVMSGSJ-UHFFFAOYSA-N 0.000 description 1
- MQWGIYGSMXBQBN-UHFFFAOYSA-N CN.COC(=S)CCCCCP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=S)CCCCCP(=O)(O)O.c1ccc2ccccc2c1 MQWGIYGSMXBQBN-UHFFFAOYSA-N 0.000 description 1
- YIJOVWLXKXIJBX-UHFFFAOYSA-N CN.COC(=S)CCCCCP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=S)CCCCCP(=O)(O)O.c1ccc2ncccc2c1 YIJOVWLXKXIJBX-UHFFFAOYSA-N 0.000 description 1
- DZUGAGLCJMVBBC-UHFFFAOYSA-N CN.COC(=S)CCCCOP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=S)CCCCOP(=O)(O)O.c1ccc2ccccc2c1 DZUGAGLCJMVBBC-UHFFFAOYSA-N 0.000 description 1
- FAPUELUDTYBRIX-UHFFFAOYSA-N CN.COC(=S)CCCCOP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.COC(=S)CCCCOP(=O)(O)O.c1ccc2ncccc2c1 FAPUELUDTYBRIX-UHFFFAOYSA-N 0.000 description 1
- SHJOYOLQFOZHMO-UHFFFAOYSA-N CN.COC(=S)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=S)CCCCP(=O)(O)O.O=c1ccc2ccccc2o1 SHJOYOLQFOZHMO-UHFFFAOYSA-N 0.000 description 1
- OGAIOVJJSBLQHB-UHFFFAOYSA-N CN.COC(=S)CCCCP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=S)CCCCP(=O)(O)O.c1ccccc1 OGAIOVJJSBLQHB-UHFFFAOYSA-N 0.000 description 1
- UPFWMRQTTSKYOS-UHFFFAOYSA-N CN.COC(=S)CCCNC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=S)CCCNC(=N)N.O=c1ccc2ccccc2o1 UPFWMRQTTSKYOS-UHFFFAOYSA-N 0.000 description 1
- WSNINAIFRVSZPL-UHFFFAOYSA-N CN.COC(=S)CCCNC(=N)N.c1ccc2ccccc2c1 Chemical compound CN.COC(=S)CCCNC(=N)N.c1ccc2ccccc2c1 WSNINAIFRVSZPL-UHFFFAOYSA-N 0.000 description 1
- VISZTUCMBSJVHJ-UHFFFAOYSA-N CN.COC(=S)CCCNC(=N)N.c1ccc2ncccc2c1 Chemical compound CN.COC(=S)CCCNC(=N)N.c1ccc2ncccc2c1 VISZTUCMBSJVHJ-UHFFFAOYSA-N 0.000 description 1
- BDLZGNQOZZSLAS-UHFFFAOYSA-N CN.COC(=S)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=S)CCCOP(=O)(O)O.O=c1ccc2ccccc2o1 BDLZGNQOZZSLAS-UHFFFAOYSA-N 0.000 description 1
- SUHGGLBZETZFQG-UHFFFAOYSA-N CN.COC(=S)CCCOP(=O)(O)O.c1ccccc1 Chemical compound CN.COC(=S)CCCOP(=O)(O)O.c1ccccc1 SUHGGLBZETZFQG-UHFFFAOYSA-N 0.000 description 1
- ASYWJZAEYQTEHL-UHFFFAOYSA-N CN.COC(=S)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COC(=S)CCCS(=O)(=O)O.O=c1ccc2ccccc2o1 ASYWJZAEYQTEHL-UHFFFAOYSA-N 0.000 description 1
- LXSDXKNESDFSMC-UHFFFAOYSA-N CN.COC(=S)CCCS(=O)(=O)O.c1ccc2ccccc2c1 Chemical compound CN.COC(=S)CCCS(=O)(=O)O.c1ccc2ccccc2c1 LXSDXKNESDFSMC-UHFFFAOYSA-N 0.000 description 1
- FDYPFPWYNLOBTQ-UHFFFAOYSA-N CN.COC(=S)CCCS(=O)(=O)O.c1ccccc1 Chemical compound CN.COC(=S)CCCS(=O)(=O)O.c1ccccc1 FDYPFPWYNLOBTQ-UHFFFAOYSA-N 0.000 description 1
- JVZSKDRZNFOYLJ-UHFFFAOYSA-N CN.COCCCNC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.COCCCNC(=N)N.O=c1ccc2ccccc2o1 JVZSKDRZNFOYLJ-UHFFFAOYSA-N 0.000 description 1
- WXGYFCSHQPSYTG-UHFFFAOYSA-N CN.COCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COCCCP(=O)(O)O.O=c1ccc2ccccc2o1 WXGYFCSHQPSYTG-UHFFFAOYSA-N 0.000 description 1
- ODYBQTZYZOIWCK-UHFFFAOYSA-N CN.COCCCP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COCCCP(=O)(O)O.c1ccc2ccccc2c1 ODYBQTZYZOIWCK-UHFFFAOYSA-N 0.000 description 1
- GWBUNSSLJXZDDI-UHFFFAOYSA-N CN.COCCCP(=O)(O)O.c1ccccc1 Chemical compound CN.COCCCP(=O)(O)O.c1ccccc1 GWBUNSSLJXZDDI-UHFFFAOYSA-N 0.000 description 1
- BMPWJZOATZSKJU-UHFFFAOYSA-N CN.COCCCS(=O)(=O)O.c1ccc2ccccc2c1 Chemical compound CN.COCCCS(=O)(=O)O.c1ccc2ccccc2c1 BMPWJZOATZSKJU-UHFFFAOYSA-N 0.000 description 1
- INHCAAKLTOWDOT-UHFFFAOYSA-N CN.COCCCS(=O)(=O)O.c1ccc2ncccc2c1 Chemical compound CN.COCCCS(=O)(=O)O.c1ccc2ncccc2c1 INHCAAKLTOWDOT-UHFFFAOYSA-N 0.000 description 1
- WEPIRXXDAXMWGE-UHFFFAOYSA-N CN.COCCCS(=O)(=O)O.c1ccccc1 Chemical compound CN.COCCCS(=O)(=O)O.c1ccccc1 WEPIRXXDAXMWGE-UHFFFAOYSA-N 0.000 description 1
- GURGEEMDRKWDDA-UHFFFAOYSA-N CN.COCCNC(=N)N.c1ccc2ccccc2c1 Chemical compound CN.COCCNC(=N)N.c1ccc2ccccc2c1 GURGEEMDRKWDDA-UHFFFAOYSA-N 0.000 description 1
- ICCHPYKXTLJYER-UHFFFAOYSA-N CN.COCCNC(=N)N.c1ccc2ncccc2c1 Chemical compound CN.COCCNC(=N)N.c1ccc2ncccc2c1 ICCHPYKXTLJYER-UHFFFAOYSA-N 0.000 description 1
- RYXRNDZUUCMAEC-UHFFFAOYSA-N CN.COCCNC(=N)N.c1ccccc1 Chemical compound CN.COCCNC(=N)N.c1ccccc1 RYXRNDZUUCMAEC-UHFFFAOYSA-N 0.000 description 1
- OGHUFNJFSKJBAG-UHFFFAOYSA-N CN.COCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COCCOP(=O)(O)O.O=c1ccc2ccccc2o1 OGHUFNJFSKJBAG-UHFFFAOYSA-N 0.000 description 1
- ZUAQTOANDBFLLC-UHFFFAOYSA-N CN.COCCOP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.COCCOP(=O)(O)O.c1ccc2ccccc2c1 ZUAQTOANDBFLLC-UHFFFAOYSA-N 0.000 description 1
- OGXHGIHQMMJTDC-UHFFFAOYSA-N CN.COCCOP(=O)(O)O.c1ccccc1 Chemical compound CN.COCCOP(=O)(O)O.c1ccccc1 OGXHGIHQMMJTDC-UHFFFAOYSA-N 0.000 description 1
- PBGXJVLKGXVKIX-UHFFFAOYSA-N CN.COCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.COCCS(=O)(=O)O.O=c1ccc2ccccc2o1 PBGXJVLKGXVKIX-UHFFFAOYSA-N 0.000 description 1
- QNVODJCNIQPXFN-UHFFFAOYSA-N CN.CSCCCCC(=N)N.c1ccc2ccccc2c1 Chemical compound CN.CSCCCCC(=N)N.c1ccc2ccccc2c1 QNVODJCNIQPXFN-UHFFFAOYSA-N 0.000 description 1
- IIUAIFBWXMWHOD-UHFFFAOYSA-N CN.CSCCCCC(=N)N.c1ccc2ncccc2c1 Chemical compound CN.CSCCCCC(=N)N.c1ccc2ncccc2c1 IIUAIFBWXMWHOD-UHFFFAOYSA-N 0.000 description 1
- XOVIJBCGFMUUGH-UHFFFAOYSA-N CN.CSCCCCC(=N)N.c1ccccc1 Chemical compound CN.CSCCCCC(=N)N.c1ccccc1 XOVIJBCGFMUUGH-UHFFFAOYSA-N 0.000 description 1
- VXBPZZYLSWILIN-UHFFFAOYSA-N CN.CSCCCP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CSCCCP(=O)(O)O.O=c1ccc2ccccc2o1 VXBPZZYLSWILIN-UHFFFAOYSA-N 0.000 description 1
- ZERRCJSMDYWKEU-UHFFFAOYSA-N CN.CSCCCP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.CSCCCP(=O)(O)O.c1ccc2ccccc2c1 ZERRCJSMDYWKEU-UHFFFAOYSA-N 0.000 description 1
- NNCCHZZYQNAIIA-UHFFFAOYSA-N CN.CSCCCP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.CSCCCP(=O)(O)O.c1ccc2ncccc2c1 NNCCHZZYQNAIIA-UHFFFAOYSA-N 0.000 description 1
- NJHFWGNCGJCDOR-UHFFFAOYSA-N CN.CSCCCP(=O)(O)O.c1ccccc1 Chemical compound CN.CSCCCP(=O)(O)O.c1ccccc1 NJHFWGNCGJCDOR-UHFFFAOYSA-N 0.000 description 1
- BFJQGCRDPMZLKB-UHFFFAOYSA-N CN.CSCCNC(=N)N.O=c1ccc2ccccc2o1 Chemical compound CN.CSCCNC(=N)N.O=c1ccc2ccccc2o1 BFJQGCRDPMZLKB-UHFFFAOYSA-N 0.000 description 1
- MTWPKZYJPRMMFJ-UHFFFAOYSA-N CN.CSCCOP(=O)(O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CSCCOP(=O)(O)O.O=c1ccc2ccccc2o1 MTWPKZYJPRMMFJ-UHFFFAOYSA-N 0.000 description 1
- QGAIHKLYUFEXDS-UHFFFAOYSA-N CN.CSCCOP(=O)(O)O.c1ccc2ccccc2c1 Chemical compound CN.CSCCOP(=O)(O)O.c1ccc2ccccc2c1 QGAIHKLYUFEXDS-UHFFFAOYSA-N 0.000 description 1
- CFOLBYKTFYOGET-UHFFFAOYSA-N CN.CSCCOP(=O)(O)O.c1ccc2ncccc2c1 Chemical compound CN.CSCCOP(=O)(O)O.c1ccc2ncccc2c1 CFOLBYKTFYOGET-UHFFFAOYSA-N 0.000 description 1
- JDADZRYPUBCLJW-UHFFFAOYSA-N CN.CSCCOP(=O)(O)O.c1ccccc1 Chemical compound CN.CSCCOP(=O)(O)O.c1ccccc1 JDADZRYPUBCLJW-UHFFFAOYSA-N 0.000 description 1
- VVYPTCDRKXSUNH-UHFFFAOYSA-N CN.CSCCS(=O)(=O)O.O=c1ccc2ccccc2o1 Chemical compound CN.CSCCS(=O)(=O)O.O=c1ccc2ccccc2o1 VVYPTCDRKXSUNH-UHFFFAOYSA-N 0.000 description 1
- GXYSPEWZKIPFDR-UHFFFAOYSA-N CN.CSCCS(=O)(=O)O.c1ccc2ccccc2c1 Chemical compound CN.CSCCS(=O)(=O)O.c1ccc2ccccc2c1 GXYSPEWZKIPFDR-UHFFFAOYSA-N 0.000 description 1
- VPUWSOICQIJEGL-UHFFFAOYSA-N CN.CSCCS(=O)(=O)O.c1ccc2ncccc2c1 Chemical compound CN.CSCCS(=O)(=O)O.c1ccc2ncccc2c1 VPUWSOICQIJEGL-UHFFFAOYSA-N 0.000 description 1
- ZETUOYIRJZNITE-UHFFFAOYSA-N CN.CSCCS(=O)(=O)O.c1ccccc1 Chemical compound CN.CSCCS(=O)(=O)O.c1ccccc1 ZETUOYIRJZNITE-UHFFFAOYSA-N 0.000 description 1
- VBWLEBYNYNMLQZ-UHFFFAOYSA-N CN.[H]S(=O)(=O)CCCC(=S)OC.c1ccc2ncccc2c1 Chemical compound CN.[H]S(=O)(=O)CCCC(=S)OC.c1ccc2ncccc2c1 VBWLEBYNYNMLQZ-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 229940125644 antibody drug Drugs 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000007515 arrhenius acids Chemical class 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 125000000613 asparagine group Chemical class N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- QHXLIQMGIGEHJP-UHFFFAOYSA-N boron;2-methylpyridine Chemical compound [B].CC1=CC=CC=N1 QHXLIQMGIGEHJP-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 150000007516 brønsted-lowry acids Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 238000000738 capillary electrophoresis-mass spectrometry Methods 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 229910001914 chlorine tetroxide Inorganic materials 0.000 description 1
- TVWHTOUAJSGEKT-UHFFFAOYSA-N chlorine trioxide Chemical compound [O]Cl(=O)=O TVWHTOUAJSGEKT-UHFFFAOYSA-N 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- HUHQYGLWMOYZRH-UHFFFAOYSA-L dibutyl(dichloro)stannane phenylsilane Chemical compound [SiH3]C1=CC=CC=C1.CCCC[Sn](Cl)(Cl)CCCC HUHQYGLWMOYZRH-UHFFFAOYSA-L 0.000 description 1
- 125000006003 dichloroethyl group Chemical group 0.000 description 1
- 125000004774 dichlorofluoromethyl group Chemical group FC(Cl)(Cl)* 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 1
- 125000006001 difluoroethyl group Chemical group 0.000 description 1
- LTVOKYUPTHZZQH-UHFFFAOYSA-N difluoromethane Chemical group F[C]F LTVOKYUPTHZZQH-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000005433 dihydrobenzodioxinyl group Chemical group O1C(COC2=C1C=CC=C2)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000004611 dihydroisoindolyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000005045 dihydroisoquinolinyl group Chemical group C1(NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 150000002009 diols Chemical group 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 230000000755 effect on ion Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010265 fast atom bombardment Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004186 food analysis Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000012434 mixed-mode chromatography Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- UDGSVBYJWHOHNN-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine Chemical compound CCN(CC)CCN UDGSVBYJWHOHNN-UHFFFAOYSA-N 0.000 description 1
- GINQYTLDMNFGQP-UHFFFAOYSA-N n,n-dimethylformamide;methylsulfinylmethane Chemical compound CS(C)=O.CN(C)C=O GINQYTLDMNFGQP-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004305 normal phase HPLC Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000013364 oligosaccharide-mapping technique Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000012510 peptide mapping method Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 229940117953 phenylisothiocyanate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001843 polymethylhydrosiloxane Polymers 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 238000012514 protein characterization Methods 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000003491 tear gas Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Definitions
- glycans Analysis of glycans is used for protein research and can be important to clinical chemists and pharmaceutical manufacturers, especially where glycosylation profiling of proteins is monitored to ensure consistency of a therapeutic product. Therefore, fluorescent labeling of gglycans is beneficial because the sensitivity and selectivity of glycan detection can be improved as well as the chromatographic behavior.
- MS Mass spectrometry
- glycans via mass spectroscopy as well as fluorescence and ultraviolet (“UV”) by tagging glycans, particularly N-linked glycan and O-linked glycans, using compounds of the various formulas are described herein.
- the methods described herein include derivatization of other biomolecules including proteins, peptides and/or biopolymers containing an aldehyde or ketone group, with one or more fluorescent, MS active compounds by reductive amination or rapid tagging to produce derivatized glycan having a pKa >7 and between about 200 ⁇ and about 1000 ⁇ of nonpolar surface area.
- the non-polar surface area can be used to estimate the hydrophobicity of a reagent.
- nonpolar surface area can be estimated as in the procedure described by Walker et. al., Hydrophobic Derivatization of N - linked Glycans for Increased Ion Abundance in Electrospray Ionization Mass Spectrometry, 22 J. AM. SOC. MASS SPECTROM. 1309 (2011). As the non-polar surface area or hydrophobicity of the reagent is increased, the signal of the derivatized glycan is increased.
- the present methods use labeling moieties for reductive amination of glycans that are constructed to combine a high pKa (>7) basic residue with a functional group that affords comparatively significant non-polar surface area.
- a high pKa >7 basic residue
- a functional group that affords comparatively significant non-polar surface area.
- the combination of nonpolar surface area and high pKa is not restricted to compounds that are fluorescently active.
- nonpolar surface area can be combined advantageously with low pKa acidic moieties to enhance negative ion mode electrospray ionization mass spectrometry.
- glycans such as oligosaccharides, N-linked glycans, O-linked glycans and other biomolecules
- the present methods provide for the analysis of tagged glycans via two different analytical methods, fluorescent and/or mass spectroscopic analysis.
- the analytical methods include: (a) tagging a glycan with a reagent to provide improved fluorescent signal in liquid chromatography, and (b) analyzing glycans tagged with a fluorescent and MS active compounds through reductive amination.
- this methodology can be extended to capillary electrophoresis combined with fluorescence and MS detection.
- the methods of tagging can use compounds of formulas described herein.
- Each compound can be the reagent for fluorescence and enhanced MS signaling.
- the MS active, fluorescence tagging compounds can be of the structural Formula I:
- FL is a fluorophore such as a phenyl, quinoline, napthalene, coumarin or rhodamine compound.
- compounds of Formula I can be of any of the following structural formula, and salts or solvates thereof:
- each R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and each of R 4 , R 5 , R 6 and R 7 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H.
- the compounds described herein can have optical centers. Therefore, the compounds can occur in different enantiomeric and disastereomeric configurations. Stereoisomers of such compounds of each formula, as well as racemic compounds and racemic mixtures and other mixtures of stereoisomers thereof can occur.
- FIG. 1 shows chemical structure of a compound referred to as 6-ADEQ and a schematic for its use in reductive amination of an oligosaccharide.
- FIGS. 2 A, 2 B, 2 C and 2 D show a comparison of signal provided by 6-ADEQ versus 2-AB labeled Man 5 oligosaccharide.
- FIG. 2 A shows HILIC fluorescence by 6-ADEQ and
- FIG. 2 B shows base peak intensity MS chromatograms obtained for 6 pmoles of each type of labeled Man5 oligosaccharide with 6-ADEQ.
- FIG. 2 C shows HILIC fluorescence by 2-AB and
- FIG. 2 D shows base peak intensity MS chromatograms obtained for 6 pmoles of each type of labeled Man5 oligosaccharide with 2-AB.
- FIGS. 3 A, 3 B, 3 C, 3 D and 3 E depicts certain rapid tagging glycosylamine reagents and the corresponding derivatized glycan product.
- FIG. 3 A depicts Compound 1 and its corresponding derivatized glycan product.
- FIG. 3 B depicts Compound 2 and its corresponding derivatized glycan product.
- FIG. 3 C depicts Compound 3 and its corresponding derivatized glycan product.
- FIG. 3 D depicts Compound 4 and its corresponding derivatized glycan product.
- FIG. 3 E depicts Compound 5 and its corresponding derivatized glycan product.
- FIGS. 4 A, 4 B and 4 C shows a comparison of HILIC-MS Base Peak Intensity Chromatograms obtained for N-Glycans Labeled with Compounds 1, 2, and 3 of FIGS. 3 A, 3 B and 3 C (respectively) using an Ion Mobility Capable of Mass Spectrometer (Waters Synapt G2-S, Milford, Mass.). N-glycans from 0.4 ⁇ g of anti-citrinin IgG1 monoclonal antibody were analyzed in each analysis.
- FIG. 4 A shows the results labeled with Compound 1 ( FIG. 3 A ).
- FIG. 4 B shows the results labeled with Compound 2 ( FIG. 3 B ).
- FIG. 4 C shows the results labeled with Compound 3 ( FIG. 3 C ).
- FIG. 5 shows a comparison of MS response factors as obtained for an FA2 Glycan Labeled with Compounds 1, 2, and 3 of FIG. 3 A , FIG. 3 B and FIG. 3 C (respectively) using an Ion Mobility Capable QT of Mass Spectrometer (Waters Synapt G2-S, Milford, Mass.).
- FIGS. 6 A, 6 B, and 6 C show a comparison of HILIC-MS base peak intensity chromatograms obtained for N-glycans labeled with compounds 1, 4, and 5 of FIG. 3 A , FIG. 3 D and FIG. 3 E (respectively) using a QT of Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.). N-glycans from 0.1 ⁇ g of anti-citrinin IgG1 monoclonal antibody were analyzed in each analysis.
- FIG. 6 A shows the results for Compound 1
- FIG. 6 B shows the results for Compound 4
- FIG. 6 C shows the results for Compound 5.
- FIG. 7 shows a comparison of MS response factors as obtained for an FA2 Glycan Labeled with Compounds 1, 4, and 5 of FIG. 3 A , FIG. 3 D , and FIG. 3 E (respectively) using a QT of Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.).
- FIGS. 8 A, 8 B and 8 C show a comparison of Mass Spectra obtained for a FA2Ga1Sg1 N-Glycan Labeled with Compounds 1, 4, and 5 of FIG. 3 A , FIG. 3 E and FIG. 3 D (respectively) using a QTof Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.).
- FIG. 8 A shows the results labeled with Compound 1
- FIG. 8 B shows the results labeled with Compound 5
- FIG. 8 C show the results labeled with Compound 4.
- FIG. 9 shows estimated non-polar surface area and pKa values of various tagging moieties.
- FIG. 10 shows an ESI mass spectrum of a derivatized bovine ribonuclease B tryptic glycopeptide tagged with a compound presented herein where generated ions were 2+ and 3+.
- FIG. 11 shows an ESI mass spectrum of a native (underivatized) bovine ribonuclease B tryptic glycopeptide where generated ions were 1+ and 2+.
- FIG. 12 provides a comparison of the ESI extracted ion chromatograms for two RFMS-labelled and native bovine ribonuclease B tryptic glycopeptides where ESI of the RFMS-labelled bovine ribonuclease B tryptic glycopeptides generated more intense ion signals than the native bovine ribonuclease B tryptic glycopeptides.
- FIG. 13 shows an ESI mass spectrum of a native tryptic glycopeptide from bovine fetuin presented herein where generated ions were 4+, 5+, and 6+.
- FIG. 14 shows an ESI mass spectrum a derivatized bovine fetuin tryptic glycopeptide tagged with a compound provided herein and ESI generated large amounts of 4+ and 5+ ions as well as 6+, 7+ and 8+ions.
- Glycans play a significant role in physiological and pathological processes. Tagging glycans (otherwise sometimes referred to herein as “labeling glycans”) with MS fluorescent active compounds can improve detection via chromatographic methods including mass spectrum detection and allow for versatile analysis of glycans. Yang et. al., Glycan Analysis by Isobaric Aldehyde Reactive Tags and Mass Spectrometry, 85 ANAL CHEM. 8188 (2013).
- Quantitative analysis of glycans from normal and disease specimens can provide insight into disease onset and progression.
- Relative glycan quantification can be accomplished through modification of the glycans with either chromogenic or fluorogenic tags for optical measurement or isotopic tags for mass spectrometric analysis.
- the ion abundance of N-linked glycans in electrospray ionization mass spectrometry (ESI MS) can be increased by derivatizing the glycans with neutral, hydrophobic reagents.
- glycopeptides of biological and pharmaceutical interest are post-translationally modified and/or present at low abundance levels.
- Such analytes include N- and O-linked glycopeptides.
- Glycopeptide site microheterogeneity analysis by LC/MS is designed to characterize and quantify each glycoform of a peptide.
- glycopeptides lack appropriate chromophores on the glycan moiety and they ionize poorly by electrospray ionization (“ESI”) in comparison with peptides of similar molecular weight. This deficiency leads to low signals in both MS and optical detection.
- ESI electrospray ionization
- the microheterogeneity of the glycopeptides causes the glycopeptides to be present in proteolytic digestion at very low relative abundances.
- the glycan can be labeled (also referred to herein as “tagged” or “derivatized”) with one of the compounds described herein in a sample, and then subjected to liquid chromatography, mass spectrometry, and fluorescence detection.
- the methods provide the use of a labeling moiety for reductive amination of saccharides that is constructed to combine a high pKa (>7) basic residue with a functional group that affords a significant non-polar surface area in the labeled glycan.
- proteins including glycoproteins
- a tagging reagent is then added to the peptide mixture.
- Compounds described herein can be used to label (tag) peptides, or analogous tags can be used.
- To derivatize the glycan general conditions for the reductive amination reaction can be applied for tagging as described below.
- rapid tagging can proceed via nucleophilic attack and substitution.
- a nucleophile from a peptide attacks an NHS carbamate reactive group.
- the peptide is thereby derivatized via a urea linkage to be labeled with a tag containing a hydrophobic quinolone fluorescent group and tertiary amine charge tag.
- the moieties on a peptide that are targeted for derivatization include any residues containing primary or secondary amines.
- Peptides contain at least one such reside, namely an amino (N) terminus.
- a given peptide can contain one or more primary or secondary amines residues, most typically from containing one more lysine residues. Reactions can be optimized to minimize labeling of other potential, albeit significantly weaker, nucleophiles, including but not limited to hydroxyl and imidazole groups.
- the reaction can be completed in minutes at room temperature. Yet, as described herein, molar excesses of reagent, pH, ionic strength, and buffer identity/composition can be selected. More specifically, conditions of the labeling reaction, including temperature, organic solvent composition, organic solvent concentration, buffer composition, pH, ionic strength, molar excess of reagent, and time are selected and controlled such that desired reaction selectivity between primary/secondary amines and hydroxyl groups is achieved. In turn, the yield of labeled reaction product is optimized and the generation of “over-labeled” species is minimized. In other words, the reaction product is optimized and the generation of species modified by any number of labels greater than the number of primary/secondary amines in minimized. However, sometimes over-labeling cannot be avoided.
- a SepPak aminopropyl SPE sorbent in the form of a ⁇ Elution plate can be conditioned with 200 ⁇ L of water.
- the wells can be equilibrated with 200 ⁇ L of 15:85 water/acetonitrile.
- Acetonitrile diluted samples can be then loaded.
- the well can be washed with two (2) 600 ⁇ L volumes of 1:9:90 (v/v/v) formic acid/water/acetonitrile.
- the labeled glycopeptides can then be eluted with three (3) 30 ⁇ L volumes of SPE Elution Buffer (200 mM ammonium acetate in 5% CAN).
- SPE Elution Buffer 200 mM ammonium acetate in 5% CAN.
- a diol bonded or hydrophilic-lipophilic balanced sorbent containing a sufficiently hydrophilic moiety
- ion pairing wash solvents can be used in the SPE cleanup of labeled glycopeptides to improve selectivity between retention of glycopeptides versus non-glycopeptides.
- solid phase extraction is an optional step.
- analyses can be directly performed on the labeling reaction mixture.
- tagged glycopeptides resulting from the above sample preparation are then subjected to LC/optical/MS analysis for structural characterization and glycan site microheterogeneity analysis.
- the labeled glycopeptides show higher optical and mass spectral signals.
- the gain in the enhanced signals offers higher confidence in peptide characterization and quantification.
- MSMS fragmentation coverage is optimized in a way that benefits mass spectrometric structural investigations.
- a multitude of separations can be performed for the analysis, including but not limited to hydrophilic interaction chromatography (HILIC), reversed phase chromatography and mixed mode chromatography (i.e. anion exchange reversed phase).
- Labeled glycopeptides can be separated by HILIC using the materials and methods outlined in US Published Patent Application No. US2015/0316515, at ⁇ [452] to [479], incorporated herein by reference.
- the labeled glycopeptides can be separated using the charge surface reversed phase chromatographic materials described in US Patent Pub. No. 2013/0319086, ⁇ [0008] to [0084], and [0347] to [0352], incorporated herein by reference.
- the chromatographic materials and glycan separation techniques described in U.S. Patent Application No 62/326,783 filed Apr. 24, 2016 (unpublished) are also applicable. While the present methods are described for glycopeptide analyses, these methods can be applied generally to obtain any labeled peptides with enhanced detection properties.
- labeling and “tagging” are used interchangeably through this specification.
- a “derivatized biomolecule refers to a molecule that has been labeled or tagged with the MS active, fluorescent compound.
- alkoxy refers to an alkyl ether radical and the term alkyl is as defined herein.
- suitable alkyl ether radicals include methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, iso-butoxy, sec-butoxy, tert-butoxy, and the like.
- alkyl refers to a straight-chain or branched-chain alkyl radical containing from 1 to and including 20, preferably 1 to 10, and more preferably 1 to 6, carbon atoms. Alkyl groups can be optionally substituted as defined herein without changing or affecting the fluorescent or mass spec properties of the molecule.
- alkyl radicals include methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, pentyl, iso-amyl, hexyl, octyl, nonyl and the like.
- alkylene refers to a saturated aliphatic group derived from a straight or branched chain saturated hydrocarbon attached at two or more positions, such as methylene (—CH 2 —).
- alkylamino can be a mono- or dialkylated groups (also referred to “dialkylamino”) such as, for example, N-methylamino, N-ethylamino, N,N-dimethylamino, N,N-ethylmethylamino and the like and combination, refers to —NRR′, wherein R is independently selected from the group consisting of hydrogen and alkyl, and R′ is alkyl, any of which can themselves be optionally substituted and the dialkyamino group can further comprise a spacer (sometimes referred to as a linker or linker group).
- a molecular spacer or simply a “spacer” in chemistry is any flexible part of a molecule that provides a connection between two other parts of a molecule
- parent molecular moiety means and includes phenyl, quinoline, coumarin or rhodamine.
- amino refers to —NRR′, wherein R and R′ are independently selected from the group consisting of hydrogen, alkyl, acyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, and heterocycloalkyl, any of which can themselves be optionally substituted.
- aryl as used herein, alone or in combination, means a carbocyclic aromatic system containing one, two or three rings wherein such rings can be attached together in a pendent manner or can be fused.
- aryl embraces aromatic radicals such as benzyl, phenyl, naphthyl, anthracenyl, phenanthryl, indanyl, indenyl, annulenyl, azulenyl, tetrahydronaphthyl, and biphenyl.
- benzo and “benz,” as used herein, alone or in combination, refer to the divalent radical C 6 H 4 ⁇ derived from benzene. Examples include benzothiophene and benzimidazole.
- carbamate refers to an ester of carbamic acid (—NHCOO—) which can be attached to the parent molecular moiety from either the nitrogen or acid end, and which can be optionally substituted as defined herein.
- O-carbamyl as used herein, alone or in combination, refers to a —OC(O)NRR′, group-with R and R′ as defined herein.
- N-carbamyl as used herein, alone or in combination, refers to a ROC(O)NR′-group, with R and R′ as defined herein.
- carbonyl when alone includes formyl [—C(O)H] and in combination is a —C(O)— group.
- carboxy refers to —C(O)OH or the corresponding “carboxylate” anion, such as is in a carboxylic acid salt.
- An “O-carboxy” group refers to a RC(O)O— group, where R is as defined herein.
- a “C-carboxy” group refers to a —C(O)OR groups where R is as defined herein.
- cycloalkyl refers to a carbocyclic substituent obtained by removing a hydrogen from a saturated carbocyclic molecule and having three to fourteen carbon atoms. In one embodiment, a cycloalkyl substituent has three to ten carbon atoms. Examples of cycloalkyl include cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
- halo or halogen, as used herein, alone or in combination, refers to fluorine, chlorine, bromine, or iodine.
- haloalkoxy refers to a haloalkyl group attached to the parent molecular moiety through an oxygen atom.
- haloalkyl refers to an alkyl radical having the meaning as defined above wherein one or more hydrogens are replaced with a halogen. Specifically embraced are monohaloalkyl, dihaloalkyl and polyhaloalkyl radicals.
- a monohaloalkyl radical for one example, can have an iodo, bromo, chloro or fluoro atom within the radical.
- Dihalo and polyhaloalkyl radicals can have two or more of the same halo atoms or a combination of different halo radicals.
- haloalkyl radicals include fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, pentafluoroethyl, heptafluoropropyl, difluorochloromethyl, dichlorofluoromethyl, difluoroethyl, difluoropropyl, dichloroethyl and dichloropropyl.
- Haloalkylene refers to a haloalkyl group attached at two or more positions. Examples include fluoromethylene (—CFH—), difluoromethylene (—CF 2 —), chloromethylene (—CHCl—) and the like.
- heteroalkyl refers to a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof, fully saturated or containing from 1 to 3 degrees of unsaturation, consisting of the stated number of carbon atoms and from one to three heteroatoms selected from the group consisting of O, N, and S, and wherein the nitrogen and sulfur atoms can optionally be oxidized and the nitrogen heteroatom can optionally be quaternized.
- the heteroatom(s) O, N and S can be placed at any interior position of the heteroalkyl group. Up to two heteroatoms can be consecutive, such as, for example, —CH 2 —NH—OCH 3 .
- heterocycloalkyl and, interchangeably, “heterocycle,” as used herein, alone or in combination, each refer to a saturated, partially unsaturated, or fully unsaturated monocyclic, bicyclic, or tricyclic heterocyclic radical containing at least one, preferably 1 to 4, and more preferably 1 to 2 heteroatoms as ring members, wherein each said heteroatom can be independently selected from the group consisting of nitrogen, oxygen, and sulfur, and wherein there are preferably 3 to 8 ring members in each ring, more preferably 3 to 7 ring members in each ring, and most preferably 5 to 6 ring members in each ring.
- Heterocycloalkyl and “heterocycle” are intended to include sulfones, sulfoxides, N-oxides of tertiary nitrogen ring members, and carbocyclic fused and benzo fused ring systems; additionally, both terms also include systems where a heterocycle ring is fused to an aryl group, as defined herein, or an additional heterocycle group.
- Heterocycle groups of the compounds are exemplified by aziridinyl, azetidinyl, 1,3-benzodioxolyl, dihydroisoindolyl, dihydroisoquinolinyl, dihydrocinnolinyl, dihydrobenzodioxinyl, dihydro[1,3]oxazolo[4,5-b]pyridinyl, benzothiazolyl, dihydroindolyl, dihy-dropyridinyl, 1,3-dioxanyl, 1,4-dioxanyl, 1,3-dioxolanyl, isoindolinyl, morpholinyl, piperazinyl, pyrrolidinyl, tetrahydropyridinyl, piperidinyl, thiomorpholinyl, and the like.
- the heterocycle groups can be optionally substituted unless specifically prohibited.
- the term “optionally substituted” means the anteceding group can be substituted or unsubstituted.
- the substituents of an “optionally substituted” group can include, without limitation, one or more substituents independently selected from the following groups or a specific designated set of groups, alone or in combination: lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower heteroalkyl, lower heterocycloalkyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower perhaloalkyl, lower perhaloalkoxy, lower cycloalkyl, phenyl, aryl, aryloxy, lower alkoxy, lower haloalkoxy, oxo, lower acyloxy, carbonyl, carboxyl, lower alkylcarbonyl, lower carboxyester, lower carboxamido, cyano, hydrogen, halogen, hydroxy, amino, lower alkylamino
- Two substituents can be joined together to form a fused five-, six-, or seven-membered carbocyclic or heterocyclic ring consisting of zero to three heteroatoms, for example forming methylenedioxy or ethylenedioxy.
- An optionally substituted group can be unsubstituted (e.g., —CH 2 CH 3 ), fully substituted (e.g., —CF 2 CF 3 ), monosubstituted (e.g., —CH 2 CH 2 F) or substituted at a level anywhere in-between fully substituted and monosubstituted (e.g., —CH 2 CF 3 ).
- R or the term R′ refers to a moiety selected from the group consisting of hydrogen, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl and heterocycloalkyl, any of which can be optionally substituted.
- aryl, heterocycle, R, etc. occur more than one time in a formula or generic structure, its definition at each occurrence is independent of the definition at every other occurrence.
- certain groups can be attached to a parent molecular moiety or can occupy a position in a chain of elements from either end as written.
- an unsymmetrical group such as —C(O)N(R)— can be attached to the parent molecular moiety at either the carbon or the nitrogen.
- bond refers to a covalent linkage between two atoms, or two moieties when the atoms joined by the bond are considered to be part of larger substructure.
- a bond can be single, double, or triple unless otherwise specified.
- a dashed line between two atoms in a drawing of a molecule indicates that an additional bond can be present or absent at that position.
- PTMs Post Translational Modifications
- a hydrogen bond is an electromagnetic attractive interaction between polar molecules, where hydrogen is bonded to an electronegative atom such as nitrogen or oxygen.
- the hydrogen bond represents a strong dipole-dipole attraction. These hydrogen-bond attractions can occur between molecules (intermolecular) or within different parts of a single molecule (intramolecular).
- a hydrogen atom is attached to an electronegative atom, it is considered a hydrogen bond donor.
- the electronegative atom is considered a hydrogen bond acceptor, whether it is bonded to a hydrogen atom or not.
- the compounds described herein can also be in the form of a salt or solvate, or acid addition salts.
- a salt for example, in acid-base neutralization, an acid and a base react to form water and a salt. Basically, to react together, there must be the transfer of protons between acids and bases.
- different acids can produce different ions. For example, an Arrhenius acid produces hydronium ions when it dissociates in water.
- a Bronsted-Lowry acid is a proton donor that donates hydrogen ions to the base.
- proton acceptors and proton donors are the basis for the reaction and are referred to sometimes as a conjugate base or a conjugate acid.
- a conjugate pair refers to acids and bases with common features, where there is an equal loss/gain of protons between the pairs.
- NH 4 + is the conjugate acid to the base NH 3 because NH 3 gains a hydrogen ion to form NH 4 + as H 2 O donates a hydrogen ion to form OH ⁇ , the conjugate base.
- a Lewis acid accepts an electron pair and a Lewis base donates an electron pair donor.
- the proton H + can be an electron pair acceptor.
- a compound can be both, a Lewis acid and a Lewis base, depending on the reaction.
- methyl iodide can behave as both, a Lewis acid and a Lewis base, where the methyl group is donated to form a salt.
- the compounds of the formulas described herein can have quaternary nitrogens.
- the quaternary nitrogens will have a positive charge on the nitrogen and can be associated with a counterion and include all quaternary amine-counterion complexes of compounds when a compound includes a quaternary amine group.
- acids which can be employed to form a salt of any of the compounds provided herein include inorganic acids and organic acids as well known to those skilled in the art such as, but not limited to, N-hydroxysuccinimide, hydrochloric, hydrofluoric, hydroiodic, hydrobromic, sulfuric, hydrosulfuric, thiosulfuric, hydrocyanic, phosphoric, phosphorous, hydrochlorous, chlorous, nitrous, nitric, chloric, perchloric, sulfurous, oxalic, maleic, succinic, and citric. Salts can also be formed by coordination of the compounds with an alkali metal or alkaline earth ion.
- acids can form a salt including, but not limited to, 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid (L), aspartic acid (L), benzenesulfonic acid, benzoic acid, camphoric acid (+), camphor-10-sulfonic a cid (+), capric acid (decanoic acid), caproic acid (hexanoic acid), caprylic acid (octanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, ethanesulfonic acid, formic acid, fumaric acid, galactaric acid
- the counterion can be the conjugate base formed after reacting a compound or groups of compounds with an acid. In other words, counterion holds the opposite charge to that of the compound or compounds it is associated with.
- the counterion represents the anionic part of the salt.
- counterions of a salt compound described herein can include, but are not limited to, any of the following common anions and oxoanions: N-hydroxysuccinimidyl, hydride (H ⁇ ), fluoride (F ⁇ ), chloride (Cl ⁇ ), bromide (BP), iodide (I ⁇ ), oxide (O 2 ⁇ ), hydroxide (OH ⁇ ), peroxide (O 2 2 ⁇ ), sulfide (S 2 ⁇ ), hydrogen sulfide (HS ⁇ ), selenide (Se 2 ⁇ ), nitride (N 3 ⁇ ), azide (N 3 ⁇ ), phosphide (P 3 ⁇ ), arsinide (As 3 ⁇ ), carbide (C 4 ⁇ ), cyanide (CN ⁇ ), hypochlorite (ClO 1 ⁇ ), chlorite (ClO 2 ⁇ ), chlorate (ClO 3 ⁇ ), perchlorate (ClO
- glycans including N-linked glycans and O-linked glycans, with MS active fluorescent compounds of Formula I, as well as conjugates resulting therefrom are provided.
- the glycan is tagged, derivatized or conjugated through an aldehyde or ketone with the amine of a compound provided herein via reductive amination.
- New compounds also referred herein to as “reagents” and/or “molecules”) specific for N-linked and O-linked glycans amino acids and peptides, are provided for enhanced MS detection and fluorescence tagging of glycans and other biomolecules with enhanced MS signals.
- the reaction times necessary to carry out the tagging process (or otherwise sometimes referred to herein as “labeling”) can be performed efficiently and applied to a wider group of biopolymers.
- the described compounds are useful in a wide variety of processes that rely on glycan and amino acid/peptide analysis for essential information of a product, process, or protein.
- the molecules described herein can be used in processes such as protein characterization, cell culture monitoring, synthetic peptide manufacturing, and food analysis.
- N-linked glycans are attached to asparagines via an N-acetylglucosamine (“GlcNAc”) residue in an Asn-Xxx-(Ser, Thr) motif where Xxx can be any amino acid except proline.
- GlcNAc N-acetylglucosamine
- O-linked glycans are attached to either Serine or Threonine. N-linked glycans can be removed from the glycoprotein chemically or enzymatically.
- N-linked glycans include, but are not limited to, mannobiose (Man2), mannotriose (Man3), mannotetraose (Man4), mannopentaose (Man5), mannohexaose (Man6) and mannoheptaose (Man7).
- Other glycans include A2, FA2, M5, FA1G1, A2G1, FA2G1, FA2G2, FA2G1Ga1, FA2G2Ga1, FA2G2Sg1, FA2G1Ga2, FA2G2GaSg1
- the reaction can be conducted in the presence of reducing agents such as sodium cyanoborohydride, sodium triacetoxyborohydride, picoline borane.
- the reductive amination is conducted in aqueous media.
- the reductive amination reaction of aldehyde containing compounds can be conducted in non-aqueous solvents.
- Reagents that can facilitate reductive amination include LiAlH 4 , ZnCl 2 —Zn(BH4) 2 ; NiCl 2 —NaBH 4 ; Ti(iPrO) 4 -polymethylhydrosiloxane; Ti(i-PrO) 4 —NaBH 4 ; Bu 3 SnH; Bu 2 SnClH and Bu 2 SnIH; decaborane; silica gel-Zn(BH4) 2 ; Et 3 SiH-trifluoroacetic acid; pyridine—BH 3 ; phenylsilane-dibutyltin dichloride. Basu et. al., 4 SYNLETT 555 (2003).
- the reaction can be conducted in a mixture of citric acid and/or acetic acid with an organic solvent such as dimethylsulfoxide dimethylformamide, formamide, hexamethylphosphoramide, hexamethylphosphorus triamide, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone or dimethylacetamide.
- the reaction can also be conducted in a solvent selected from tetrahydrofuran, dichloromethane, 1,2-dichloroethane, ethanol, methanol or isopropanol, toluene and xylene, and mixtures thereof.
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with MS active, fluorescence tagging quinoline derivatives of the structural Formula II:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- methods include tagging glycans and other biomolecules with compounds of Formula IIA:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- compositions are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R 1 is hydrogen.
- methods wherein compounds are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R 2 is hydrogen.
- compounds are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R 1 and R 2 are hydrogen.
- exemplary compounds Table A of the structural Formulas II, IIA, IIB, IIC, IID, IIE, IIF or IIG which can be used in the methods described herein for fluorescent labeling of glycans and for subsequent analysis by means of liquid chromatography and mass spectrometry.
- the compounds of structural Formulas II, IIA, IIB, IIC, IID, IIE, IIF or IIG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- Methods for tagging, derivatizing or conjugating glycans containing at least one ketone group or an aldehyde group with a compound of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or a compound of Table A by reductive amination reaction are further provided.
- This reaction between any one or more of the compounds and the glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride.
- the reaction can be carried out in a solution or suspension of a compound of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or a compound of Table A in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride
- organic solvent for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry comprise the step of labeling the glycan in a sample by reacting with one or more of the compounds of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or compound of Table A for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans and other biomolecules can be conjugated to MS active fluorescent compounds of Formula II and salts or solvates thereof.
- the following schematic shows the tagging of a glycan using a compound of Formula II through reductive amination:
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with compounds of the structural Formula III:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG wherein R 1 is hydrogen.
- the compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG include compounds wherein R 2 is hydrogen.
- the compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG include compounds wherein R 1 and R 2 are hydrogen.
- exemplary compounds (Table B) of the structural Formulas III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG which can be useful for labeling glycans and subsequent analysis by means of liquid chromatography and mass spectrometry.
- the compounds of structural Formulas III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- the methods for tagging, derivatizing or conjugating glycans containing at least one ketone group or an aldehyde group with a compound of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG or a compound of Table B by reductive amination reaction are provided.
- the reaction between a compound of Formula III and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent selected from sodium cyanoborohydride or sodium triacetoxyborohydride.
- the reaction can be carried out in a solution or suspension of a compound of Formula III, IIIA, IIIB, IIIG, IIID, IIIE, IIIF or IIIG or a compound of Table B in an acidic media, for example in citric acid or acetic acid, and mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride
- organic solvent for example, tetrohydrofuran or dimethylsulfoxide.
- the analytical method comprises the steps of labeling the glycan in the sample by reacting with a compound of Formula III, IIIA, IIIB, IIIG, IIID, IIIE, IIIF or IIIG or a compound of Table B for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans can be conjugated to MS active fluorescent compounds of Formula III and salts or solvates thereof.
- the following general schematic shows the tagging of a glycan using a compound of Formula III through reductive amination:
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with MS active, fluorescence tagging reagents of the structural Formula IV:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- exemplary compounds (Table C) of the structural Formulas IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG which can be useful for fluorescent labeling of glycans and subsequent analysis by means of liquid chromatography and mass spectrometry.
- the compounds of structural Formulas IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- the compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG include compounds wherein R 1 is hydrogen. In an embodiment, further provided are compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG including compounds wherein R 2 is hydrogen. In an embodiment, compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG include compounds wherein R 1 and R 2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group with a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG or a compound of Table C by reductive amination reaction are further provided.
- the reaction between a compound of Formula II and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride.
- the reaction can be carried out in a solution or suspension of a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG or a compound of Table B in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride
- organic solvent for example, tetrohydrofuran or dimethylsulfoxide.
- the analytical method comprises the steps of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans can be conjugated to MS active fluorescent compounds of Formula IV and salts or solvates thereof.
- the following general schematic shows the tagging of a glycan using a compound of Formula IV through reductive amination:
- Methods for labeling (tagging) and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with compounds of the structural Formula V, VI, VII, VIII or IX:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- methods for tagging glycans and other biomolecules with compounds of Formula VA, VIA, VIIA, VIIIA or IXA, and salts or solvates thereof are provided.
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl.
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- methods for tagging glycans and other biomolecules with compounds of Formula VC, VIC, VIIC, VIIIC or IXC, or salts and solvates thereof are provided:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- methods for tagging glycans and other biomolecules with compounds of Formula VD, VID, VIID, VIIID or IXD, or salts or solvates are provided.
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- methods for tagging glycans and other biomolecules with compounds of Formula VE, VIE, VIIE, VIIIE or IXE are provided:
- each of R 1 and R 2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R a is selected from
- R b is oxo or
- R c , R d , R e , R f and R g are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- compounds of V, VI, VII, VIII or IX wherein R 1 is hydrogen.
- compounds of Formula V, VI, VII, VIII or IX wherein R 2 is hydrogen.
- compounds of Formula V, VI, VII, VIII or IX include compounds wherein R 1 and R 2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group, with a compound of Formula V, VI, VII, VIII, IX or a compound of Table D by reductive amination reaction are further provided.
- the reaction between a compound of Formula V, VI, VII, VIII or IX and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride.
- the reaction can be carried out in a solution or suspension of a compound of Formula V, VI, VII, VIII or IX or a compound of Table D in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- the analytical method comprises the steps of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula V, VI, VII, VIII or IX or a compound of Table D for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Methods for tagging glycans can be accomplished by reductive amination of glycans with MS active, fluorescence tagging phenyl derivatives of Formula X:
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- methods for tagging biomolecules, such as glycans, with a compound of Formula XC is provided as follows:
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3 and CO 2 H;
- R 3 b is
- exemplary compounds (Table E) of the structural Formulas X, XA, XB, XC, XD, XE, XF or XG which can be useful for fluorescent labeling of glycans and subsequent analysis by means of liquid chromatography and mass spectrometry.
- the compounds of structural Formulas X, XA, XB, XC, XD, XE, XF or XG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- compounds of X, XA, XB, XC, XD, XE, XF or XG wherein R 1 is hydrogen.
- compounds of Formula X, XA, XB, XC, XD, XE, XF or XG wherein R 2 is hydrogen.
- compounds of Formula X, XA, XB, XC, XD, XE, XF or XG include compounds wherein R 1 and R 2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group with a compound of Formula X, XA, XB, XC, XD, XE, XF or XG or a compound of Table E by reductive amination reaction are further provided.
- reaction between a compound of Formula X, XA, XB, XC, XD, XE, XF or XG and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride.
- a reducing agent such as from sodium cyanoborohydride or sodium triacetoxyborohydride.
- the reaction can be carried out in a solution or suspension of a compound of Formula X, XA, XB, XC, XD, XE, XF or XG or a compound of Table D in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride
- organic solvent for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry include the step of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula X, XA, XB, XC, XD, XE, XF or XG for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- glycans can be conjugated to MS active fluorescent compounds of Formula X and salts or solvates thereof.
- the following general schematic shows the tagging of a glycan using a compound of Formula X through reductive amination:
- the organic layer was separated and the aqueous layer was extracted with 2 mL of dichloromethane.
- the organic phases were combined, dried, and then evaporated to dryness to provide the crude material. This was subjected to standard organic chemistry purification techniques to provide the desired material C in >95% purity.
- OPA o-phthalaldehyde
- mercaptan The o-phthalaldehyde procedure can detect amino acids with a typical detectable level in the order of about 100 femtomole (fmol).
- an adduct can be unstable and, therefore, should be prepared shortly before the detection step.
- the reagent may not form a derivative with secondary amino acids.
- FMOC 9-fluorenylmethylchloroformate
- PITC phenylisothiocyanate
- the dansyl chloride method provides stable derivatives with a minimum detectability in the order of about 1.5 pmol. It is able to detect secondary amines and cysteine, but it results in multiple derivatives.
- Fluorescent succinimidocarbamates are useful as derivatizing agents for amines, amino acids, peptides, phosphates and other classes of compounds.
- succinimidocarbamate reagent When the succinimidocarbamate reagent is used to tag a compound with a fluorescent group, a detection limit of about 1 pmol can be achieved.
- These reagents can be used in conjunction with modern separation techniques such as high performance liquid chromatography, thin layer chromatography or capillary electrophoresis.
- the present methods are not restricted to any specific linkage chemistry or attachment mechanism.
- the following determinations can be performed separately: (1) the glycosylated sites; (2) the glycosylated site occupancy; (3) the structure and amount of each glycan at each site: and (4) the number of glycoforms.
- Harvey, D. J. Identification of Protein - Bound Carbohydrates by Mass Spectrometry, 1 PROTEOMICS 311-319 (2001) at 312, incorporated herein by reference.
- MS can provide the answers to each of these steps. Hence the need for enhanced MS signals. Because of the branched nature of the glycan, however, structural determination of the glycan is complicated.
- the monosaccharide unit, the anomericity and ring size of each monosaccharide, the monosaccharide sequence and ring conformation together with identification of other groups must be determined.
- MS can be used directly or indirectly to make these determinations using MALDI and/or ESI as the preferred MS technique. Id. at 313-316, incorporated herein by reference.
- Compounds described herein are useful for derivatizing glycans because they can form stable, highly fluorescent MS derivative compounds and conjugate glycans.
- the general methodology for an analysis of a glycan or amino acid derivatized by these compounds include three closely related processes: (1) formation of derivatives in the sample; (2) separation of the derivatives; and (3) detection of the separated derivatives.
- the first step is generally performed by reacting a mixture with one of the present compounds as a reagent to yield a derivatized compound.
- the derivatives provide a fluorescent signal which can then be detected in the detection stage of the analysis.
- the separation step is based upon the differences in the chemical structure of the derivatives.
- the derivatized compounds can differ from each other in the same way that the chemical structures of the precursor compounds differ.
- the derivatives must be separated so that the detector signal can be correctly related to the concentration of each derivative.
- the derivatized glycans can be separated and detected by chromatography, e.g., by high performance liquid chromatography (“HPLC”) or capillary zone electrophoresis (“CZE”).
- the detection step is generally carried out using either an absorbance or fluorescence detector. As each derivative is eluted from the chromatographic column after separation, its presence and quantity is detected by a mass spectrometer and/or by the absorbance or emission of light. The sensitivity of the assay depends upon the strength of the signal produced.
- LC liquid chromatography
- Fluorescent measurements are sensitive and quantitative; the low detection limit is in the low femtomoles.
- mass spectrometry instrumentation With recent advancements in mass spectrometry instrumentation, the combination of liquid chromatography, fluorescence and MS has gained more popularity as an analytical instrument platform for routine characterization of fluorescently labeled N-linked glycans. Therefore, relative quantitation and molecular weight measurements can be done in a single analysis. Shigeo Suzuki et al., Comparison of the Sensitivities of Various Derivatives of Oligosaccharides in LC/MS with Fast Atom Bombardment and Electrospray Ionization Interfaces, 1006 A NAL C HEM 2073 (1996). However, a challenge has been that glycans do not ionize efficiently via electro-spray-ionization (“ESI”).
- EI electro-spray-ionization
- Absorbance detection is generally used in protein mapping work. Two different detection processes which are often used for this purpose are: a) detection at 210-215 nm using a single wavelength detector; and b) broadband spectral detection using a photodiode array (PDA) detector.
- PDA photodiode array
- all peptides absorb at that wavelength, thus the user can ensure that all peptides eluted from the column are detected.
- One difficulty with this technique is that a wide variety of compounds absorb in this region of the spectrum, and extreme care must be taken to ensure that all reagents, eluents, glassware, etc. are scrupulously clean to ensure that the observed signal is solely from the peptides.
- the PDA detector collects the spectra of the eluent at specific time intervals (e.g. a spectrum between 200 and 350 nm is collected every second). This provides more information than a single wavelength and thus can assist in distinguishing between peptides which can elute with similar retention times.
- the condition of the sample is important.
- Compounds other than analyte will generally have an adverse effect on ion yield and are preferably removed.
- carbohydrates are particularly susceptible to the effects of salts.
- many carbohydrates occur as mixtures. Therefore, it is important to ensure that isolation and purification techniques do not cause fractionation of the sample with a loss of quantitative information.
- the compounds described herein can enhance ionization efficiency of the reductively aminated saccharides, particularly O-linked glycans, when the tagged glycan is subsequently electrosprayed in positive ion mode to create protonated ions.
- This phenomenon can be attributed to two attributes of the reagent: its high gas phase basicity and hydrophobicity that produces non-polar surface area.
- 6-ADEQ a compound referred to herein as 6-ADEQ is shown structurally below.
- 6-ADEQ can be used to enhance the fluorescence and ionization efficiency of aldehyde containing molecules, such as saccharides or oligosaccharides. As described below, in comparison with oligosaccharides labeled with 2-aminobenzamide (“2-AB”),
- the 6-ADEQ labeled oligosaccharide has been found to yield six (6) times greater fluorescence signal and approximately 250 times greater positive ion mode MS signal when analyzed by hydrophilic interaction liquid chromatography. (Example 1, FIG. 2 ).
- the 6-ADEQ label has a unique ability to enhance the ionization efficiency of reductively aminated saccharides when they are electrosprayed in positive ion mode to create protonated ions. This can be attributed to two attributes of the 6-ADEQ label: its high gas phase basicity and its hydrophobicity.
- procainamide While labeling compounds bearing high pKa, basic residues have previously been used for reductive amination of saccharides, previous studies showed procainamide to be most effective at improving MS response. See e.g., Klapoetke, S. et al., The Evaluation of a Novel Approach for the Profiling and Identification of N - linked Glycan With a Procainamide Tag by HPLC With Fluorescent and Mass Spectrometric Detection. J Pharm Biomed Anal, 53 (3), 315-24 (2010). While procainamide has a tertiary amine side chain that is identical to 6-ADEQ, it has a non-polar surface area of only 181 ⁇ . The larger non-polar surface area of 207 ⁇ contributes to the ability of 6-ADEQ to more effectively increase MS response factors.
- the present methods combine the benefits of non-polar surface area with a pKa greater than 7 to provide enhanced MS signaling.
- the pKa is between about 7 to 10 or between about 10 to 13.
- the non-polar surface areas of these labeling compounds are, at a minimum, 10% greater than procainamide as shown and described herein.
- the reagents described herein can enhance positive ion mode MS analyses of peptides and/or glycopeptides.
- amine residues are modified by the introduction of a tag (label) having high non-polar surface area combined with a high pkA basic residue.
- label a tag having high non-polar surface area combined with a high pkA basic residue.
- this combination improves the ionization of peptides during positive ion mode MS analyses.
- Peptides are routinely separated by chromatography under acidic conditions where acidic groups present on a peptide or glycopeptide (aspartic and glutamic amino acids and the groups of monosaccharides known as sialic acids) are protonated.
- the peptide or glycopeptide once modified adopts higher charge states because of the enhanced basicity.
- a sulfonate anion is added to the fluorescent group for detection in UHPLC and to improve the sensitivity of matrix-assisted laser desorption/ionization (“MALDI”) measurements made in the negative ion mode.
- MALDI matrix-assisted laser desorption/ionization
- the reagent is designed to convert the N-terminus or the side chains of lysine residues into an acidic functionality containing the label that is linked to the peptide through a neutral urea bond to improve the analysis sensitivity in the negative ion mode of MALDI.
- the change in chemical properties of the reagent can compromise an analytical technique for peptides in measured in the positive ion mode MS.
- MALDI is a soft ionization technique used in mass spectrometry, allowing the analysis of biomolecules (biopolymers such as DNA, proteins, peptides/glycopeptides, and glycans) and large organic molecules including polymers, dendrimers, and other macromolecules which tend to be fragile and fragment when ionized by more conventional ionization methods.
- MALDI is similar in character to electrospray ionization (“ESI”) in that both techniques are relatively soft ways of obtaining intact ions of large molecules in the gas phase, though MALDI produces far fewer multiple charged ions.
- MALDI methodologies are typically a three-step processes. First, the sample is mixed with a suitable matrix material and applied to a metal plate. Second, a pulsed laser irradiates the sample, triggering ablation and desorption of the sample and matrix material. Finally, analyte molecules are ionized by being protonated or deprotonated in the hot plume of ablated gases, and can then be accelerated into a mass analyzer.
- LC-MS analysis is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography and the mass analysis capabilities of mass spectrometry (“MS”).
- MS mass spectrometry
- LC-MS is a powerful technique that has a very high measurement sensitivity, making it useful in many applications. Its application is oriented towards the separation, general detection, and potential identification of analytes having a specific mass in the presence of other compounds (i.e., in complex mixtures), e.g., natural products from natural-products extracts and pure substances from mixtures of chemical intermediates.
- Preparative LC-MS systems can be used for rapid mass-directed purification of specific substances from such mixtures that are important in basic research, and pharmaceutical, agrochemical, food, and other industries. Like gas chromatography-mass spectrometry, it allows analysis and detection even of minute amounts of a substance.
- ETD electron transfer dissociation
- CID collision-induced dissociation
- m/z effective mass-to-charge range
- Mannose 5 (Man5) oligosaccharide was reductively aminated in high yield with either one of two different reagents, 2-aminobenzamide (“2-AB”) and 6-ADEQ ( FIG. 1 ).
- 2-AB 2-aminobenzamide
- 6-ADEQ FIG. 1
- the resulting labeled mannose 5 species were then separated at equivalent mass loads using hydrophilic interaction liquid chromatography (“HILIC”) and subsequently detected by fluorescence and electrospray ionization (“ESI”) mass spectrometry (“MS”).
- HILIC hydrophilic interaction liquid chromatography
- ESI fluorescence and electrospray ionization
- MS mass spectrometry
- a procedure for reductive amination was adapted from Szabo et al to prepare 6-ADEQ labeled Man 5 oligosaccharide.
- Szabo et. al. Improved Sample Preparation Method for Glycan Analysis of Glycoproteins by CE - LIF and CE - MS, ELECTROPHORESIS 31, 1389 (2010).
- 800 pmol of dried Man 5 was reconstituted in 10 ⁇ L of 350 mM 6-ADEQ in 1.2M citric acid.
- 10 ⁇ L of 1M sodium cyanoborohydride in tetrahydrofuran was subsequently mixed. The resulting mixture was incubated at 55° C. After 1 hour, the reaction was quenched via addition of 120 ⁇ L water.
- 2-AB labeled Man 5 was prepared using a similar reductive amination procedure, specifically a protocol adapted from work by Bigge et al. Nonselective and Efficient Fluorescent Labeling of Glycans Using 2- Amino Benzamide and Anthranilic Acid, Anal Biochem, 230(2), 229 (1995).
- 800 pmol of dried Man 5 was reconstituted in 20 ⁇ L of 350 mM 2-AB and 1M sodium cyanoborohydride in 30:70 acetic acid/dimethylsulfoxide. The resulting mixture was incubated at 55° C. After three hours, the reaction was quenched via addition of 120 ⁇ L water.
- Man 5 oligosaccharides were analyzed by HILIC chromatography with an ACQUITY UPLC Glycan BEH Amide column. As they eluted from the column, the different labeled forms of Man 5 were serially detected by fluorescence and ESI ⁇ MS per the experimental conditions listed below.
- Polarity ES+ Acquisition 500-2000 m/z (1 Hz) Capillary (kV) 2.5 Source Temperature (° C.) 120 Sampling Cone 70 Source Offset 50 Desolvation Temperature (° C.) 350 Desolvation Gas Flow (L/Hr) 500 Nebulizer Gas Flow (Bar) 6.0 Data corresponding to this comparison example are portrayed in FIG. 2 .
- methods for tagging a glycan or another biopolymer for enhanced mass spectroscopy signal and fluorescence comprising the steps of providing a glycan or another biopolymer containing an aldehyde group and reacting the glycan or biopolymer with an amphipathic compound having a non-polar surface area of more than about 200 ⁇ and having a primary amine group under conditions that can facilitate reductive amination wherein a conjugate of said amphipathic compound and said glycan is formed.
- the non-polar surface area is between about 200 ⁇ and about 1000 ⁇ or between about 200 ⁇ and about 600 ⁇ or between about 200 ⁇ and about 500 ⁇ or between about 200 ⁇ and about 500 ⁇ .
- reagents such as RapiFluor-MS
- RapiFluor-MS reagents that can be used to prepare labeled glycosylamines for hydrophilic interaction chromatography in as little as 30 minutes.
- RapiFluor-MS While facilitating fast preparations, RapiFluor-MS also yields inordinate gains in mass spectrometric (MS) sensitivity when glycans are analyzed by positive ion mode electrospray ionization mass spectrometry (ESI+MS).
- MS mass spectrometric
- ESI+MS positive ion mode electrospray ionization mass spectrometry
- the mass spectrometric (MS) response factors of RapiFluor-MS labeled glycans have been benchmarked against other rapid tagging, glycosylamine reagents and their corresponding label moieties, including those that produce benzamide, quinoline, procainamide and procaine derivatives ( FIG. 3 A , FIG. 3 B , FIG. 3 C , FIG. 3 D and FIG. 3 E ).
- the results of these experiments show that the RapiFluor-MS label (from Compound 1) gives a ⁇ 600 ⁇ increase in MS response versus a benzamide label (from Compound 2) and a ⁇ 200 ⁇ increase in MS response versus a quinoline label (from Compound 3) ( FIG. 4 A , FIG.
- RapiFluor-MS label gives a ⁇ 2 ⁇ increase in MS response versus procainamide and procaine-based labels (from Compounds 4 and 5, respectively) ( FIG. 6 A , FIG. 6 B , and FIG. 6 C and FIG. 7 ). Additionally, it has been observed that RapiFluor-MS labeled glycans adopt comparatively higher average charge states ( FIG. 8 A , FIG. 8 B , and FIG. 8 C ).
- the RapiFluor-MS reagent incorporates an amphipathic label onto glycans that concomitantly increases their hydrophobicity and basicity. As has now been discovered, these characteristics define a unique type of labeled glycan structure that exhibits unprecedented gas phase proton affinity. Importantly, this methodology is not restricted to any one linkage chemistry and can be achieved with various rapid tagging glycosylamine labeling reagents. See e.g., U.S. patent application Ser. Nos. 14/458,760 (published as US2014/0350263) at ⁇ [0008]-[0022], [0054]-[182] and [0191] and Ser. No. 15/005,619 (unpublished), incorporated by reference. Instead, this methodology encompasses two chemical aspects that can be imparted by a rapid tagging glycosylamine reagent: hydrophobicity and basicity. Two exemplary formula of rapid tagging glycosylamine labeling reagents include:
- the RapiFluor-MS label is unique in that it combines a high pKa ionizable group with a large non-polar surface area ( FIG. 9 ). Not surprisingly, the RapiFluor-MS label exhibits the highest non-polar surface area, as is consistent with it also exhibiting the highest ESI+MS response factors.
- the present methods use a rapid tagging glycosylamine reagent that yields a labeling moiety having both a high pKa (>7) ionizable group and a functionality that affords a comparatively large non-polar surface area.
- a rapid tagging glycosylamine reagent that yields a labeling moiety having both a high pKa (>7) ionizable group and a functionality that affords a comparatively large non-polar surface area.
- Such rapid tagging glycosylamines reagents are taught in U.S. patent application Ser. No. 14/458,760 (published as US2014/0350263) at ⁇ [0008]-[0022], [0054]-[182] and [0191] and Ser. No. 15/005,619 (unpublished), incorporated by reference.
- the non-polar surface areas of these label moieties are, at a minimum, 10% greater than an analogous procainamide-based label.
- N-glycans (glycosylamines) labeled with Compounds 1, 2 and 3 were evaluated via HILIC separations obtained with a UHPLC chromatograph (ACQUITY UPLC H-Class Bio, Waters, Milford, Mass.). Labeled glycans from 0.4 ⁇ g glycoprotein were separated using a 2.1 ⁇ 50 mm column packed with 1.7 ⁇ m amide bonded organosilica (130 ⁇ ) stationary phase (ACQUITY UPLC Glycan BEH Amide 130 ⁇ , Waters, Milford, Mass.) along with an aqueous mobile phase comprised of 50 mM ammonium formate (pH 4.4) and another of ACN.
- FIG. 4 A , FIG. 4 B , and FIG. 4 C shows the HILIC-MS base peak intensity chromatograms for N-glycans from anti-citrinin murine IgG1 as labeled with Compounds 1, 2, and 3, respectively. MS (base peak intensity) response factors were calculated from these analyses and are shown in FIG. 5 .
- N-glycans (glycosylamines) labeled with Compounds 1, 4 and 5 were evaluated via HILIC separations obtained with a UHPLC chromatograph (ACQUITY UPLC H-Class Bio, Waters, Milford, Mass.). Labeled glycans from 0.1 ⁇ g glycoprotein were separated using a 2.1 ⁇ 50 mm column packed with 1.7 ⁇ m amide bonded organosilica (130 ⁇ ) stationary phase (ACQUITY UPLC Glycan BEH Amide 130 ⁇ , Waters, Milford, Mass.) along with an aqueous mobile phase comprised of 50 mM ammonium formate (pH 4.4) and another of ACN.
- FIG. 6 A , FIG. 6 B , and FIG. 6 C shows the HILIC-MS base peak intensity chromatograms for N-glycans from anti-citrinin murine IgG1 as labeled with Compounds 1, 4, and 5, respectively.
- MS (base peak intensity) response factors were calculated from these analyses and are shown in FIG. 7 .
- glycopeptides provide a wealth of data, including site-specific glycan information.
- glycans are difficult to characterize by routine LC-MS/MS approaches. Their collision-induced dissociation patterns show extensive glycan fragmentation, while the peptide backbone is unaffected. This can be useful for determining the glycan's composition, but hinders a definitive answer regarding its amino acid sequence.
- electron-transfer dissociation can be used for glycopeptide backbone fragmentation, when derivatized to allow higher charge states to be generated shifting their m/z values towards the effective region for ETD.
- FLR fluorescent
- MS mass spectrometry
- Glycoproteins were resuspended at 5 ⁇ g/ ⁇ L in phosphate-buffered saline containing 0.1% Rapigest surfactant and 10 mM TCEP. Proteins were denatured at 60° C. for 1 hour (“hr.”) and alkylated for 1 hr. with 25 mM iodoacetamide. Trypsin was added at 1:20 ratio and the proteins were digested for 18 hrs.
- the derivatization reagent was solubilized in DFM at 100 mg/mL and a 6.5- ⁇ L aliquot was added to a 5- ⁇ L aliquot of the digest (diluted with 20 ⁇ L of 100 mM, pH 8 phosphate buffer and 6.5 ⁇ L of DMF). After 5 minutes, a second 6.5 ⁇ L aliquot of the reagent was added. After quenching the reaction with TRIS, the samples were analyzed by optimized hydrophilic interaction liquid chromatography (HILIC)/UPLC-MS.
- HILIC hydrophilic interaction liquid chromatography
- HILIC separation of glycopeptides requires the use of TFA, frequently at 0.1% (v/v) so that the separation is driven more by the glycans than the peptide backbone, therefore, the TFA spiked mobile phase in HILIC mode separates glycopeptide glycoforms more efficiently than reversed phase chromatography.
- TFA as a modifier leads to decreased MS responses and generates ions with lower charges.
- the minimum amount of TFA required should be used and the optimized mobile phase conditions were determined to be 0.01% TFA/0.1% formic acid (v/v).
- the N-termini and lysine side chains were derivatized with a rapid glycan labelling molecule with a tertiary amino group in a simple one-step reaction.
- the reagent was directly added to an aliquot of the digest with no sample cleanup.
- ESI generated glycopeptides with additional higher charge states.
- native glycopeptides of ribonuclease B were observed in the 1+ and 2+ charge states due to the short peptide length, while the derivatized analogues were detected as 2+ and 3+ ions. ( FIG. 10 & FIG. 11 ).
- the CID spectra of the more highly charged derivatized species were very similar to those of the native analytes.
- the ETD spectra of the native glycopeptides largely failed to produce significant peptide backbone fragmentation, as the m/z values were beyond the most effective ETD region.
- the ETD spectra appear to show enhanced fragmentation and allowed site-specific information to be obtained.
- positive-mode ESI produced a 2+ ion for the native analyte, while the derivatized version produced significant amounts of the 3+ ion.
- charge-state enhancements for larger glycopeptides. Increasing the charge state of glycopeptides will significantly enhance their ETD fragmentation efficiency, allowing scientists to effectively fragment the peptide backbone, while leaving the glycan intact and attached to the peptide.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 16/312,800 filed Dec. 21, 2018 which is a 371 National Stage filing of International Application No. PCT/US2017/038119 filed Jun. 19, 2017 which claims priority to U.S. Provisional Patent Application No. 62/352,734 filed Jun. 21, 2016 and U.S. Provisional Patent Application No. 62/483,015 filed Apr. 7, 2017. The contents of each are incorporated herein by reference in their entirety.
- Analysis of glycans is used for protein research and can be important to clinical chemists and pharmaceutical manufacturers, especially where glycosylation profiling of proteins is monitored to ensure consistency of a therapeutic product. Therefore, fluorescent labeling of gglycans is beneficial because the sensitivity and selectivity of glycan detection can be improved as well as the chromatographic behavior. However, upon derivatization with a reagent that provides a fluorescent moiety, the identity of the compound can only be speculated. Mass spectrometry (“MS”) is required to identify the specific compound. Furthermore, certain tagging reagents have good fluorescence signal, but a poor MS signal.
- There is a need, therefore, for methods for tagging glycans to provide both mass spectrometry and fluorescence signals through diverse sets of reaction conditions with reactivity to various functional groups that might be present in the glycan.
- Methods of analyzing glycans via mass spectroscopy as well as fluorescence and ultraviolet (“UV”) by tagging glycans, particularly N-linked glycan and O-linked glycans, using compounds of the various formulas are described herein. The methods described herein include derivatization of other biomolecules including proteins, peptides and/or biopolymers containing an aldehyde or ketone group, with one or more fluorescent, MS active compounds by reductive amination or rapid tagging to produce derivatized glycan having a pKa >7 and between about 200 Å and about 1000 Å of nonpolar surface area. The non-polar surface area can be used to estimate the hydrophobicity of a reagent. Furthermore, nonpolar surface area can be estimated as in the procedure described by Walker et. al., Hydrophobic Derivatization of N-linked Glycans for Increased Ion Abundance in Electrospray Ionization Mass Spectrometry, 22 J. AM. SOC. MASS SPECTROM. 1309 (2011). As the non-polar surface area or hydrophobicity of the reagent is increased, the signal of the derivatized glycan is increased.
- Hence, the present methods use labeling moieties for reductive amination of glycans that are constructed to combine a high pKa (>7) basic residue with a functional group that affords comparatively significant non-polar surface area. Indeed, the combination of nonpolar surface area and high pKa is not restricted to compounds that are fluorescently active. Furthermore, nonpolar surface area can be combined advantageously with low pKa acidic moieties to enhance negative ion mode electrospray ionization mass spectrometry.
- Also, provided are methods of tagging of glycans such as oligosaccharides, N-linked glycans, O-linked glycans and other biomolecules include, but not limited to, proteins and peptides that contain an aldehyde or ketone group, with the MS active fluorescent compounds described herein. The present methods provide for the analysis of tagged glycans via two different analytical methods, fluorescent and/or mass spectroscopic analysis. The analytical methods include: (a) tagging a glycan with a reagent to provide improved fluorescent signal in liquid chromatography, and (b) analyzing glycans tagged with a fluorescent and MS active compounds through reductive amination. Moreover, this methodology can be extended to capillary electrophoresis combined with fluorescence and MS detection.
- In particular, the methods of tagging can use compounds of formulas described herein. Each compound can be the reagent for fluorescence and enhanced MS signaling. Generally, the MS active, fluorescence tagging compounds can be of the structural Formula I:
- wherein
FL is a fluorophore such as a phenyl, quinoline, napthalene, coumarin or rhodamine compound. - More particularly, compounds of Formula I can be of any of the following structural formula, and salts or solvates thereof:
- wherein each R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H;
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12; - Ra is selected from
-
- and
Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and
each of R4, R5, R6 and R7 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H. - Furthermore, the compounds described herein can have optical centers. Therefore, the compounds can occur in different enantiomeric and disastereomeric configurations. Stereoisomers of such compounds of each formula, as well as racemic compounds and racemic mixtures and other mixtures of stereoisomers thereof can occur.
-
FIG. 1 shows chemical structure of a compound referred to as 6-ADEQ and a schematic for its use in reductive amination of an oligosaccharide. -
FIGS. 2A, 2B, 2C and 2D show a comparison of signal provided by 6-ADEQ versus 2-AB labeledMan 5 oligosaccharide.FIG. 2A shows HILIC fluorescence by 6-ADEQ andFIG. 2B shows base peak intensity MS chromatograms obtained for 6 pmoles of each type of labeled Man5 oligosaccharide with 6-ADEQ.FIG. 2C shows HILIC fluorescence by 2-AB andFIG. 2D shows base peak intensity MS chromatograms obtained for 6 pmoles of each type of labeled Man5 oligosaccharide with 2-AB. -
FIGS. 3A, 3B, 3C, 3D and 3E depicts certain rapid tagging glycosylamine reagents and the corresponding derivatized glycan product.FIG. 3A depictsCompound 1 and its corresponding derivatized glycan product.FIG. 3B depictsCompound 2 and its corresponding derivatized glycan product.FIG. 3C depictsCompound 3 and its corresponding derivatized glycan product.FIG. 3D depictsCompound 4 and its corresponding derivatized glycan product. AndFIG. 3E depictsCompound 5 and its corresponding derivatized glycan product. -
FIGS. 4A, 4B and 4C shows a comparison of HILIC-MS Base Peak Intensity Chromatograms obtained for N-Glycans Labeled withCompounds FIGS. 3A, 3B and 3C (respectively) using an Ion Mobility Capable of Mass Spectrometer (Waters Synapt G2-S, Milford, Mass.). N-glycans from 0.4 μg of anti-citrinin IgG1 monoclonal antibody were analyzed in each analysis.FIG. 4A shows the results labeled with Compound 1 (FIG. 3A ).FIG. 4B shows the results labeled with Compound 2 (FIG. 3B ). AndFIG. 4C shows the results labeled with Compound 3 (FIG. 3C ). -
FIG. 5 shows a comparison of MS response factors as obtained for an FA2 Glycan Labeled withCompounds FIG. 3A ,FIG. 3B andFIG. 3C (respectively) using an Ion Mobility Capable QT of Mass Spectrometer (Waters Synapt G2-S, Milford, Mass.). -
FIGS. 6A, 6B, and 6C show a comparison of HILIC-MS base peak intensity chromatograms obtained for N-glycans labeled withcompounds FIG. 3A ,FIG. 3D andFIG. 3E (respectively) using a QT of Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.). N-glycans from 0.1 μg of anti-citrinin IgG1 monoclonal antibody were analyzed in each analysis.FIG. 6A shows the results forCompound 1,FIG. 6B shows the results forCompound 4, andFIG. 6C shows the results forCompound 5. -
FIG. 7 shows a comparison of MS response factors as obtained for an FA2 Glycan Labeled withCompounds FIG. 3A ,FIG. 3D , andFIG. 3E (respectively) using a QT of Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.). -
FIGS. 8A, 8B and 8C show a comparison of Mass Spectra obtained for a FA2Ga1Sg1 N-Glycan Labeled withCompounds FIG. 3A ,FIG. 3E andFIG. 3D (respectively) using a QTof Mass Spectrometer (Waters Xevo G2-XS, Milford, Mass.).FIG. 8A shows the results labeled withCompound 1,FIG. 8B shows the results labeled withCompound 5 andFIG. 8C show the results labeled withCompound 4. -
FIG. 9 shows estimated non-polar surface area and pKa values of various tagging moieties. -
FIG. 10 shows an ESI mass spectrum of a derivatized bovine ribonuclease B tryptic glycopeptide tagged with a compound presented herein where generated ions were 2+ and 3+. -
FIG. 11 shows an ESI mass spectrum of a native (underivatized) bovine ribonuclease B tryptic glycopeptide where generated ions were 1+ and 2+. -
FIG. 12 provides a comparison of the ESI extracted ion chromatograms for two RFMS-labelled and native bovine ribonuclease B tryptic glycopeptides where ESI of the RFMS-labelled bovine ribonuclease B tryptic glycopeptides generated more intense ion signals than the native bovine ribonuclease B tryptic glycopeptides. -
FIG. 13 shows an ESI mass spectrum of a native tryptic glycopeptide from bovine fetuin presented herein where generated ions were 4+, 5+, and 6+. -
FIG. 14 shows an ESI mass spectrum a derivatized bovine fetuin tryptic glycopeptide tagged with a compound provided herein and ESI generated large amounts of 4+ and 5+ ions as well as 6+, 7+ and 8+ions. - Glycans play a significant role in physiological and pathological processes. Tagging glycans (otherwise sometimes referred to herein as “labeling glycans”) with MS fluorescent active compounds can improve detection via chromatographic methods including mass spectrum detection and allow for versatile analysis of glycans. Yang et. al., Glycan Analysis by Isobaric Aldehyde Reactive Tags and Mass Spectrometry, 85 ANAL CHEM. 8188 (2013).
- Quantitative analysis of glycans from normal and disease specimens can provide insight into disease onset and progression. Relative glycan quantification can be accomplished through modification of the glycans with either chromogenic or fluorogenic tags for optical measurement or isotopic tags for mass spectrometric analysis. Yang, et al., Id. The ion abundance of N-linked glycans in electrospray ionization mass spectrometry (ESI MS) can be increased by derivatizing the glycans with neutral, hydrophobic reagents. Walker, et al., Hydrophobic Derivatization of N-linked Glycans for Increased Ion Abundance in Electrospray Ionization Mass Spectrometry, 22 J. AM. SOC. MASS SPECTROM. 1309 (2011).
- Many peptides of biological and pharmaceutical interest are post-translationally modified and/or present at low abundance levels. Such analytes include N- and O-linked glycopeptides. Glycopeptide site microheterogeneity analysis by LC/MS is designed to characterize and quantify each glycoform of a peptide. However, glycopeptides lack appropriate chromophores on the glycan moiety and they ionize poorly by electrospray ionization (“ESI”) in comparison with peptides of similar molecular weight. This deficiency leads to low signals in both MS and optical detection. Furthermore, the microheterogeneity of the glycopeptides causes the glycopeptides to be present in proteolytic digestion at very low relative abundances.
- Provided herein are methods of tagging and analyzing glycans such as N-linked glycans, O-linked glycans and other aldehyde terminated saccharides. To analyze a glycan, the glycan can be labeled (also referred to herein as “tagged” or “derivatized”) with one of the compounds described herein in a sample, and then subjected to liquid chromatography, mass spectrometry, and fluorescence detection. The methods provide the use of a labeling moiety for reductive amination of saccharides that is constructed to combine a high pKa (>7) basic residue with a functional group that affords a significant non-polar surface area in the labeled glycan.
- In the methods presented herein, proteins, including glycoproteins, are first denatured and enzymatically digested into peptide fragments. A tagging reagent is then added to the peptide mixture. Compounds described herein can be used to label (tag) peptides, or analogous tags can be used. To derivatize the glycan, general conditions for the reductive amination reaction can be applied for tagging as described below.
- Alternatively, in certain methods, rapid tagging can proceed via nucleophilic attack and substitution. In this instance, a nucleophile from a peptide attacks an NHS carbamate reactive group. The peptide is thereby derivatized via a urea linkage to be labeled with a tag containing a hydrophobic quinolone fluorescent group and tertiary amine charge tag. The moieties on a peptide that are targeted for derivatization include any residues containing primary or secondary amines. Peptides contain at least one such reside, namely an amino (N) terminus. In addition, a given peptide can contain one or more primary or secondary amines residues, most typically from containing one more lysine residues. Reactions can be optimized to minimize labeling of other potential, albeit significantly weaker, nucleophiles, including but not limited to hydroxyl and imidazole groups.
- If rapid tagging reagents are utilized such as the compounds described herein, the reaction can be completed in minutes at room temperature. Yet, as described herein, molar excesses of reagent, pH, ionic strength, and buffer identity/composition can be selected. More specifically, conditions of the labeling reaction, including temperature, organic solvent composition, organic solvent concentration, buffer composition, pH, ionic strength, molar excess of reagent, and time are selected and controlled such that desired reaction selectivity between primary/secondary amines and hydroxyl groups is achieved. In turn, the yield of labeled reaction product is optimized and the generation of “over-labeled” species is minimized. In other words, the reaction product is optimized and the generation of species modified by any number of labels greater than the number of primary/secondary amines in minimized. However, sometimes over-labeling cannot be avoided.
- Regardless of the type of labeling step employed, after the labeling reaction, excess labeling reagent and a significant proportion of non-glycopeptides can be removed by solid phase extraction, either in an offline or online format. As an example, to isolate and purify the labeled glycopeptides, a SepPak aminopropyl SPE sorbent in the form of a μElution plate can be conditioned with 200 μL of water. The wells can be equilibrated with 200 μL of 15:85 water/acetonitrile. Acetonitrile diluted samples can be then loaded. The well can be washed with two (2) 600 μL volumes of 1:9:90 (v/v/v) formic acid/water/acetonitrile. The labeled glycopeptides can then be eluted with three (3) 30 μL volumes of SPE Elution Buffer (200 mM ammonium acetate in 5% CAN). Alternatively, a diol bonded or hydrophilic-lipophilic balanced sorbent (containing a sufficiently hydrophilic moiety) could be used for accomplishing this step. In addition, ion pairing wash solvents can be used in the SPE cleanup of labeled glycopeptides to improve selectivity between retention of glycopeptides versus non-glycopeptides. Furthermore, solid phase extraction is an optional step. Alternatively, analyses can be directly performed on the labeling reaction mixture.
- Regardless of the type of labeling step employed, tagged glycopeptides resulting from the above sample preparation are then subjected to LC/optical/MS analysis for structural characterization and glycan site microheterogeneity analysis. In these types of analyses, the labeled glycopeptides show higher optical and mass spectral signals. The gain in the enhanced signals offers higher confidence in peptide characterization and quantification. Also, MSMS fragmentation coverage is optimized in a way that benefits mass spectrometric structural investigations. A multitude of separations can be performed for the analysis, including but not limited to hydrophilic interaction chromatography (HILIC), reversed phase chromatography and mixed mode chromatography (i.e. anion exchange reversed phase). Labeled glycopeptides can be separated by HILIC using the materials and methods outlined in US Published Patent Application No. US2015/0316515, at ¶¶ [452] to [479], incorporated herein by reference. Similarly, the labeled glycopeptides can be separated using the charge surface reversed phase chromatographic materials described in US Patent Pub. No. 2013/0319086, ¶¶ [0008] to [0084], and [0347] to [0352], incorporated herein by reference. The chromatographic materials and glycan separation techniques described in U.S. Patent Application No 62/326,783 filed Apr. 24, 2016 (unpublished) are also applicable. While the present methods are described for glycopeptide analyses, these methods can be applied generally to obtain any labeled peptides with enhanced detection properties.
- As described herein, the terms “labeling” and “tagging” are used interchangeably through this specification. A “derivatized biomolecule refers to a molecule that has been labeled or tagged with the MS active, fluorescent compound.
- The term “alkoxy,” as used herein, alone or in combination, refers to an alkyl ether radical and the term alkyl is as defined herein. Examples of suitable alkyl ether radicals include methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, iso-butoxy, sec-butoxy, tert-butoxy, and the like.
- The term “alkyl,” as used herein, alone or in combination, refers to a straight-chain or branched-chain alkyl radical containing from 1 to and including 20, preferably 1 to 10, and more preferably 1 to 6, carbon atoms. Alkyl groups can be optionally substituted as defined herein without changing or affecting the fluorescent or mass spec properties of the molecule. Examples of alkyl radicals include methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, pentyl, iso-amyl, hexyl, octyl, nonyl and the like.
- The term “alkylene,” as used herein, alone or in combination, refers to a saturated aliphatic group derived from a straight or branched chain saturated hydrocarbon attached at two or more positions, such as methylene (—CH2—).
- The term “alkylamino,” as used herein can be a mono- or dialkylated groups (also referred to “dialkylamino”) such as, for example, N-methylamino, N-ethylamino, N,N-dimethylamino, N,N-ethylmethylamino and the like and combination, refers to —NRR′, wherein R is independently selected from the group consisting of hydrogen and alkyl, and R′ is alkyl, any of which can themselves be optionally substituted and the dialkyamino group can further comprise a spacer (sometimes referred to as a linker or linker group). A molecular spacer or simply a “spacer” in chemistry is any flexible part of a molecule that provides a connection between two other parts of a molecule
- The term “parent molecular moiety” as used herein means and includes phenyl, quinoline, coumarin or rhodamine.
- The term “amino,” as used herein, alone or in combination, refers to —NRR′, wherein R and R′ are independently selected from the group consisting of hydrogen, alkyl, acyl, heteroalkyl, aryl, cycloalkyl, heteroaryl, and heterocycloalkyl, any of which can themselves be optionally substituted.
- The term “aryl,” as used herein, alone or in combination, means a carbocyclic aromatic system containing one, two or three rings wherein such rings can be attached together in a pendent manner or can be fused. The term “aryl” embraces aromatic radicals such as benzyl, phenyl, naphthyl, anthracenyl, phenanthryl, indanyl, indenyl, annulenyl, azulenyl, tetrahydronaphthyl, and biphenyl.
- The terms “benzo” and “benz,” as used herein, alone or in combination, refer to the divalent radical C6H4═ derived from benzene. Examples include benzothiophene and benzimidazole.
- The term “carbamate,” as used herein, alone or in combination, refers to an ester of carbamic acid (—NHCOO—) which can be attached to the parent molecular moiety from either the nitrogen or acid end, and which can be optionally substituted as defined herein.
- The term “O-carbamyl” as used herein, alone or in combination, refers to a —OC(O)NRR′, group-with R and R′ as defined herein.
- The term “N-carbamyl” as used herein, alone or in combination, refers to a ROC(O)NR′-group, with R and R′ as defined herein.
- The term “carbonyl,” as used herein, when alone includes formyl [—C(O)H] and in combination is a —C(O)— group.
- The term “carboxy,” as used herein, refers to —C(O)OH or the corresponding “carboxylate” anion, such as is in a carboxylic acid salt. An “O-carboxy” group refers to a RC(O)O— group, where R is as defined herein. A “C-carboxy” group refers to a —C(O)OR groups where R is as defined herein.
- The term “cycloalkyl” refers to a carbocyclic substituent obtained by removing a hydrogen from a saturated carbocyclic molecule and having three to fourteen carbon atoms. In one embodiment, a cycloalkyl substituent has three to ten carbon atoms. Examples of cycloalkyl include cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
- The term “halo,” or “halogen,” as used herein, alone or in combination, refers to fluorine, chlorine, bromine, or iodine.
- The term “haloalkoxy,” as used herein, alone or in combination, refers to a haloalkyl group attached to the parent molecular moiety through an oxygen atom.
- The term “haloalkyl,” as used herein, alone or in combination, refers to an alkyl radical having the meaning as defined above wherein one or more hydrogens are replaced with a halogen. Specifically embraced are monohaloalkyl, dihaloalkyl and polyhaloalkyl radicals. A monohaloalkyl radical, for one example, can have an iodo, bromo, chloro or fluoro atom within the radical. Dihalo and polyhaloalkyl radicals can have two or more of the same halo atoms or a combination of different halo radicals. Examples of haloalkyl radicals include fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, pentafluoroethyl, heptafluoropropyl, difluorochloromethyl, dichlorofluoromethyl, difluoroethyl, difluoropropyl, dichloroethyl and dichloropropyl. “Haloalkylene” refers to a haloalkyl group attached at two or more positions. Examples include fluoromethylene (—CFH—), difluoromethylene (—CF2—), chloromethylene (—CHCl—) and the like.
- The term “heteroalkyl,” as used herein, alone or in combination, refers to a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof, fully saturated or containing from 1 to 3 degrees of unsaturation, consisting of the stated number of carbon atoms and from one to three heteroatoms selected from the group consisting of O, N, and S, and wherein the nitrogen and sulfur atoms can optionally be oxidized and the nitrogen heteroatom can optionally be quaternized. The heteroatom(s) O, N and S can be placed at any interior position of the heteroalkyl group. Up to two heteroatoms can be consecutive, such as, for example, —CH2—NH—OCH3.
- The terms “heterocycloalkyl” and, interchangeably, “heterocycle,” as used herein, alone or in combination, each refer to a saturated, partially unsaturated, or fully unsaturated monocyclic, bicyclic, or tricyclic heterocyclic radical containing at least one, preferably 1 to 4, and more preferably 1 to 2 heteroatoms as ring members, wherein each said heteroatom can be independently selected from the group consisting of nitrogen, oxygen, and sulfur, and wherein there are preferably 3 to 8 ring members in each ring, more preferably 3 to 7 ring members in each ring, and most preferably 5 to 6 ring members in each ring. “Heterocycloalkyl” and “heterocycle” are intended to include sulfones, sulfoxides, N-oxides of tertiary nitrogen ring members, and carbocyclic fused and benzo fused ring systems; additionally, both terms also include systems where a heterocycle ring is fused to an aryl group, as defined herein, or an additional heterocycle group. Heterocycle groups of the compounds are exemplified by aziridinyl, azetidinyl, 1,3-benzodioxolyl, dihydroisoindolyl, dihydroisoquinolinyl, dihydrocinnolinyl, dihydrobenzodioxinyl, dihydro[1,3]oxazolo[4,5-b]pyridinyl, benzothiazolyl, dihydroindolyl, dihy-dropyridinyl, 1,3-dioxanyl, 1,4-dioxanyl, 1,3-dioxolanyl, isoindolinyl, morpholinyl, piperazinyl, pyrrolidinyl, tetrahydropyridinyl, piperidinyl, thiomorpholinyl, and the like. The heterocycle groups can be optionally substituted unless specifically prohibited.
- The term “optionally substituted” means the anteceding group can be substituted or unsubstituted. When substituted, the substituents of an “optionally substituted” group can include, without limitation, one or more substituents independently selected from the following groups or a specific designated set of groups, alone or in combination: lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower heteroalkyl, lower heterocycloalkyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower perhaloalkyl, lower perhaloalkoxy, lower cycloalkyl, phenyl, aryl, aryloxy, lower alkoxy, lower haloalkoxy, oxo, lower acyloxy, carbonyl, carboxyl, lower alkylcarbonyl, lower carboxyester, lower carboxamido, cyano, hydrogen, halogen, hydroxy, amino, lower alkylamino, arylamino, amido, nitro, thiol, lower alkylthio, arylthio, lower alkylsulfinyl, lower alkylsulfonyl, arylsulfinyl, arylsulfonyl, arylthio, sulfonate, sulfonic acid, trisubstituted silyl, N3, SH, SCH3, C(O)CH3, CO2CH3, CO2H, pyridinyl, thiophene, furanyl, lower carbamate, and lower urea. Two substituents can be joined together to form a fused five-, six-, or seven-membered carbocyclic or heterocyclic ring consisting of zero to three heteroatoms, for example forming methylenedioxy or ethylenedioxy. An optionally substituted group can be unsubstituted (e.g., —CH2CH3), fully substituted (e.g., —CF2CF3), monosubstituted (e.g., —CH2CH2F) or substituted at a level anywhere in-between fully substituted and monosubstituted (e.g., —CH2CF3). Where substituents are recited without qualification as to substitution, both substituted and unsubstituted forms are encompassed. Where a substituent is qualified as “substituted,” the substituted form is specifically intended. Additionally, different sets of optional substituents to a moiety can be defined as needed; in these cases, the optional substitution will be as defined, often immediately following the phrase, “optionally substituted with.”
- The term R or the term R′, appearing by itself and without a number designation, unless otherwise defined, refers to a moiety selected from the group consisting of hydrogen, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl and heterocycloalkyl, any of which can be optionally substituted. Such R and R′ groups should be understood to be optionally substituted as defined herein. Whether an R group has a number designation or not, every R group, including R, R′ and Rn where n =(1, 2, 3, . . . n), every substituent, and every term should be understood to be independent of every other in terms of selection from a group. Should any variable, substituent, or term (e.g. aryl, heterocycle, R, etc.) occur more than one time in a formula or generic structure, its definition at each occurrence is independent of the definition at every other occurrence. Those of skill in the art will further recognize that certain groups can be attached to a parent molecular moiety or can occupy a position in a chain of elements from either end as written. Thus, by way of example only, an unsymmetrical group such as —C(O)N(R)— can be attached to the parent molecular moiety at either the carbon or the nitrogen.
- The term “bond” refers to a covalent linkage between two atoms, or two moieties when the atoms joined by the bond are considered to be part of larger substructure. A bond can be single, double, or triple unless otherwise specified. A dashed line between two atoms in a drawing of a molecule indicates that an additional bond can be present or absent at that position. The development and production of therapeutic proteins is becoming the fastest-growing segment of the pharmaceutical industry. The efficacy, stability and protein secretion of these large molecule drugs depend on their Post Translational Modifications (“PTMs”). Glycosylation is the most complex and common PTM and plays a vital role in the safety and efficacy of many therapeutic proteins such as recombinant antibodies. Several studies have shown the correlation between glycosylation variations caused by cell line selection and changes in culture medium parameters. Patrick Hossler et al., Optimal and Consistent Protein Glycosylation in Mammalian Cell Culture, 19 G
LYCOBIOLOGY 926 (2009). These variations can have a profound effect on the biological activities of the mAb drugs, which leads to changes in drug potency in the final product. Regulatory agencies require monitoring of batch-to-batch recombinant antibody drug production quality and mandate detailed assessment of the protein glycosylation micro-heterogeneity and consistency. - The compounds described herein can also form hydrogen bonds with other compounds. A hydrogen bond is an electromagnetic attractive interaction between polar molecules, where hydrogen is bonded to an electronegative atom such as nitrogen or oxygen. The hydrogen bond represents a strong dipole-dipole attraction. These hydrogen-bond attractions can occur between molecules (intermolecular) or within different parts of a single molecule (intramolecular). When a hydrogen atom is attached to an electronegative atom, it is considered a hydrogen bond donor. The electronegative atom is considered a hydrogen bond acceptor, whether it is bonded to a hydrogen atom or not.
- Asymmetric centers exist in the compounds presented herein. These centers are designated by the symbols “R” or “S,” depending on the configuration of substituents around the chiral carbon atom. It should be understood that the compounds encompass all stereochemical isomeric forms, including diastereomeric, enantiomeric, and epimeric forms, as well as d-isomers and 1-isomers, and mixtures thereof. Individual stereoisomers of compounds can be prepared synthetically from commercially available starting materials which contain chiral centers or by preparation of mixtures of enantiomeric products followed by separation such as conversion to a mixture of diastereomers followed by separation or recrystallization, chromatographic techniques, direct separation of enantiomers on chiral chromatographic columns, or any other appropriate method known in the art. Starting compounds of certain stereochemistry are either commercially available or can be made and resolved by techniques known in the art. Additionally, the compounds described can exist as geometric isomers and includes all cis, trans, syn, anti, entgegen (E), and zusammen (Z) isomers as well as the appropriate mixtures thereof. Additionally, compounds can exist as tautomers. All tautomeric isomers are provided. Additionally, the present compounds can exist in unsolvated as well as solvated forms with pharmaceutically acceptable solvents such as water, ethanol, and the like. In general, the solvated forms are considered equivalent to the unsolvated forms.
- Hence, the compounds described herein can also be in the form of a salt or solvate, or acid addition salts. Through a reaction with either organic or inorganic acids, compounds presented herein or groups of compounds can form a salt. For example, in acid-base neutralization, an acid and a base react to form water and a salt. Basically, to react together, there must be the transfer of protons between acids and bases. Also, different acids can produce different ions. For example, an Arrhenius acid produces hydronium ions when it dissociates in water. Similarly, a Bronsted-Lowry acid is a proton donor that donates hydrogen ions to the base. Hence, proton acceptors and proton donors are the basis for the reaction and are referred to sometimes as a conjugate base or a conjugate acid. A conjugate pair refers to acids and bases with common features, where there is an equal loss/gain of protons between the pairs. For example, NH4 + is the conjugate acid to the base NH3 because NH3 gains a hydrogen ion to form NH4 + as H2O donates a hydrogen ion to form OH−, the conjugate base. On the other hand, under a different theory, a Lewis acid accepts an electron pair and a Lewis base donates an electron pair donor. Accordingly, the proton H+ can be an electron pair acceptor. Moreover, a compound can be both, a Lewis acid and a Lewis base, depending on the reaction. For example, methyl iodide can behave as both, a Lewis acid and a Lewis base, where the methyl group is donated to form a salt.
- The compounds of the formulas described herein can have quaternary nitrogens. The quaternary nitrogens will have a positive charge on the nitrogen and can be associated with a counterion and include all quaternary amine-counterion complexes of compounds when a compound includes a quaternary amine group.
- Examples of acids which can be employed to form a salt of any of the compounds provided herein include inorganic acids and organic acids as well known to those skilled in the art such as, but not limited to, N-hydroxysuccinimide, hydrochloric, hydrofluoric, hydroiodic, hydrobromic, sulfuric, hydrosulfuric, thiosulfuric, hydrocyanic, phosphoric, phosphorous, hydrochlorous, chlorous, nitrous, nitric, chloric, perchloric, sulfurous, oxalic, maleic, succinic, and citric. Salts can also be formed by coordination of the compounds with an alkali metal or alkaline earth ion. In addition, other acids can form a salt including, but not limited to, 1-hydroxy-2-naphthoic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetamidobenzoic acid, 4-aminosalicylic acid, acetic acid, adipic acid, ascorbic acid (L), aspartic acid (L), benzenesulfonic acid, benzoic acid, camphoric acid (+), camphor-10-sulfonic a cid (+), capric acid (decanoic acid), caproic acid (hexanoic acid), caprylic acid (octanoic acid), carbonic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, ethanesulfonic acid, formic acid, fumaric acid, galactaric acid, gentisic acid, glucoheptonic acid (D), gluconic acid (D), glucuronic acid (D), glutamic acid, glutaric acid, glycerophosphoric acid, isobutyric acid, lactic acid (DL), lactobionic acid, lauric acid, maleic acid, malic acid (−L), malonic acid, mandelic acid (DL), methanesulfonic acid, naphthalene-1,5, disulfonic acid, naphthalene-2-sulfonic acid, nicotinic acid, nitric acid, oleic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, proprionic acid, pyroglutamic acid (−L), salicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tartaric acid (+L), thiocyanic acid, toluenesulfonic acid (p), undecylenic acid.
- For the compounds described herein, the counterion can be the conjugate base formed after reacting a compound or groups of compounds with an acid. In other words, counterion holds the opposite charge to that of the compound or compounds it is associated with. Thus, with respect to possible salts of the compounds herein having a conjugate acid of NH4 +, the counterion represents the anionic part of the salt. In addition, it can be possible to have four organic substituents on the nitrogen. These species are not amines but are quaternary ammonium cations having a charged nitrogen center. Quaternary ammonium salts can exist with many kinds of anions.
- Hence, counterions of a salt compound described herein can include, but are not limited to, any of the following common anions and oxoanions: N-hydroxysuccinimidyl, hydride (H−), fluoride (F−), chloride (Cl−), bromide (BP), iodide (I−), oxide (O2−), hydroxide (OH−), peroxide (O2 2−), sulfide (S2−), hydrogen sulfide (HS−), selenide (Se2−), nitride (N3−), azide (N3 −), phosphide (P3−), arsinide (As3−), carbide (C4−), cyanide (CN−), hypochlorite (ClO1 −), chlorite (ClO2 −), chlorate (ClO3 −), perchlorate (ClO4 −), sulfite (SO3 2−), sulfate (SO4 2−), hydrogen sulfate (HSO4 −), thiosulfate (S2O3 2−), nitrite (NO2 −), nitrate (NO3 −), phosphite (PO3 2−), phosphate (PO4 3−), (mono)hydrogen phosphate (HPO4 2−), dihydrogen phosphate (H2PO4 −), carbonate (CO3 2−), hydrogen carbonate (HCO3 −), oxalate (C2O4 2−), cyanate (NCO−), isocyanate (OCN−), thiocyanate (SCN−), chromate (CrO4 2−), dichromate (Cr2O7 2−), permanganate (MnO4 −).
- Methods for tagging glycans including N-linked glycans and O-linked glycans, with MS active fluorescent compounds of Formula I, as well as conjugates resulting therefrom are provided. In an embodiment, the glycan is tagged, derivatized or conjugated through an aldehyde or ketone with the amine of a compound provided herein via reductive amination.
- New compounds (also referred herein to as “reagents” and/or “molecules”) specific for N-linked and O-linked glycans amino acids and peptides, are provided for enhanced MS detection and fluorescence tagging of glycans and other biomolecules with enhanced MS signals. Using these reagents, the reaction times necessary to carry out the tagging process (or otherwise sometimes referred to herein as “labeling”) can be performed efficiently and applied to a wider group of biopolymers. The described compounds are useful in a wide variety of processes that rely on glycan and amino acid/peptide analysis for essential information of a product, process, or protein. As such, the molecules described herein can be used in processes such as protein characterization, cell culture monitoring, synthetic peptide manufacturing, and food analysis.
- More specifically, N-linked glycans are attached to asparagines via an N-acetylglucosamine (“GlcNAc”) residue in an Asn-Xxx-(Ser, Thr) motif where Xxx can be any amino acid except proline. O-linked glycans are attached to either Serine or Threonine. N-linked glycans can be removed from the glycoprotein chemically or enzymatically. Examples of N-linked glycans include, but are not limited to, mannobiose (Man2), mannotriose (Man3), mannotetraose (Man4), mannopentaose (Man5), mannohexaose (Man6) and mannoheptaose (Man7). Other glycans include A2, FA2, M5, FA1G1, A2G1, FA2G1, FA2G2, FA2G1Ga1, FA2G2Ga1, FA2G2Sg1, FA2G1Ga2, FA2G2GaSg1
- To derivatize the glycan, general conditions for the reductive amination reaction can be applied for tagging as described below. For example, the reaction can be conducted in the presence of reducing agents such as sodium cyanoborohydride, sodium triacetoxyborohydride, picoline borane. In an embodiment, the reductive amination is conducted in aqueous media. In an embodiment, the reductive amination reaction of aldehyde containing compounds can be conducted in non-aqueous solvents. Reagents that can facilitate reductive amination include LiAlH4, ZnCl2—Zn(BH4)2; NiCl2—NaBH4; Ti(iPrO)4-polymethylhydrosiloxane; Ti(i-PrO)4—NaBH4; Bu3SnH; Bu2SnClH and Bu2SnIH; decaborane; silica gel-Zn(BH4)2; Et3SiH-trifluoroacetic acid; pyridine—BH3; phenylsilane-dibutyltin dichloride. Basu et. al., 4 SYNLETT 555 (2003). The reaction can be conducted in a mixture of citric acid and/or acetic acid with an organic solvent such as dimethylsulfoxide dimethylformamide, formamide, hexamethylphosphoramide, hexamethylphosphorus triamide, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone or dimethylacetamide. The reaction can also be conducted in a solvent selected from tetrahydrofuran, dichloromethane, 1,2-dichloroethane, ethanol, methanol or isopropanol, toluene and xylene, and mixtures thereof.
- The following schematic shows the tagging of a glycan using a compound of Formula I through reductive amination:
- where FL and R3 are as described above.
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with MS active, fluorescence tagging quinoline derivatives of the structural Formula II:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12;
and salts or solvates thereof. - In an embodiment, methods include tagging glycans and other biomolecules with compounds of Formula IIA:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIB are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIC are provided:
- wherein
each R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IID are provided:
- wherein
each R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIE are provided:
- wherein
each R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIF are provided:
- wherein
each R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIG are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - Provided herein are methods for tagging glycan wherein compounds are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R1 is hydrogen. In an embodiment, further provided are methods wherein compounds are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R2 is hydrogen. Methods are provided wherein compounds are of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG wherein R1 and R2 are hydrogen.
- In addition, provided below are exemplary compounds (Table A) of the structural Formulas II, IIA, IIB, IIC, IID, IIE, IIF or IIG which can be used in the methods described herein for fluorescent labeling of glycans and for subsequent analysis by means of liquid chromatography and mass spectrometry. The compounds of structural Formulas II, IIA, IIB, IIC, IID, IIE, IIF or IIG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- Methods for tagging, derivatizing or conjugating glycans containing at least one ketone group or an aldehyde group with a compound of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or a compound of Table A by reductive amination reaction are further provided. This reaction between any one or more of the compounds and the glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride. The reaction can be carried out in a solution or suspension of a compound of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or a compound of Table A in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry are provided. These methods comprise the step of labeling the glycan in a sample by reacting with one or more of the compounds of Formula II, IIA, IIB, IIC, IID, IIE, IIF or IIG, or compound of Table A for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans and other biomolecules can be conjugated to MS active fluorescent compounds of Formula II and salts or solvates thereof. The following schematic shows the tagging of a glycan using a compound of Formula II through reductive amination:
-
- wherein FL R1, R2 and R3 are as described herein.
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with compounds of the structural Formula III:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; - R3 is
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IIIA are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIIB are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IIIC are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IIID are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods are provided for tagging glycans with compounds of Formula IIIE:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IIIF are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IIIG are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, provided are compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG wherein R1 is hydrogen. In an embodiment, the compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG include compounds wherein R2 is hydrogen. In an embodiment, the compounds of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG include compounds wherein R1 and R2 are hydrogen.
- In addition, provided below are exemplary compounds (Table B) of the structural Formulas III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG which can be useful for labeling glycans and subsequent analysis by means of liquid chromatography and mass spectrometry. The compounds of structural Formulas III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- The methods for tagging, derivatizing or conjugating glycans containing at least one ketone group or an aldehyde group with a compound of Formula III, IIIA, IIIB, IIIC, IIID, IIIE, IIIF or IIIG or a compound of Table B by reductive amination reaction are provided. The reaction between a compound of Formula III and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent selected from sodium cyanoborohydride or sodium triacetoxyborohydride. The reaction can be carried out in a solution or suspension of a compound of Formula III, IIIA, IIIB, IIIG, IIID, IIIE, IIIF or IIIG or a compound of Table B in an acidic media, for example in citric acid or acetic acid, and mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry are provided. The analytical method comprises the steps of labeling the glycan in the sample by reacting with a compound of Formula III, IIIA, IIIB, IIIG, IIID, IIIE, IIIF or IIIG or a compound of Table B for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans can be conjugated to MS active fluorescent compounds of Formula III and salts or solvates thereof. The following general schematic shows the tagging of a glycan using a compound of Formula III through reductive amination:
- wherein FL R1, R2 and R3 are as described above.
- Methods for tagging and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with MS active, fluorescence tagging reagents of the structural Formula IV:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IVA are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula IVB are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans with compounds of Formula IVC are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IVD are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IVE are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging glycans with compounds of Formula IVF are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In an embodiment, methods for tagging (labeling) glycans and other biomolecules with compounds of Formula IVG are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In addition, provided below are exemplary compounds (Table C) of the structural Formulas IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG which can be useful for fluorescent labeling of glycans and subsequent analysis by means of liquid chromatography and mass spectrometry. The compounds of structural Formulas IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- The compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG include compounds wherein R1 is hydrogen. In an embodiment, further provided are compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG including compounds wherein R2 is hydrogen. In an embodiment, compounds of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG include compounds wherein R1 and R2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group with a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG or a compound of Table C by reductive amination reaction are further provided. The reaction between a compound of Formula II and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride. The reaction can be carried out in a solution or suspension of a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG or a compound of Table B in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry are provided. The analytical method comprises the steps of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula IV, IVA, IVB, IVC, IVD, IVE, IVF or IVG for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Glycans can be conjugated to MS active fluorescent compounds of Formula IV and salts or solvates thereof. The following general schematic shows the tagging of a glycan using a compound of Formula IV through reductive amination:
- wherein FL R1, R2 and R3 are as described above.
- Methods for labeling (tagging) and analyzing glycans can be accomplished by fluorescence and mass spectroscopy following reductive amination of glycans with compounds of the structural Formula V, VI, VII, VIII or IX:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12;
Ra is selected from -
- Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula VA, VIA, VIIA, VIIIA or IXA, and salts or solvates thereof, are provided.
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
Ra is selected from -
- and
Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl. - In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula VB, VIB, VIIB, VIIIB or IXB or salts and solvates thereof, are provided wherein
- each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H;
-
- z=1−12;
Ra is selected from -
- Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula VC, VIC, VIIC, VIIIC or IXC, or salts and solvates thereof are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
- Ra is selected from
- Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula VD, VID, VIID, VIIID or IXD, or salts or solvates, are provided.
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
Ra is selected from -
- Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- In an embodiment, methods for tagging glycans and other biomolecules with compounds of Formula VE, VIE, VIIE, VIIIE or IXE are provided:
- wherein
each of R1 and R2 is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
Ra is selected from -
- Rc, Rd, Re, Rf and Rg are independently selected from hydrogen and optionally substituted alkyl; and salts or solvates thereof.
- In addition, provided below are exemplary compounds (Table D) of the structural Formulas V, VI, VII, VIII and IX which can be useful for fluorescent labeling of glycans and subsequent analysis by means of liquid chromatography and mass spectrometry. The compounds of structural Formulas V, VI, VII, VIII and IX could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- In an embodiment, provided herein are compounds of V, VI, VII, VIII or IX wherein R1 is hydrogen. In an embodiment, further provided are compounds of Formula V, VI, VII, VIII or IX wherein R2 is hydrogen. In an embodiment, compounds of Formula V, VI, VII, VIII or IX include compounds wherein R1 and R2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group, with a compound of Formula V, VI, VII, VIII, IX or a compound of Table D by reductive amination reaction are further provided. The reaction between a compound of Formula V, VI, VII, VIII or IX and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride. The reaction can be carried out in a solution or suspension of a compound of Formula V, VI, VII, VIII or IX or a compound of Table D in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry are provided. The analytical method comprises the steps of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula V, VI, VII, VIII or IX or a compound of Table D for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- Methods for tagging glycans can be accomplished by reductive amination of glycans with MS active, fluorescence tagging phenyl derivatives of Formula X:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- R3a is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl;
-
- y=0−12;
z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XA is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XB is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XC is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XD is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XE is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XF is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In yet another embodiment, methods for tagging biomolecules, such as glycans, with a compound of Formula XG is provided as follows:
- wherein
R1 is selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N3, SH, SCH3, C(O)CH3, CO2CH3 and CO2H; -
- z=1−12;
and salts or solvates thereof. - In addition, provided below are exemplary compounds (Table E) of the structural Formulas X, XA, XB, XC, XD, XE, XF or XG which can be useful for fluorescent labeling of glycans and subsequent analysis by means of liquid chromatography and mass spectrometry. The compounds of structural Formulas X, XA, XB, XC, XD, XE, XF or XG could be optionally substituted with any group that does not substantially reduce the fluorescence of the compound.
- In an embodiment, provided herein are compounds of X, XA, XB, XC, XD, XE, XF or XG wherein R1 is hydrogen. In an embodiment, further provided are compounds of Formula X, XA, XB, XC, XD, XE, XF or XG wherein R2 is hydrogen. In an embodiment, compounds of Formula X, XA, XB, XC, XD, XE, XF or XG include compounds wherein R1 and R2 are hydrogen.
- Methods for tagging, derivatizing or conjugating glycans and other biopolymers containing at least one ketone group or an aldehyde group with a compound of Formula X, XA, XB, XC, XD, XE, XF or XG or a compound of Table E by reductive amination reaction are further provided. The reaction between a compound of Formula X, XA, XB, XC, XD, XE, XF or XG and an aldehyde containing biopolymer, such as a glycan can be conducted under conditions that facilitate reductive amination in the presence of a reducing agent, such as from sodium cyanoborohydride or sodium triacetoxyborohydride. The reaction can be carried out in a solution or suspension of a compound of Formula X, XA, XB, XC, XD, XE, XF or XG or a compound of Table D in an acidic media, for example in citric acid or acetic acid, and by mixing with a solution or suspension of a reducing agent such as cyanoborohydride or sodium triacetoxyborohydride in an organic solvent, for example, tetrohydrofuran or dimethylsulfoxide.
- Methods for analyzing a glycan and other biomolecules containing an aldehyde group in a sample by means of liquid chromatography and mass spectrometry are provided. These analytical methods include the step of labeling the biomolecule, such as a glycan, in the sample by reacting with a compound of Formula X, XA, XB, XC, XD, XE, XF or XG for a time and under conditions suitable to facilitate the labeling through reductive amination; and subjecting the labeled conjugate to liquid chromatography and mass spectrometry.
- As provided herein, glycans can be conjugated to MS active fluorescent compounds of Formula X and salts or solvates thereof. The following general schematic shows the tagging of a glycan using a compound of Formula X through reductive amination:
- wherein FL R1, R2 and R3 are as described above.
- The process of reductive amination can be used to label aldehyde containing glycans and other biomolecules with compounds described herein. Further these compounds like other compounds presented in U.S. patent application Ser. No. 14/458,760 (published as US2014/0350263) and Ser. No. 15/005,619 (unpublished) might be used to rapidly label glycans under certain conditions.
- The following schemes I and II can be used to make the compounds described herein.
- 40 mg of B was dissolved in 2.5 mL of a 1:4 mixture of dimethylformamide: dichloromethane in a 10 mL flask equipped with a stir bar and purged with N2. 1.7 mg of dimethyl aminopyridine and 181 μL of dicyclohexylcarbodiimide were then added to the flask. After stirring for 10 min, 2-(diethylamino) ethylamine (57 mg) in 3 mL of dichloromethane was added to the flask. This was then stirred at room temperature for 20 hours. After this time, 3 mL of water was added to the reaction flask. The organic layer was separated and the aqueous layer was extracted with 2 mL of dichloromethane. The organic phases were combined, dried, and then evaporated to dryness to provide the crude material. This was subjected to standard organic chemistry purification techniques to provide the desired material C in >95% purity.
- 1.8 g of C was dissolved in a mixture of 5.3 g of trifluoracetic acid in 30 mL of dichloromethane. The reaction mixture was stirred at room temperature for 48 hours. After removal of the solvent under reduced pressure, the crude material was dissolved in 30 mL of 0.5 N HCl. This mixture was then extracted with 50 mL aliquots of ethyl acetate. The organic phases were combined, dried, and then evaporated to dryness to yield 1.2 gram of the crude product. This was subjected to standard organic chemistry purification techniques to provide the desired material D in >98% purity.
- The method used for Scheme I is applicable to Scheme II for making the compounds presented herein.
- A few alternative derivatization procedures have been developed to permit the assay of glycans by high performance liquid chromatographic and electrophoretic separations. Under certain conditions, the compounds presented herein can be subject to rapid tagging processes where reagent solution is added to released glycans at room temperature for four or five minutes, and then lyophilized and subsequently reconstituted in acetonitrile/water solution. Other possible derivatization methods that might be utilized to tag glycans with the reagents described herein include:
- (1) The o-phthalaldehyde (“OPA”)/mercaptan method. The OPA procedure can detect amino acids with a typical detectable level in the order of about 100 femtomole (fmol). Here, an adduct can be unstable and, therefore, should be prepared shortly before the detection step. Also, the reagent may not form a derivative with secondary amino acids.
- (2) The 9-fluorenylmethylchloroformate (“FMOC”) method. The FMOC procedure provides for stable derivatives having a minimum detectable level in the order of a few hundred fmol. Free tryptophan and cystine are sometimes difficult to quantitate. The derivatizing reagent is preferably removed from the reaction mixture by an extraction step because it is itself fluorescent. The reagent has also been reported to form multiple derivatives with histidine. The reagent can be hazardous to work with, because it is corrosive and is a lachrymator.
- (3) The phenylisothiocyanate (“PITC”) method. The PITC procedure yields stable derivatives which are formed rapidly. It can be used for both primary and secondary amino acids, as well as cysteine. The method uses absorbance as the detection procedure, and can provide a minimum detection limit of 1 pmol. However, the derivatives are not fluorescent and detection must be performed at 254 nm, which does not allow for good detection selectivity.
- (4) The dansyl chloride method. The dansyl chloride method provides stable derivatives with a minimum detectability in the order of about 1.5 pmol. It is able to detect secondary amines and cysteine, but it results in multiple derivatives.
- (5) Fluorescent succinimidocarbamates are useful as derivatizing agents for amines, amino acids, peptides, phosphates and other classes of compounds. When the succinimidocarbamate reagent is used to tag a compound with a fluorescent group, a detection limit of about 1 pmol can be achieved. These reagents can be used in conjunction with modern separation techniques such as high performance liquid chromatography, thin layer chromatography or capillary electrophoresis.
- The present methods are not restricted to any specific linkage chemistry or attachment mechanism.
- Most amino acids and/or glycans are not readily detectable in the absence of a strong chromophore or fluorophore or MS active moiety. The absorbance and fluorescence response are quite weak. One tactic used to maximize the sensitivity of an assay is to convert the compound of interest into a derivative that exhibits a better response for the detection method being utilized. The selection of a derivatizing agent is an important choice in the development of an analytical procedure. The derivatizing agent affects the ultimate sensitivity and accuracy of the analysis by maximizing the sensitivity, yield and stability of the derivatized molecules.
- Basically, the following determinations can be performed separately: (1) the glycosylated sites; (2) the glycosylated site occupancy; (3) the structure and amount of each glycan at each site: and (4) the number of glycoforms. Harvey, D. J., Identification of Protein-Bound Carbohydrates by Mass Spectrometry, 1 PROTEOMICS 311-319 (2001) at 312, incorporated herein by reference. In most situations, MS can provide the answers to each of these steps. Hence the need for enhanced MS signals. Because of the branched nature of the glycan, however, structural determination of the glycan is complicated. Here, the monosaccharide unit, the anomericity and ring size of each monosaccharide, the monosaccharide sequence and ring conformation together with identification of other groups must be determined. With the exception of ring conformation, MS can be used directly or indirectly to make these determinations using MALDI and/or ESI as the preferred MS technique. Id. at 313-316, incorporated herein by reference.
- Compounds described herein are useful for derivatizing glycans because they can form stable, highly fluorescent MS derivative compounds and conjugate glycans. The general methodology for an analysis of a glycan or amino acid derivatized by these compounds include three closely related processes: (1) formation of derivatives in the sample; (2) separation of the derivatives; and (3) detection of the separated derivatives. The first step is generally performed by reacting a mixture with one of the present compounds as a reagent to yield a derivatized compound. The derivatives provide a fluorescent signal which can then be detected in the detection stage of the analysis.
- The separation step is based upon the differences in the chemical structure of the derivatives. The derivatized compounds can differ from each other in the same way that the chemical structures of the precursor compounds differ. The derivatives must be separated so that the detector signal can be correctly related to the concentration of each derivative. The derivatized glycans can be separated and detected by chromatography, e.g., by high performance liquid chromatography (“HPLC”) or capillary zone electrophoresis (“CZE”).
- The detection step is generally carried out using either an absorbance or fluorescence detector. As each derivative is eluted from the chromatographic column after separation, its presence and quantity is detected by a mass spectrometer and/or by the absorbance or emission of light. The sensitivity of the assay depends upon the strength of the signal produced.
- Analytical methods of analyzing glycans have become considerably sophisticated. Exemplary analytical instrumentation includes CE-, HPAEC-PAD, HILIC-LC/FLR, RPLC/MS, and MALDI-MS. Liquid chromatography (“LC”) separation with fluorescence detection is frequently used in the pharmaceutical industry for the characterization of enzymatically/chemically released glycan, typically tagged with a fluorescent dye at the reducing end of a glycan. Kalyan R. Anumula & Shirish T. Dhume, High Resolution and High Sensitivity Methods for Oligosaccharide Mapping and Characterization by Normal Phase High Performance Liquid Chromatography Following Derivatization with Highly Fluorescent Anthranilic Acid, 8 G
LYCOBIOLOGY 685 (1998); Karina Marin̆o et al., A Systematic Approach to Protein Glycosylation Analysis: A Path Through the Maze, 6 NATURE CHEMICAL BIOLOGY 713 (2010). - Fluorescent measurements are sensitive and quantitative; the low detection limit is in the low femtomoles. With recent advancements in mass spectrometry instrumentation, the combination of liquid chromatography, fluorescence and MS has gained more popularity as an analytical instrument platform for routine characterization of fluorescently labeled N-linked glycans. Therefore, relative quantitation and molecular weight measurements can be done in a single analysis. Shigeo Suzuki et al., Comparison of the Sensitivities of Various Derivatives of Oligosaccharides in LC/MS with Fast Atom Bombardment and Electrospray Ionization Interfaces, 1006 A
NAL CHEM 2073 (1996). However, a challenge has been that glycans do not ionize efficiently via electro-spray-ionization (“ESI”). - Absorbance detection is generally used in protein mapping work. Two different detection processes which are often used for this purpose are: a) detection at 210-215 nm using a single wavelength detector; and b) broadband spectral detection using a photodiode array (PDA) detector. In the first method, all peptides absorb at that wavelength, thus the user can ensure that all peptides eluted from the column are detected. One difficulty with this technique is that a wide variety of compounds absorb in this region of the spectrum, and extreme care must be taken to ensure that all reagents, eluents, glassware, etc. are scrupulously clean to ensure that the observed signal is solely from the peptides. In the second method, the PDA detector collects the spectra of the eluent at specific time intervals (e.g. a spectrum between 200 and 350 nm is collected every second). This provides more information than a single wavelength and thus can assist in distinguishing between peptides which can elute with similar retention times.
- To obtain high quality mass spectra, the condition of the sample is important. Compounds other than analyte will generally have an adverse effect on ion yield and are preferably removed. Indeed, while small amounts of sodium are essential for ionization by MALDI, carbohydrates are particularly susceptible to the effects of salts. Moreover, many carbohydrates occur as mixtures. Therefore, it is important to ensure that isolation and purification techniques do not cause fractionation of the sample with a loss of quantitative information.
- In addition, we have discovered that the compounds described herein can enhance ionization efficiency of the reductively aminated saccharides, particularly O-linked glycans, when the tagged glycan is subsequently electrosprayed in positive ion mode to create protonated ions. This phenomenon can be attributed to two attributes of the reagent: its high gas phase basicity and hydrophobicity that produces non-polar surface area.
- For example, a compound referred to herein as 6-ADEQ is shown structurally below.
- See, WO2013/049622 A1 at page 32. 6-ADEQ can be used to enhance the fluorescence and ionization efficiency of aldehyde containing molecules, such as saccharides or oligosaccharides. As described below, in comparison with oligosaccharides labeled with 2-aminobenzamide (“2-AB”),
- the 6-ADEQ labeled oligosaccharide has been found to yield six (6) times greater fluorescence signal and approximately 250 times greater positive ion mode MS signal when analyzed by hydrophilic interaction liquid chromatography. (Example 1,
FIG. 2 ). The 6-ADEQ label has a unique ability to enhance the ionization efficiency of reductively aminated saccharides when they are electrosprayed in positive ion mode to create protonated ions. This can be attributed to two attributes of the 6-ADEQ label: its high gas phase basicity and its hydrophobicity. - While labeling compounds bearing high pKa, basic residues have previously been used for reductive amination of saccharides, previous studies showed procainamide to be most effective at improving MS response. See e.g., Klapoetke, S. et al., The Evaluation of a Novel Approach for the Profiling and Identification of N-linked Glycan With a Procainamide Tag by HPLC With Fluorescent and Mass Spectrometric Detection. J Pharm Biomed Anal, 53 (3), 315-24 (2010). While procainamide has a tertiary amine side chain that is identical to 6-ADEQ, it has a non-polar surface area of only 181 Å. The larger non-polar surface area of 207 Å contributes to the ability of 6-ADEQ to more effectively increase MS response factors.
- Analysis of glycans by ESI has been hampered by the hydrophilicity of the sugar functional groups that create a higher free energy of solvation and are more difficult to desorb from the electrospray droplet in the generation of gas-phase ions. See, Walker, H. S., et al., Hydrophobic Derivatization of N-linked Glycans for Increased Ion Abundance in Electrospray Ionization Mass Spectrometry, J. Am. Soc. Mass Spectrom. 22, 1039-1317 (2011) Imparting additional hydrophobic functions onto glycan molecules allows the glycans to be less solvated and have a higher surface activity in the precursor electrospray droplet. Id. As this droplet is desolvated, a series of Coulombic fission events occur where smaller droplets are ejected from the surface of the original droplet. Id. As reported, in comparison with native glycans, the more hydrophobic derivatized glycans are the more likely they will have higher surface activity and are then significantly enriched in the progeny droplets which further desolvated and eventually produce gas-phase ions.
- Hence, to increase the ion abundance of analytes in mass spectrometry, the present methods combine the benefits of non-polar surface area with a pKa greater than 7 to provide enhanced MS signaling. In an embodiment, the pKa is between about 7 to 10 or between about 10 to 13. The non-polar surface areas of these labeling compounds are, at a minimum, 10% greater than procainamide as shown and described herein.
- The reagents described herein can enhance positive ion mode MS analyses of peptides and/or glycopeptides. In the present methods, amine residues are modified by the introduction of a tag (label) having high non-polar surface area combined with a high pkA basic residue. As shown in Example IV below, this combination improves the ionization of peptides during positive ion mode MS analyses. Peptides are routinely separated by chromatography under acidic conditions where acidic groups present on a peptide or glycopeptide (aspartic and glutamic amino acids and the groups of monosaccharides known as sialic acids) are protonated. The peptide or glycopeptide once modified adopts higher charge states because of the enhanced basicity.
- Conversely, certain reagents have been designed to alter the basicity of a peptide or glycopeptide. For example, in one method, a sulfonate anion is added to the fluorescent group for detection in UHPLC and to improve the sensitivity of matrix-assisted laser desorption/ionization (“MALDI”) measurements made in the negative ion mode. Hendel, J. H., et al., A Fluorescent Labeling and Enrichment System for Glycopeptides Generated from Proteolytic Digestion of IgG mAbs; A System That Can Be Used as Part of the Peptide Mapping Workflow, USP Workshop on Glycosylation Analysis for Biopharmaceuticals, Rockville, Md., August 25-26; Rockville, Md., 2015. With this type of modification targeted to amine residues, the reagent is designed to convert the N-terminus or the side chains of lysine residues into an acidic functionality containing the label that is linked to the peptide through a neutral urea bond to improve the analysis sensitivity in the negative ion mode of MALDI. The change in chemical properties of the reagent, however, can compromise an analytical technique for peptides in measured in the positive ion mode MS.
- Analyses of peptides and glycopeptides by MALDI are different than the LC/MS analysis. MALDI is a soft ionization technique used in mass spectrometry, allowing the analysis of biomolecules (biopolymers such as DNA, proteins, peptides/glycopeptides, and glycans) and large organic molecules including polymers, dendrimers, and other macromolecules which tend to be fragile and fragment when ionized by more conventional ionization methods. MALDI is similar in character to electrospray ionization (“ESI”) in that both techniques are relatively soft ways of obtaining intact ions of large molecules in the gas phase, though MALDI produces far fewer multiple charged ions.
- MALDI methodologies are typically a three-step processes. First, the sample is mixed with a suitable matrix material and applied to a metal plate. Second, a pulsed laser irradiates the sample, triggering ablation and desorption of the sample and matrix material. Finally, analyte molecules are ionized by being protonated or deprotonated in the hot plume of ablated gases, and can then be accelerated into a mass analyzer.
- On the other hand, LC-MS analysis is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography and the mass analysis capabilities of mass spectrometry (“MS”). LC-MS is a powerful technique that has a very high measurement sensitivity, making it useful in many applications. Its application is oriented towards the separation, general detection, and potential identification of analytes having a specific mass in the presence of other compounds (i.e., in complex mixtures), e.g., natural products from natural-products extracts and pure substances from mixtures of chemical intermediates. Preparative LC-MS systems can be used for rapid mass-directed purification of specific substances from such mixtures that are important in basic research, and pharmaceutical, agrochemical, food, and other industries. Like gas chromatography-mass spectrometry, it allows analysis and detection even of minute amounts of a substance.
- In addition to the increased measurement sensitivity in positive ion mode MS for tags described herein, another important change to the MS results was observed. This was the ability of this tag to generate highly charged ESI ions. For example, as shown in
FIGS. 10 and 12 , ESI generated nonderivatized glycopeptide derived from bovine ribonuclease B generated at 2+ ion while the same glycopeptide following labeling produced at 3+ ion. Similarly, as shown inFIGS. 13 and 14 , ESI generated underivatized glycopeptide from bovine fetuin produced 4+ and 5+ ions. The tagged analogue produced significantly higher amounts of the 4+ ion as well as 6+ and 7+ ions. The 6+ and 7+ were only observed for the derivatized glycopeptide. - The ability of the tag to generate more highly charged ions has favorable implications for tandem MS (or “MSMS”) analyses, particularly, electron transfer dissociation (“ETD”). ETD is a complementary technique to collision-induced dissociation (“CID”) and is often used to fragment peptides that carry labile modifications, such as glycopeptides. However, ETD is limited to an effective mass-to-charge range (m/z). Coon, J. J., Collisions or Electrons? Protein Sequence Analysis in the 21st Century, Anal Chem 2009; 81: 3208-3215. Many underivatized glycopeptides will have ions that fall outside of this rage. However, the ability of the tags described herein to generate more highly charged ions shifts the m/z values of glycopeptides within the effective window for ETD.
- The analysis of peptides with negatively-charged tags requires special conditions for their analysis. High pH conditions should be used during their separations and such methods are not yet as robust as the low pH conditions used for hydrophilic interaction chromatography (“HILIC”) of glycopeptides and reversed-phase columns used in the separation of peptides. Additionally, CID of negatively charged ions generally produces abundant levels of neutral losses and internal fragments which are difficult to interpret. Brinkworth, C. S., et al., Negative Ion Fragmentations of Deprotonated Peptides: Backbone Cleavages Directed Through Both Asp and Glu, Rapid Communications in Mass Spectrometry 2001; 15: 1965-1973; See also, Steinborner, S. T., et al., The Negative Ion Mass Spectra of [M−H]-Ions Derived From Caeridin and Dynastin Peptides, Internal Backbone Cleavages Directed Through Asp and Asn Residues, Rapid Communications in Mass Spectrometry 1997; 11: 253-258. The ETD of negative ions has been demonstrated but is still far from a routine technique. Riley, N. M., et al., The Negative Mode Proteome with Activated Ion Negative Electron Transfer Dissociation (AI-NETD), Mol Cell Proteomics 2015; 14: 2644-2660.
- Mannose 5 (Man5) oligosaccharide was reductively aminated in high yield with either one of two different reagents, 2-aminobenzamide (“2-AB”) and 6-ADEQ (
FIG. 1 ). The resulting labeledmannose 5 species were then separated at equivalent mass loads using hydrophilic interaction liquid chromatography (“HILIC”) and subsequently detected by fluorescence and electrospray ionization (“ESI”) mass spectrometry (“MS”). - A procedure for reductive amination was adapted from Szabo et al to prepare 6-ADEQ labeled
Man 5 oligosaccharide. Szabo et. al., Improved Sample Preparation Method for Glycan Analysis of Glycoproteins by CE-LIF and CE-MS, ELECTROPHORESIS 31, 1389 (2010). For this labeling reaction, 800 pmol of driedMan 5 was reconstituted in 10 μL of 350 mM 6-ADEQ in 1.2M citric acid. Into this solution, 10 μL of 1M sodium cyanoborohydride in tetrahydrofuran was subsequently mixed. The resulting mixture was incubated at 55° C. After 1 hour, the reaction was quenched via addition of 120 μL water. - 2-AB labeled
Man 5 was prepared using a similar reductive amination procedure, specifically a protocol adapted from work by Bigge et al. Nonselective and Efficient Fluorescent Labeling of Glycans Using 2-Amino Benzamide and Anthranilic Acid, Anal Biochem, 230(2), 229 (1995). For this labeling reaction, 800 pmol of driedMan 5 was reconstituted in 20 μL of 350 mM 2-AB and 1M sodium cyanoborohydride in 30:70 acetic acid/dimethylsulfoxide. The resulting mixture was incubated at 55° C. After three hours, the reaction was quenched via addition of 120 μL water. - To benchmark the sensitivity gains afforded by 6-ADEQ, the above-mentioned
Man 5 oligosaccharides were analyzed by HILIC chromatography with an ACQUITY UPLC Glycan BEH Amide column. As they eluted from the column, the different labeled forms ofMan 5 were serially detected by fluorescence and ESI−MS per the experimental conditions listed below. -
-
Column Waters ACQUITY UPLC Glycan BEH Amide 130Å 1.7 μm 2.1 × 50 mm Mobile Phase A 50 mM Ammonium Formate Buffer, pH 4.4 Mobile Phase B Acetonitrile Column 60° C. Temperature Injection Volume l μL Sample 6 pmol/μL Concentration Fluorescence 6-ADEQ Labeled—Ex 370 nm/Em 480 nm (5 Hz) Detection 2-AB Labeled—Ex 330 nm/Em 420 nm (5 Hz) -
-
Time Flow (min) Rate(mL/min) % A % B Curve Initial 0.500 20.0 80.0 Initial 16.00 0.500 45.0 55.0 6 16.30 0.500 100.0 0.0 6 17.30 0.500 100.0 0.0 6 17.60 0.500 20.0 80.0 6 20.00 0.500 100.0 0.0 6 -
-
Polarity ES+ Acquisition: 500-2000 m/z (1 Hz) Capillary (kV) 2.5 Source Temperature (° C.) 120 Sampling Cone 70 Source Offset 50 Desolvation Temperature (° C.) 350 Desolvation Gas Flow (L/Hr) 500 Nebulizer Gas Flow (Bar) 6.0
Data corresponding to this comparison example are portrayed inFIG. 2 . - As such, methods for tagging a glycan or another biopolymer for enhanced mass spectroscopy signal and fluorescence comprising the steps of providing a glycan or another biopolymer containing an aldehyde group and reacting the glycan or biopolymer with an amphipathic compound having a non-polar surface area of more than about 200 Å and having a primary amine group under conditions that can facilitate reductive amination wherein a conjugate of said amphipathic compound and said glycan is formed. In an embodiment, the non-polar surface area is between about 200 Å and about 1000 Å or between about 200 Å and about 600 Å or between about 200 Å and about 500 Å or between about 200 Å and about 500 Å.
- We further propose the use of reagents, such as RapiFluor-MS, that can be used to prepare labeled glycosylamines for hydrophilic interaction chromatography in as little as 30 minutes. Lauber, M. A.; Yu, Y. Q.; Brousmiche, D. W.; Hua, Z.; Koza, S. M.; Magnelli, P.; Guthrie, E.; Taron, C. H.; Fountain, K. J., Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI−MS Detection, Anal Chem 87 (10), 5401-9 (2015). While facilitating fast preparations, RapiFluor-MS also yields inordinate gains in mass spectrometric (MS) sensitivity when glycans are analyzed by positive ion mode electrospray ionization mass spectrometry (ESI+MS).
- The mass spectrometric (MS) response factors of RapiFluor-MS labeled glycans have been benchmarked against other rapid tagging, glycosylamine reagents and their corresponding label moieties, including those that produce benzamide, quinoline, procainamide and procaine derivatives (
FIG. 3A ,FIG. 3B ,FIG. 3C ,FIG. 3D andFIG. 3E ). The results of these experiments show that the RapiFluor-MS label (from Compound 1) gives a ˜600× increase in MS response versus a benzamide label (from Compound 2) and a ˜200× increase in MS response versus a quinoline label (from Compound 3) (FIG. 4A ,FIG. 4B ,FIG. 4C andFIG. 5 ). Moreover, it has also been observed that the RapiFluor-MS label gives a ˜2× increase in MS response versus procainamide and procaine-based labels (fromCompounds FIG. 6A ,FIG. 6B , andFIG. 6C andFIG. 7 ). Additionally, it has been observed that RapiFluor-MS labeled glycans adopt comparatively higher average charge states (FIG. 8A ,FIG. 8B , andFIG. 8C ). - The RapiFluor-MS reagent incorporates an amphipathic label onto glycans that concomitantly increases their hydrophobicity and basicity. As has now been discovered, these characteristics define a unique type of labeled glycan structure that exhibits unprecedented gas phase proton affinity. Importantly, this methodology is not restricted to any one linkage chemistry and can be achieved with various rapid tagging glycosylamine labeling reagents. See e.g., U.S. patent application Ser. Nos. 14/458,760 (published as US2014/0350263) at ¶ [0008]-[0022], [0054]-[182] and [0191] and Ser. No. 15/005,619 (unpublished), incorporated by reference. Instead, this methodology encompasses two chemical aspects that can be imparted by a rapid tagging glycosylamine reagent: hydrophobicity and basicity. Two exemplary formula of rapid tagging glycosylamine labeling reagents include:
-
- wherein
- X=C or N;
- R1 is O═C═N— or
-
- ;
- R2 is independently selected from —H, —C1-C8 alkyl, —C1-C8 cycloalkyl, halo, dialkylamino, CH2-dialkylamino, aminocarbonyl, alkoxycarbonyl, or alkoxy, but not Cl or O═C═N—; and
- R3 and R4 are independently selected from —H, alkyl, alkyl amino, alkylsulfonic acid, alkyl phosphonic acid, wherein either R3 or R4 is alkylamino, alkyl phosphonic acid, or alkylsulfonic acid.
-
- wherein
- m=0−9;
- n=0−9;
- X=C or N
- R1 is O═C═N—, S═C═N—, or
-
- R2 is independently selected from methylene, substituted nitrogen, oxygen, carbonyl, amide, ester, sulfur, sulfoxide, or sulfone;
- R3 and R4 are independently selected from —H, alkyl, alkyl amino, alkylsulfonic acid, alkyl phosphonic acid, wherein either R3 or R4 is alkylamino, alkyl phosphonic acid, or alkylsulfonic acid; and
- R5 is independently selected from —H, —C1-C8 alkyl, —C1-C8 cycloalkyl, halo, dialkylamino, CH2-dialkylamino, aminocarbonyl, alkoxycarbonyl, or alkoxy, but not Cl when R1 is O═C═N—, and when R1 is S═C═N, R5 is H.
- Out of the previously described labels, the RapiFluor-MS label is unique in that it combines a high pKa ionizable group with a large non-polar surface area (
FIG. 9 ). Not surprisingly, the RapiFluor-MS label exhibits the highest non-polar surface area, as is consistent with it also exhibiting the highest ESI+MS response factors. - Therefore, the present methods use a rapid tagging glycosylamine reagent that yields a labeling moiety having both a high pKa (>7) ionizable group and a functionality that affords a comparatively large non-polar surface area. Such rapid tagging glycosylamines reagents are taught in U.S. patent application Ser. No. 14/458,760 (published as US2014/0350263) at ¶ [0008]-[0022], [0054]-[182] and [0191] and Ser. No. 15/005,619 (unpublished), incorporated by reference. The non-polar surface areas of these label moieties are, at a minimum, 10% greater than an analogous procainamide-based label.
- The response factors of N-glycans (glycosylamines) labeled with
Compounds -
FIG. 4A ,FIG. 4B , andFIG. 4C shows the HILIC-MS base peak intensity chromatograms for N-glycans from anti-citrinin murine IgG1 as labeled withCompounds FIG. 5 . - The response factors of N-glycans (glycosylamines) labeled with
Compounds -
FIG. 6A ,FIG. 6B , andFIG. 6C shows the HILIC-MS base peak intensity chromatograms for N-glycans from anti-citrinin murine IgG1 as labeled withCompounds FIG. 7 . - The analysis of glycopeptides provides a wealth of data, including site-specific glycan information. However, glycans are difficult to characterize by routine LC-MS/MS approaches. Their collision-induced dissociation patterns show extensive glycan fragmentation, while the peptide backbone is unaffected. This can be useful for determining the glycan's composition, but hinders a definitive answer regarding its amino acid sequence. However, electron-transfer dissociation can be used for glycopeptide backbone fragmentation, when derivatized to allow higher charge states to be generated shifting their m/z values towards the effective region for ETD. Here, we utilized a rapid tagging molecule developed to improve fluorescent (FLR) and mass spectrometry (MS) performance for glycans, that when used to derivatize glycopeptides shows increased charge states and frequently, enhanced MS detection.
- Glycoproteins were resuspended at 5 μg/μL in phosphate-buffered saline containing 0.1% Rapigest surfactant and 10 mM TCEP. Proteins were denatured at 60° C. for 1 hour (“hr.”) and alkylated for 1 hr. with 25 mM iodoacetamide. Trypsin was added at 1:20 ratio and the proteins were digested for 18 hrs. The derivatization reagent was solubilized in DFM at 100 mg/mL and a 6.5-μL aliquot was added to a 5-μL aliquot of the digest (diluted with 20 μL of 100 mM,
pH 8 phosphate buffer and 6.5 μL of DMF). After 5 minutes, a second 6.5 μL aliquot of the reagent was added. After quenching the reaction with TRIS, the samples were analyzed by optimized hydrophilic interaction liquid chromatography (HILIC)/UPLC-MS. - A successful LC-MS glycopeptide characterization requires optimization of HILILC mobile-phase conditions and derivatization to enhance their ESI-generated charge states. HILIC separation of glycopeptides requires the use of TFA, frequently at 0.1% (v/v) so that the separation is driven more by the glycans than the peptide backbone, therefore, the TFA spiked mobile phase in HILIC mode separates glycopeptide glycoforms more efficiently than reversed phase chromatography. However, including TFA as a modifier leads to decreased MS responses and generates ions with lower charges. The minimum amount of TFA required should be used and the optimized mobile phase conditions were determined to be 0.01% TFA/0.1% formic acid (v/v).
- To generate more highly charged ions, the N-termini and lysine side chains were derivatized with a rapid glycan labelling molecule with a tertiary amino group in a simple one-step reaction. The reagent was directly added to an aliquot of the digest with no sample cleanup. Following the derivatization, ESI generated glycopeptides with additional higher charge states. For example, native glycopeptides of ribonuclease B were observed in the 1+ and 2+ charge states due to the short peptide length, while the derivatized analogues were detected as 2+ and 3+ ions. (
FIG. 10 &FIG. 11 ). ESI of a native fetuin glycopeptide generated 4+ and 5+ ions predominantly, while the derivatized ones were observed as 3+-8+ ions. (FIG. 14 ). Additionally, the MS sensitivity was improved for many glycopeptides, by a factor of 3 to 5× being commonly observed. - The CID spectra of the more highly charged derivatized species were very similar to those of the native analytes. The ETD spectra of the native glycopeptides largely failed to produce significant peptide backbone fragmentation, as the m/z values were beyond the most effective ETD region. However, following derivatization, the ETD spectra appear to show enhanced fragmentation and allowed site-specific information to be obtained.
- Derivatization of glycopeptides to improve their MS sensitivity and enhance charge states with optimized HILIC conditions allow their comprehensive characterization. As shown in
FIGS. 10A and 10B , the comparison demonstrates that the derivatized glycopeptides resulted in mass spectral signals of approximately 203× those of the native glycopeptides. A similar trend was also observed for the integrated peak area. Increasing the signal intensity will increase the ability to detect and characterize low-abundance glycopeptides. - As shown in
FIGS. 10 and 11 , positive-mode ESI produced a 2+ ion for the native analyte, while the derivatized version produced significant amounts of the 3+ ion. We expected to see further charge-state enhancements for larger glycopeptides. Increasing the charge state of glycopeptides will significantly enhance their ETD fragmentation efficiency, allowing scientists to effectively fragment the peptide backbone, while leaving the glycan intact and attached to the peptide.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/734,690 US20220381788A1 (en) | 2016-06-21 | 2022-05-02 | Methods of enhancing ms detection of tagged glycans |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662352734P | 2016-06-21 | 2016-06-21 | |
US201762483015P | 2017-04-07 | 2017-04-07 | |
PCT/US2017/038119 WO2017222975A1 (en) | 2016-06-21 | 2017-06-19 | Methods of enhancing ms detection of tagged glycans |
US201816312800A | 2018-12-21 | 2018-12-21 | |
US17/734,690 US20220381788A1 (en) | 2016-06-21 | 2022-05-02 | Methods of enhancing ms detection of tagged glycans |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2017/038119 Continuation WO2017222975A1 (en) | 2016-06-21 | 2017-06-19 | Methods of enhancing ms detection of tagged glycans |
US16/312,800 Continuation US11353461B2 (en) | 2016-06-21 | 2017-06-19 | Methods of enhancing MS detection of tagged glycans |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220381788A1 true US20220381788A1 (en) | 2022-12-01 |
Family
ID=60784923
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/312,800 Active 2037-10-30 US11353461B2 (en) | 2016-06-21 | 2017-06-19 | Methods of enhancing MS detection of tagged glycans |
US17/734,690 Pending US20220381788A1 (en) | 2016-06-21 | 2022-05-02 | Methods of enhancing ms detection of tagged glycans |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/312,800 Active 2037-10-30 US11353461B2 (en) | 2016-06-21 | 2017-06-19 | Methods of enhancing MS detection of tagged glycans |
Country Status (4)
Country | Link |
---|---|
US (2) | US11353461B2 (en) |
EP (1) | EP3471728A4 (en) |
CN (1) | CN109640994A (en) |
WO (1) | WO2017222975A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109541115B (en) * | 2018-11-28 | 2021-04-20 | 西北大学 | High-resolution sequential separation and accurate quantitative analysis method for sialylated sugar chain isomers |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120107942A1 (en) * | 2008-02-04 | 2012-05-03 | Prozyme, Inc. | Compounds and methods for rapid labeling of n-glycans |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009073975A1 (en) * | 2007-12-10 | 2009-06-18 | National Research Council Of Canada | Production of recombinant interferon proteins |
US11352325B2 (en) * | 2011-09-28 | 2022-06-07 | Waters Technologies Corporation | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals |
US10416166B2 (en) * | 2011-09-28 | 2019-09-17 | Waters Technologies Corporation | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals |
JP6774748B2 (en) * | 2014-08-13 | 2020-10-28 | ウオーターズ・テクノロジーズ・コーポレイシヨン | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals |
CN115753702A (en) * | 2014-10-30 | 2023-03-07 | 沃特世科技公司 | Method for rapid preparation of labeled glycosylamines and analysis of glycosylated biomolecules producing said labeled glycosylamines |
-
2017
- 2017-06-19 EP EP17816001.6A patent/EP3471728A4/en active Pending
- 2017-06-19 WO PCT/US2017/038119 patent/WO2017222975A1/en unknown
- 2017-06-19 CN CN201780051071.6A patent/CN109640994A/en active Pending
- 2017-06-19 US US16/312,800 patent/US11353461B2/en active Active
-
2022
- 2022-05-02 US US17/734,690 patent/US20220381788A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120107942A1 (en) * | 2008-02-04 | 2012-05-03 | Prozyme, Inc. | Compounds and methods for rapid labeling of n-glycans |
Also Published As
Publication number | Publication date |
---|---|
WO2017222975A1 (en) | 2017-12-28 |
US20190219587A1 (en) | 2019-07-18 |
CN109640994A (en) | 2019-04-16 |
US11353461B2 (en) | 2022-06-07 |
EP3471728A1 (en) | 2019-04-24 |
EP3471728A4 (en) | 2020-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11352325B2 (en) | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | |
US11448652B2 (en) | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | |
EP3309549B1 (en) | Rapid fluorescence tagging of glycans and other biomolecules with enhanced ms signals | |
JP7055634B2 (en) | Rapid Preparation of Labeled Glycosylamines and Analytical Methods for Glycosylated Biomolecules Producing It | |
EP2990401A1 (en) | Rapid fluorescence tagging of glycans and other biomolecules with enhanced mass spectrometry signals | |
US20220381788A1 (en) | Methods of enhancing ms detection of tagged glycans | |
Zheng et al. | Combination of β-elimination and liquid chromatography/quadrupole time-of-flight mass spectrometry for the determination of O-glycosylation sites | |
US20230096494A1 (en) | Isobaric Multiplex Reagents for Carbonyl Containing Compound High-Throughput Quantitative Analysis | |
US11061023B2 (en) | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | |
Smolkova et al. | Synthesis and application of BODIPY-based fluorescent labeling tag for oligosaccharide and N-linked glycan analysis by high-performance liquid chromatography with fluorescence detection | |
WO2017132177A1 (en) | Rapid fluorescence tagging of glycans and other biomolecules with enhanced ms signals | |
Wu et al. | Characterization of protein therapeutics by mass spectrometry | |
Huang | New approaches for quantitative analysis of glycopeptides using liquid chromatography-mass spectrometry | |
Zhang et al. | High sensitivity profiling of N-glycans from mouse serum using fluorescent imidazolium tags by HILIC electrospray ionisation spectrometry | |
Dalpathado | Analysis of glycans and glycoproteins by mass spectrometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WATERS TECHNOLOGIES CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BROUSMICHE, DARRYL W.;LAUBER, MATTHEW A.;REEL/FRAME:059795/0130 Effective date: 20210210 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |